WO2023058760A1 - Storage device - Google Patents

Storage device Download PDF

Info

Publication number
WO2023058760A1
WO2023058760A1 PCT/JP2022/037681 JP2022037681W WO2023058760A1 WO 2023058760 A1 WO2023058760 A1 WO 2023058760A1 JP 2022037681 W JP2022037681 W JP 2022037681W WO 2023058760 A1 WO2023058760 A1 WO 2023058760A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
water
soluble
implant
oily
Prior art date
Application number
PCT/JP2022/037681
Other languages
French (fr)
Japanese (ja)
Inventor
慶一 今井
優芽 芹川
賢洋 兒玉
真一 岡本
Original Assignee
凸版印刷株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 凸版印刷株式会社 filed Critical 凸版印刷株式会社
Publication of WO2023058760A1 publication Critical patent/WO2023058760A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds

Definitions

  • the present disclosure relates to a containment device used to place an object in vivo.
  • the cell group When placing the cell group in the body, the cell group is held with instruments such as tweezers and syringes, the surface of the tissue of the body is cut, and the instrument is inserted into the tissue. After placement of the cell population, the instrument is then withdrawn from the tissue.
  • instruments such as tweezers and syringes
  • the instrument After placement of the cell population, the instrument is then withdrawn from the tissue.
  • the instrument when the instrument is pulled out from the tissue, the cell group may sometimes come out of the tissue together with the instrument, which leads to a decrease in transplantation efficiency.
  • a storage device for solving the above problems is a storage device used for arranging an object in a living body, and is a needle-like body having a needle-like portion having a shape capable of piercing the living body,
  • the needle-shaped body is configured to hold the object inside the needle-shaped portion, and the material of the needle-shaped body includes a water-soluble material and a poorly water-soluble material. .
  • FIG. 4 is a diagram showing another example of the cross-sectional structure of the cell transplantation unit according to the first embodiment
  • FIG. 2 is a diagram showing a cross-sectional structure of a cell transplantation unit having a plurality of needle-like portions according to the first embodiment
  • FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment
  • FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment
  • FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment
  • FIG. 4 is a diagram showing a manufacturing process of the cell transplantation unit of the first embodiment
  • FIG. 4 is a diagram showing a manufacturing process of the cell transplantation unit of the first embodiment
  • FIG 4 is a diagram showing a manufacturing process of the cell transplantation unit of the first embodiment;
  • FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment;
  • FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment;
  • FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment;
  • FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment;
  • FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment;
  • FIG. 1 A first embodiment of a containing device, a cell transplantation unit, and a method for manufacturing the containing device will be described with reference to FIGS. 1 to 8.
  • FIG. The cell transplantation unit of the present embodiment is used for placing an object such as a group of cells in vivo.
  • the area in which the object is placed is within the tissue of the living body, for example, at least one of intradermal and subcutaneous, or an organ or the like.
  • the term “living body” includes not only the body and tissues of living organisms, but also biological models, which are artificial products simulating the bodies and tissues of living organisms.
  • the cell transplantation unit of the present embodiment can be used not only for arranging an object on an organism, but also for arranging an object on a biological model.
  • the statement "at least one of A and B" should be understood to mean “only A, or only B, or both A and B.”
  • the cell transplantation unit 10 has a needle-like portion 20 extending into a shape capable of being pierced into a living body.
  • the needle-like portion 20 holds an implant 50, which is an example of an object, inside thereof.
  • Needle-like part 20 is an example of a needle-like object.
  • the cell transplantation unit 10 preferably includes a support plate portion 30 that supports the proximal end of the needlelike portion 20 .
  • the support plate portion 30 is plate-shaped and has a first surface 31F and a second surface 31R opposite to the first surface 31F.
  • the needle-like part 20 is extended from the 1st surface 31F.
  • the needle-like portion 20 or the structure including the needle-like portion 20 and the support plate portion 30 is an example of a containing device configured to be able to contain an object.
  • the needle-like portion 20 may have any shape as long as it can pierce the tissue in which the implant 50 is placed. From the viewpoint of increasing the ease with which the needle-like portion 20 can be stuck into the living body, it is preferable that the needle-like portion 20 has a shape that extends along one direction and that the tip of the needle-like portion 20 is sharp.
  • the direction in which the needle-like portion 20 extends may be a direction orthogonal to the first surface 31F of the support plate portion 30, or may be a direction inclined with respect to the first surface 31F.
  • the needle-like portion 20 may have a shape such as a conical shape or a pyramidal shape in which the cross-sectional area decreases from the proximal end to the distal end.
  • the needle-like portion 20 has a shape obtained by cutting a cylinder obliquely to the direction in which it extends, or a shape in which a cone extends from the upper surface of the cylinder. , may have a shape in which the cross-sectional area decreases toward the tip.
  • the needle-like portion 20 may have a blade-like structure at its tip.
  • the distal end portion of the needle-like portion 20 may have a curved shape, or the needle-like portion 20 may have a circular shape. It may have a shape with a blunt tip, such as a columnar shape or a prismatic shape.
  • the length of the needle portion 20 is, for example, 200 ⁇ m or more and 2 mm or less, and the maximum value of the outer diameter of the needle portion 20 is, for example, 100 ⁇ m or more and 1 mm or less.
  • the needle-like portion 20 and the support plate portion 30 may be integrally formed from the same material, or may be formed separately and joined together. Further, the support plate portion 30 includes a first plate-like portion integrally formed with the needle-like portion 20 and continuing from the proximal end of the needle-like portion 20, and a second plate joined to the first plate-like portion. It may be a laminate comprising a shape portion.
  • the transplant 50 is embedded inside the needle-like portion 20.
  • the needle-like portion 20 has a receiving hole 25 which is a hole recessed inward from the proximal end of the needle-like portion 20. and the implant 50 may be accommodated in the accommodation hole 25 .
  • the housing hole 25 opens at the proximal end of the needle-like portion 20 .
  • the opening of the accommodation hole 25 is closed by the support plate portion 30 .
  • the shape and size of the accommodation hole 25 are not particularly limited as long as the implant 50 can be accommodated therein.
  • the accommodating hole 25 extends with a constant inner diameter from the opening located at the proximal end of the needle-like portion 20 and then decreases in diameter toward the bottom of the accommodating hole 25 .
  • the sectional shape of the receiving hole 25 along the direction perpendicular to the extending direction of the needle-like portion 20 is circular, and the bottom of the receiving hole 25 is a curved surface.
  • the side surface of the accommodation hole 25 may be an inclined surface, and the inner diameter of the accommodation hole 25 may gradually change from the opening.
  • the bottom surface of the accommodation hole 25 may be flat.
  • the accommodation hole 25 accommodates an auxiliary liquid 51, which is a fluid for maintaining the activity of cells in the accommodation hole 25 and assisting the engraftment of the cells after being placed in the living body.
  • the implant 50 is surrounded by an auxiliary liquid 51 within the receiving hole 25 .
  • the auxiliary liquid 51 does not have to surround the entire periphery of the implant 50.
  • the implant 50 is arranged at the bottom of the receiving hole 25, and the auxiliary liquid 51 is not present in the region from the top of the implant 50 to the opening. may cover the implant 50 .
  • FIG. 3 shows a cell transplantation unit 10C, which is another example of the cell transplantation unit 10.
  • the cell transplantation unit 10 may have multiple needle-like parts 20 .
  • An implant 50 is held in each needle 20 .
  • an assembly of the plurality of needle-like portions 20 is formed. That is, one common support plate portion 30 is arranged for a plurality of needle-like portions 20 .
  • the needle-like portions 20 may be arranged regularly or may be arranged irregularly.
  • the plurality of needle-like portions 20 may be arranged in one row, or may be arranged in a plurality of rows so that each needle-like portion 20 is positioned at each lattice point of a square lattice or a triangular lattice.
  • the intervals between the needle-like portions 20 adjacent to each other may be constant or may not be constant. Since the cell transplantation unit 10 has a plurality of needle-like portions 20, a plurality of transplants 50 can be collectively placed in the living body.
  • Implant 50 includes a group of cells.
  • a cell group contains a plurality of cells.
  • a population of cells includes one or more clusters of cells.
  • a cell mass is an aggregate of multiple cells.
  • a cell cluster may be an aggregate of a plurality of aggregated cells, or an aggregate of a plurality of cells bound by intercellular junctions.
  • the cell population may consist of a plurality of dispersed cells.
  • the cells that constitute the cell group may be undifferentiated cells or cells that have completed differentiation, and the cell group includes undifferentiated cells and differentiated cells. good too.
  • the cell group is, for example, a cell cluster that is a spheroid, an primordium, a tissue, an organ, an organoid, a mini-sized organ, or the like.
  • a group of cells has the ability to affect tissue formation in the body by being placed in the body.
  • One example of such cell populations are cell aggregates containing cells with stemness.
  • the cell group contributes to hair growth or growth, for example, by being placed intradermally or subcutaneously.
  • the cell group has the ability to function as a hair follicle organ, the ability to differentiate into the hair follicle organ, the ability to induce or promote the formation of the hair follicle organ, or the ability to induce or promote the formation of hair in the hair follicle organ.
  • the cell group may also contain cells that contribute to the control of coat color, such as pigment cells or stem cells that differentiate into pigment cells.
  • the cell group may contain vascular cells.
  • a specific example of a cell group is an organ primordium.
  • the organ primordium contains mesenchymal and epithelial cells.
  • organ primordium include cell groups such as hair follicle primordium that differentiates into hair follicle organ, liver primordium, kidney primordium, pancreatic primordium, nervous system primordium cells, and vascular system primordium cells. is.
  • the hair follicle primordium contains a cell mass composed of mesenchymal cells and a cell mass composed of epithelial cells, and these two types of cell masses are in contact with each other.
  • dermal papilla cells contained in the mesenchymal cell mass induce differentiation of hair follicle epithelial stem cells contained in the epithelial cell mass, and hair matrix cells are formed in the hair bulb formed by this. Hair is formed by repeated division of .
  • a hair follicle primordium is a group of cells that differentiate into such hair follicle organs.
  • mesenchymal cells derived from mesenchymal tissue such as dermal papilla
  • the method for producing the hair follicle primordia is not limited to the above examples.
  • the origin of the mesenchymal cells and epithelial cells used for the production of the hair follicle primordium is not limited, and these cells may be cells derived from the hair follicle organ. Cells derived from different organs may be used, or cells derived from pluripotent stem cells may be used.
  • the cell masses may also contain cell masses that contribute to engraftment and functional improvement.
  • Examples of such cell clusters are cell clusters involved in hair color, cell clusters containing vascular cells, and cell clusters that release growth factors.
  • the implant 50 may contain a member that assists the transplantation and engraftment of the cell group, and a gel-like body that protects the cell group.
  • a member that assists transplantation or engraftment of cell groups is gel beads that slowly release growth factors.
  • the auxiliary liquid 51 may be a component that does not easily inhibit the survival of cells, and is preferably a component that has a small effect on the living body when injected into the living body.
  • the auxiliary liquid 51 surrounds the implant 50 and suppresses contact and friction between the implant 50 and the inner surface of the receiving hole 25 , thereby helping to maintain the activity of the implant 50 .
  • the implant 50 contains a component close to the body fluid of the living body to wrap the implant 50 or provide nutrition to the implant 50, thereby assisting the maintenance of the activity of the implant 50 and engraftment. good too.
  • the auxiliary liquid 51 is, for example, a physiological saline solution, a substance that protects the skin such as vaseline or lotion, or a mixture thereof.
  • the auxiliary liquid 51 may contain nutritional components and components such as oxygen necessary for cell survival.
  • the auxiliary liquid 51 may be a medium for culturing cells.
  • the auxiliary liquid 51 can be a low viscosity fluid or a high viscosity fluid.
  • the auxiliary liquid 51 may be a sol or gel.
  • the needle-like portion 20 contains a water-soluble material and an oily material, and loses its shape due to dissolution, melting, or decomposition of these materials in vivo. In other words, the needle-like portion 20 dissolves in vivo. In the needle-like portion 20, the water-soluble material and the oily material are uniformly mixed. In other words, the material of needle 20 is a mixture of water-soluble material and oily material.
  • the water-soluble material preferably has biocompatibility.
  • a specific example of a water-soluble material is a water-soluble polymer.
  • Water-soluble polymers used as main components of water-soluble materials are, for example, hydroxypropylcellulose, pullulan, pectin, sodium chondroitin sulfate, dextran, collagen, atelocollagen, hyaluronic acid, and sodium hyaluronate. Needles 20 may contain more than one type of water-soluble material.
  • the oily material is water-insoluble. Specific examples of oily materials are vegetable oils, animal oils, mineral oils, and oils synthesized using these as raw materials.
  • the oily material should be a material that is unlikely to harm the living body, that is, a material that is unlikely to cause damage such as severe inflammation when in contact with the living body, and that does not have serious toxicity to tissues such as organs. is preferred.
  • Oily materials are, for example, olive oil, rapeseed oil, palm oil, squalane, vaseline, paraffin, and hard fat. Needle 20 may contain more than one type of oily material.
  • the oily material is preferably solid or semi-solid such as cream at room temperature.
  • the melting point of the oily material is, for example, preferably 15° C. or higher and 70° C. or lower, and more preferably 30° C. or higher and 40° C. or lower. If the melting point of the oil-based material is within the above range, the oil-based material is prevented from becoming liquid at room temperature, and thus the needle-like portion 20 can be easily maintained in a desired shape before use. On the other hand, since the temperature in the living body makes the oily material more likely to be liquefied, it is possible to prevent the needle-like portion 20 from remaining in the living body for a long period of time.
  • the ratio of the oily material to the total mass of the needle-like portion 20 is preferably 1% by mass or more and 60% by mass or less. Moreover, the ratio of the water-soluble material to the total mass of the needle-like portion 20 is preferably 40% by mass or more and 99% by mass or less. If the ratio of the oil-based material is 60% by mass or less and the ratio of the water-soluble material is 40% by mass or more, the strength of the needle-like portion 20 can be appropriately obtained. In addition, it becomes easier to mix the water-soluble material and the oily material, and it becomes easier to form the needle-like portion 20 into a desired shape.
  • the ratio of the oily material is 1% by mass or more and the ratio of the water-soluble material is 99% by mass or less, rapid dissolution of the needle-like portion 20 upon contact between the living body and the needle-like portion 20 can be suppressed.
  • the needle-like portion 20 may further contain an additive having a component that contributes to shaping of the needle-like portion 20 or maintenance of cell activity and engraftment.
  • the needle-like portion 20 may contain a surfactant or an emulsifier as an additive for facilitating the formation of the needle-like portion 20 .
  • the oil-based material is a material with a high melting point, such as vaseline
  • the addition of a surfactant makes it easier to mix the water-soluble material and the oil-based material.
  • sucrose fatty acid ester is preferably used as the surfactant.
  • a ratio of the surfactant to the total mass of the needle-like portion 20 is preferably 0.1% by mass or more and 5% by mass or less.
  • the content of palm oil in the needle-like portion 20 is preferably 1% by mass or more and 30% by mass or less.
  • the needle-like portion 20 contains petrolatum and sucrose fatty acid ester, and the content of petroleum jelly in the needle-like portion 20 is 5% by mass or more and 40% by mass or less, and sucrose It is preferable that the content of the fatty acid ester is 0.5% by mass or more and 2% by mass or less. Such a configuration makes it easier to form the needle-like portion 20 into a desired shape.
  • needle-like portion 20 may contain in addition to the materials described above include, for example, hydroxypropylmethylcellulose, dextrin, starch, cellulose, chitosan, pectic acid, galactan, chondroitin sulfate, carboxymethylcellulose, methylcellulose, ethylcellulose, hydroxyethylcellulose, and polyvinyl alcohol.
  • the needle-like portion 20 is transparent because the state of the implant 50 in the needle-like portion 20 can be easily confirmed from the outside.
  • the material of the support plate portion 30 may be the same as that of the needle-like portion 20 or may be different from that of the needle-like portion 20 . Further, the support plate portion 30 may or may not have the property of dissolving in water. For example, the support plate portion 30 may contain only the water-soluble material or both the water-soluble material and the oil-based material, out of the water-soluble material and the oil-based material. Alternatively, the support plate portion 30 may be made of a material different from both the water-soluble material and the oil-based material.
  • the above various materials exemplified as the material of the needle portion 20 are used.
  • a resin sheet made of a biocompatible resin may be used as the support plate portion 30 .
  • the needle-like portion 20 dissolves in water.
  • An object such as the needle-like portion 20 or the support plate portion 30 dissolves in water means that when the object is immersed in stirring water at 25° C. for 5 minutes, the weight of the object in the water is reduced. , means that 0.05% or more is eluted.
  • a method of placing the implant 50 in vivo using the cell transplantation unit 10, that is, a method of implanting the implant 50 will be described with reference to FIGS. 4 to 6.
  • FIG. The method of placing the implant 50 is, in other words, the method of using the cell transplantation unit 10 .
  • the needle-like portion 20 of the cell transplantation unit 10 is pressed against the target tissue Sk in which the implant 50 is to be placed, thereby piercing the target tissue Sk with the needle-like portion 20 .
  • the target tissue Sk is, for example, skin.
  • an applicator may be used that assists the needle-like portion 20 to enter the target tissue Sk by adjusting the force applied to the needle-like portion 20 and the direction of the needle-like portion 20 .
  • the support plate portion 30 is arranged on the surface of the target tissue Sk without entering the inside of the target tissue Sk.
  • the needle-like portion 20 when the needle-like portion 20 enters the target tissue Sk, the needle-like portion 20 comes into contact with moisture in the tissue, and the needle-like portion 20 reaches a temperature close to the body temperature of the living body. Due to being warmed, the needle-like portion 20 melts.
  • the support plate portion 30 When the support plate portion 30 has the property of dissolving in water, the support plate portion 30 also dissolves due to the contact between the support plate portion 30 and the moisture on the surface of the target tissue Sk. If the support plate portion 30 does not have the property of dissolving in water, the support plate portion 30 is peeled off from the surface of the target tissue Sk. The peeling of the support plate portion 30 may be performed before the needle-like portion 20 is completely melted, or may be performed after the needle-like portion 20 is completely melted. If the support plate portion 30 is in a form that dissolves, the support plate portion 30 does not need to be peeled off, and the labor required for using the cell transplantation unit 10 is reduced.
  • the needle-like portion 20 melts and deforms, the needle-like portion 20 collapses and disappears, exposing the implant 50 held inside the needle-like portion 20 to expose the target tissue Sk. kept inside.
  • the auxiliary liquid 51 when the auxiliary liquid 51 is contained together with the implant 50 , the auxiliary liquid 51 also permeates the tissue around the implant 50 . Components of the needle-like portion 20 are diffused and absorbed in the living body. This completes the placement of the implant 50 in vivo.
  • the implant 50 is inserted into the living body while being held by the needle-like portion 20, and the needle-like portion 20 disappears into the living body. placed. Therefore, since an instrument such as tweezers is not pulled out of the living body when the implant 50 is placed in the living body, the implant 50 is prevented from coming out of the living body together with the instrument. Therefore, the placement efficiency of the implant 50 is enhanced, and the placement depth of the implant 50 within the tissue of the living body can be easily controlled to a desired depth.
  • the implant 50 is inserted into the living body while being held inside the needle-like portion 20, it is possible to protect the implant 50 from impact during insertion. Compared to the case where the implant is inserted into the living body, it becomes easier to grasp the implantation site of the implant 50 when viewed from the outside.
  • the needle-like portion 20 when the needle-like portion 20 is formed only from a water-soluble material, dissolution of the needle-like portion 20 progresses rapidly from the time the needle-like portion 20 comes into contact with the surface of the living body. Such dissolution of the needle-like portion 20 progresses from the tip portion of the needle-like portion 20 that first comes into contact with the living body. Therefore, before the distal end of the needle-like portion 20 reaches a desired depth, the shape of the distal end may be lost, making it difficult for the needle-like portion 20 to enter the tissue. Further, when the base of the needle-like portion 20 dissolves, the force that presses the cell transplantation unit 10 is less likely to be transmitted to the needle-like portion 20, which also makes it difficult for the needle-like portion 20 to enter the tissue. obtain. As a result, the needle-like portion 20 may not penetrate to the desired depth, and placement of the implant 50 into the living body may be hindered.
  • the needle-like portion 20 contains an oil-based material in addition to the water-soluble material, the needle-like portion 20 is more dense than the case where the needle-like portion 20 is made of only the water-soluble material.
  • the collapse of the shape progresses gently.
  • the ratio of the oil-based material in the needle-like portion 20 is about 50% by mass, the time required for the needle-like portion 20 to completely lose its shape is 1.2 times to 10 times of Therefore, at the initial stage when the needle-like part 20 enters the living body, the shape of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stabbed to a desired depth. Therefore, it becomes easier to place the implant 50 at the desired depth.
  • the speed at which the needle-like portion 20 dissolves can be adjusted by the types of the water-soluble material and the oil-based material, and the ratio of the oil-based material.
  • the needle portion 20 is melted.
  • the surface of the target tissue Sk where the needle-like portion 20 is stuck is covered with the support plate portion 30 . Therefore, the needle-like portion 20 and the implant 50 are prevented from slipping out of the target tissue Sk even when receiving an external impact.
  • the speed at which the support plate portion 30 dissolves can be adjusted by the material of the support plate portion 30 .
  • the support plate portion 30 contains the same types of water-soluble material and oily material as the needle-like portion 20, and the ratio of the oily material in the support plate portion 30 and the ratio of the oily material in the needle-like portion 20 are different from each other, the melting speed of the support plate portion 30 and the melting speed of the needle-like portion 20 can be made different.
  • the proportion of the oily material in each needle-like portion 20 may not be constant. That is, the first needle-like portion 20 and the second needle-like portion 20 are included in the plurality of needle-like portions 20, and the ratio of the oily material in the first needle-like portion 20 and the second needle-like portion 20 may differ from each other. According to such a configuration, the first needle-like portion 20 and the second needle-like portion 20 can have different times required for the shape to disappear. Furthermore, the oily material contained in the first needle-like portion 20 and the oily material contained in the second needle-like portion 20 may be different from each other. Moreover, the cell transplantation unit 10 may have a needle-like portion that does not contain an oily material.
  • FIG. 7 A method for manufacturing the cell transplantation unit 10 will be described with reference to FIGS. 7 and 8.
  • FIG. 7 the needle-shaped portion 20 is formed by filling an intaglio 80 having recesses 81 corresponding to the desired shape of the needle-shaped portion 20 with a needle-shaped portion forming liquid, which is a liquid containing the material of the needle-shaped portion 20 . and formed by solidifying the filling.
  • the implant 50 is placed inside the needle 20 from a tray such as a culture vessel after solidification of the filler.
  • the needle-shaped portion forming liquid is produced by, for example, dissolving a water-soluble material in a solvent such as water, and then mixing the solution with an oily material.
  • the material may be heated when generating the needle-shaped portion forming liquid. Solidification of the filling may be performed by drying, or ultraviolet rays or heat may be used.
  • the accommodating hole 25 When forming the accommodation hole 25 , by controlling the filling and solidification of the needle-shaped portion forming liquid so that air bubbles gather in the central portion of the filling that becomes the needle-shaped portion 20 , a void is formed inside the needle-shaped portion 20 . is formed. Accordingly, the accommodating hole 25, which is the gap, can be formed. Alternatively, a pin-shaped structure having a shape corresponding to the receiving hole 25 may be inserted into the central portion of the filling and removed after the filling is solidified. As a result, a gap, which is the receiving hole 25, can be formed in the portion where the pin-shaped structure was positioned.
  • the support plate portion 30 is arranged on the surface positioned at the proximal end of the needle portion 20, and the needle portion 20 and the support plate portion 30 are joined.
  • the support plate portion 30 is formed, for example, by sandwiching the material of the support plate portion 30 between two plate-like members and solidifying the material.
  • the support plate portion 30 may be joined with an adhesive, or may be joined by heat welding or welding using ultrasonic vibration. Moreover, the needle-like portion 20 may be softened by heat or the like when the support plate portion 30 is joined. By releasing the needle-like portion 20 from the intaglio 80, the cell transplantation unit 10 is obtained. The release may be performed before the support plate portion 30 is joined.
  • the manufacturing method of the cell transplantation unit 10 may be different from the manufacturing method described above.
  • a concave portion corresponding to the support plate portion 30 may be provided in the intaglio 80, and the support plate portion 30 may be formed by filling the concave portion with the material of the support plate portion 30 and solidifying the material.
  • the implant 50 is inserted into the living body while being held by the needle-like portion 20, and is arranged in the living body by the needle-like portion 20 melting. Therefore, since the implant 50 is prevented from coming out of the living body, the placement efficiency of the implant 50 is enhanced, and the placement depth of the implant 50 in the tissue of the living body can be controlled to a desired depth.
  • needle-like portion 20 contains a water-soluble material and an oily material, rapid dissolution of needle-like portion 20 is suppressed. Therefore, at the initial stage when the needle-like part 20 enters the living body, the shape of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stabbed to a desired depth. Therefore, it becomes easier to place the implant 50 at the desired depth.
  • the water-soluble material contains a water-soluble polymer
  • the oily material contains at least one of vegetable oil, animal oil, mineral oil, and oil synthesized using these as raw materials. According to such a configuration, the needle-like portion 20 that is gently dissolved in the living body is preferably realized.
  • the ratio of the oily material in the needle-like portion 20 is 60% by mass or less, the strength of the needle-like portion 20 can be appropriately obtained. Further, it becomes easy to mix the water-soluble material and the oil-based material to form the needle-like portion 20 into a desired shape.
  • the water-soluble material and the oily material are uniformly mixed in the needle-like portion 20, rapid dissolution of the needle-like portion 20 can be suppressed in the entire needle-like portion 20.
  • the material of the needle-like portion 20 contains a surfactant, the water-soluble material and the oil-soluble material can easily be mixed even when the melting point of the oil-soluble material is high.
  • the support plate portion 30 contains a water-soluble material and an oily material, the support plate portion 30 melts when the support plate portion 30 comes into contact with the surface of the living body. This eliminates the need to peel off the support plate portion 30 , thereby reducing the labor required for using the cell transplantation unit 10 .
  • the melting speed of the support plate portion 30 can be adjusted by containing the oily material.
  • the dissolving speed of the support plate portion 30 can be made different from the dissolving speed of the needle-like portion 20. can.
  • the cell transplantation unit 10 has a plurality of needle-like portions 20 and the ratio of the oily material in the first needle-like portion 20 is different from the ratio of the oily material in the second needle-like portion 20,
  • the melting speed of the first needle-like portion 20 can be made different from the melting speed of the second needle-like portion 20 .
  • FIG. 9 A second embodiment of the containing device, the cell transplantation unit, and the manufacturing method of the containing device will be described with reference to FIGS. 9 to 11.
  • FIG. 9 the configuration of the needle-like portion is different from that in the first embodiment.
  • the configuration of the implant and the placement of the implant in the second embodiment are the same as in the first embodiment.
  • the differences between the second embodiment and the first embodiment will be mainly described, and the same reference numerals will be given to the same configurations as in the first embodiment, and the description thereof will be omitted.
  • the concentration of the oily material is uneven in the needle-like portion 20 of the cell transplantation unit 11 of the second embodiment.
  • the needle-like portion 20 has a water-soluble portion 21 and an oily portion 22 .
  • Needle-like part 20 is an example of a needle-like object.
  • the water-soluble part 21 contains a water-soluble material
  • the oily part 22 contains an oily material. Materials exemplified in the first embodiment are used as the water-soluble material and the oily material.
  • the configuration of the support plate portion 30 is the same as that of the first embodiment. Also, placement of the transplant 50 in vivo using the cell transplantation unit 11 of the second embodiment is performed in the same procedure as in the first embodiment.
  • the oily part 22 covers the surface of the water-soluble part 21 .
  • the water-soluble portion 21 has a shape capable of piercing a living body, like the needle-like portion 20 of the first embodiment.
  • the implant 50 is held in the water-soluble portion 21 .
  • the transplant 50 may be housed in the housing hole formed in the water-soluble portion 21, as in the cell transplantation unit 10B of the first embodiment.
  • the cell transplantation unit 11A of the first example when the needle-shaped part 20 is pierced into the living body, the water-soluble part 21 becomes difficult to come into contact with water until the oily part 22 dissolves. Therefore, the start of dissolution of the water-soluble portion 21 can be delayed compared to the case where the entire needle-like portion 20 is the water-soluble portion 21 . Therefore, in the initial period after the needle-like portion 20 has entered the living body, the needle-like portion 20 can easily stick to the living body to a desired depth because the shape of the needle-like portion 20 can easily be maintained. Therefore, it becomes easier to place the implant 50 at the desired depth.
  • the oily part 22 may cover only part of the surface of the water-soluble part 21 .
  • the shape of the tip of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stuck to a desired depth. .
  • the water-soluble portion 21 is formed. It can be formed by filling the material to form the water-soluble portion 21 .
  • the oily portion 22 may be formed by coating the surface of the water-soluble portion 21 with the material for the oily portion 22 .
  • the portion other than the oily portion 22 is the water-soluble portion 21 , and the tip portion of the needle-like portion 20 is included in the water-soluble portion 21 .
  • the oily portion 22 may be in contact with the support plate portion 30 or may be surrounded by the water-soluble portion 21 at the base of the needle-like portion 20 .
  • FIG. 10 shows a configuration in which the oily portion 22 is surrounded by the water-soluble portion 21 and the support plate portion 30. The entire base of is the oily part 22 , and the oily part 22 may be exposed on the surface of the needle-like part 20 .
  • the implant 50 may be held by the water-soluble portion 21 or may be held by the oily portion 22 .
  • the implant 50 is accommodated in the accommodation hole formed in the water-soluble portion 21 and the oily portion 22 or the accommodation hole formed in the oily portion 22.
  • the base of the needle-like portion 20 is It takes longer to dissolve. Therefore, it is suppressed that the base portion of the needle-like portion 20 rapidly dissolves and the force that presses the cell transplantation unit 11 is less likely to be transmitted to the needle-like portion 20 . Therefore, the needle-like portion 20 can easily stick to a desired depth.
  • the implant 50 may receive pressure from the liquid that is the dissolved base.
  • the oily part 22 in the base of the needle-like part 20 such sudden pressure on the implant 50 is also suppressed.
  • the shape of the base portion of the needle-like portion 20 is easily maintained, the position where the needle-like portion 20 is stuck can be easily visually recognized due to liquefaction or peeling of the support plate portion 30 .
  • the material of the oily portion 22 is formed. to form the oily part 22 .
  • FIG. 11 shows a cell transplantation unit 11C of the third example.
  • the cell transplantation unit 11C may include the oily part 22 at the distal end of the needle-like part 20, as shown in FIG.
  • the portion other than the oily portion 22 is the water-soluble portion 21 , and the base portion of the needle-like portion 20 is included in the water-soluble portion 21 .
  • the implant 50 may be held by the water-soluble portion 21 or may be held by the oily portion 22 .
  • the implant 50 is accommodated in the accommodation hole formed in the water-soluble portion 21 or the accommodation hole formed in the water-soluble portion 21 and the oily portion 22. may be
  • the tip portion of the needle-like portion 20 It becomes easy to keep the shape of Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
  • the material for the water-soluble portion 21 is added. It can be formed by filling to form the water-soluble portion 21 .
  • the position of the oily portion 22 is the same as in the first to third examples described above. can be different.
  • the oily part 22 may be located in the central part of the needle-like part 20 , or the needle-like part 20 may have a plurality of oily parts 22 separated from each other within the needle-like part 20 .
  • the water-soluble part 21 may not contain an oily material, or may contain an oily material mixed with a water-soluble material.
  • the oily part 22 may not contain a water-soluble material, or may contain a water-soluble material in a state of being mixed with the oily material.
  • the mass ratio of the oily material in the oily portion 22 is greater than the mass ratio of the oily material in the water-soluble portion 21 . That is, the concentration of the oily material is higher in the oily part 22 than in the water-soluble part 21 .
  • each of the water-soluble portion 21 and the oil-based portion 22 may contain various materials such as the additives exemplified in the first embodiment, in addition to the water-soluble material and the oil-based material.
  • the ratio of the oil-based material to the entire needle-like portion 20 is preferably 1% by mass or more and 60% by mass or less, and the ratio of the water-soluble material to the entire needle-like portion 20 is 40% by mass. % or more and 99 mass % or less.
  • the cell transplantation unit 11 may include a plurality of needle-like parts 20, as in the first embodiment.
  • the arrangement of the oily portions 22 may or may not be the same among the plurality of needle-like portions 20 .
  • the plurality of needle-like portions 20 include the first needle-like portion 20 and the second needle-like portion 20, and the position of the oily portion 22 in the first needle-like portion 20 and the second needle-like portion The position of the oily part 22 in 20 may be different.
  • the ratio and type of the oily material contained in the first needle-like portion 20 and the oily material contained in the second needle-like portion 20 may be different from each other.
  • the cell transplantation unit 11 may include the needle-like portion 20 of the first embodiment and the needle-like portion 20 of the second embodiment, or may include a needle-like portion that does not contain an oily material. .
  • the second embodiment in addition to the effects (1) to (4) and (7) to (9) of the first embodiment, the following effects can be obtained.
  • the needle-like portion 20 having the water-soluble portion 21 and the oil-based portion 22 suitably realizes the needle-like portion 20 having partially different concentrations of the oil-based material.
  • the oily part 22 is located on the surface layer of the needle-shaped part 20, the start of dissolution of the water-soluble part 21 can be delayed. It becomes easy to keep the shape that is easy to stab. Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
  • the oily part 22 is positioned at the base of the needle-shaped part 20 , the base of the needle-shaped part 20 dissolves rapidly, and the force that presses the cell transplantation unit 11 is less likely to be transmitted to the needle-shaped part 20 . Also, pressure on the implant 50 from the dissolved base fluid is reduced. In addition, since the shape of the base of the needle-like portion 20 is easily maintained, the position where the needle-like portion 20 is stuck can be easily recognized visually by the liquefaction or peeling of the support plate portion 30 .
  • the oily part 22 is positioned at the distal end of the needle-shaped part 20, the shape of the distal end of the needle-shaped part 20 is easily maintained at the initial stage when the needle-shaped part 20 enters the living body. Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
  • FIG. 12 to 27 A third embodiment of a containing device, a cell transplantation unit, and a method for manufacturing the containing device will be described with reference to FIGS. 12 to 27.
  • FIG. The third embodiment differs from the first and second embodiments in the configuration of the needle-like portion.
  • the configuration of the implant and the target of placement of the implant in the third embodiment are the same as in the first embodiment.
  • the following description will focus on the differences between the third embodiment and the first and second embodiments, and the same reference numerals will be assigned to the same configurations as in the first and second embodiments. omitted.
  • the containment device 15 comprises needles 20 extending along one direction.
  • the needle-like portion 20 has an accommodation hole 25 that is a hole for partitioning the interior of the needle-like portion 20 into a space for accommodating an implant.
  • the receiving hole 25 opens at the proximal end of the needle-like portion 20 .
  • the containment device 15 comprises a water-impermeable portion 28 that covers the inner surface of the containment hole 25 .
  • the needle-shaped body is composed of the needle-shaped portion 20 and the non-water-soluble portion 28 .
  • the non-water-soluble portion 28 has a film shape along the inner surface of the accommodation hole 25 .
  • a region defined inside the non-water-soluble portion 28 is a storage portion 26 in which the implant is stored. That is, the water-impervious portion 28 surrounds the area within the receiving cavity 25 where the implant is to be placed.
  • the housing portion 26 has a shape substantially similar to that of the housing hole 25 and opens at the proximal end of the needle-like portion 20 .
  • the material to be stored in the storage unit 26 may also include a substance for protecting the implant.
  • the shape of the needle-like part 20 is not particularly limited as long as the tip of the needle-like part 20 has a shape that can pierce the tissue in which the implant is placed. From the viewpoint of increasing the ease with which the needle-like portion 20 sticks into the living body, the tip of the needle-like portion 20 is preferably sharp.
  • the needle-like portion 20 may have a shape such as a conical shape or a pyramidal shape in which the width decreases from the proximal end to the distal end.
  • the needle-like portion 20 may have a shape obtained by cutting a cylinder obliquely to the direction in which it extends, or a shape in which a cone extends from the upper surface of the cylinder. It may have a shape with a narrower width.
  • the thinner needle portion 20 can reduce the scar formed when the needle portion 20 is pierced into the living body, while the thicker needle portion 20 increases the degree of freedom regarding the size of the accommodation hole 25. Increased, ie greater flexibility in the size and amount of implants that can be accommodated. From the viewpoint of suppressing the enlargement of the scar while suppressing the limitation on the implant that can be accommodated, in the cross section in the width direction at the position where the width of the needle-like part 20 is the largest, the outer shape of the needle-like part 20 When a virtual inscribed circle is used as a reference circle, the radius of the reference circle is preferably 50 ⁇ m or more and 2000 ⁇ m or less, more preferably 400 ⁇ m or more and 800 ⁇ m or less.
  • the width direction is a direction perpendicular to the direction in which the needle-like portion 20 extends, and the width of the needle-like portion 20 is the length of the needle-like portion 20 in the width direction.
  • the shape and size of the accommodation hole 25 are not particularly limited as long as the accommodation section 26 capable of accommodating the implant can be defined.
  • the shape and size of the accommodation hole 25 may be selected according to the size and amount of the implant within a range that does not excessively reduce the strength of the needle-like portion 20 .
  • each of accommodation hole 25 and accommodation portion 26 extends from an opening located at the proximal end of needle-like portion 20 with a constant diameter, and then toward the bottom of accommodation hole 25 and accommodation portion 26 . shrink.
  • the bottoms of the accommodation hole 25 and the accommodation portion 26 are the ends opposite to the opening, in other words, the ends of the accommodation hole 25 and the accommodation portion 26 near the tip of the needle-like portion 20 .
  • each of the accommodation hole 25 and the accommodation portion 26 along the width direction of the needle-like portion 20 is circular, and the bottom of each of the accommodation hole 25 and the accommodation portion 26 is a curved surface. That is, it can be said that each of the accommodation hole 25 and the accommodation portion 26 has a cylindrical shape with a curved bottom.
  • the diameter of the opening 27 is preferably 30 ⁇ m or more and 1800 ⁇ m or less, more preferably 300 ⁇ m or more and 700 ⁇ m or less.
  • each of the receiving hole 25 and the receiving portion 26 may be selected according to the target depth of placement of the implant.
  • the depth of the housing part 26 is preferably 50 ⁇ m or more, which facilitates the insertion of the transplanted material into the vicinity of the bottom of the housing part 26.
  • the depth of the accommodating portion 26 is 3000 ⁇ m or less.
  • the length of the needle-like portion 20 is not particularly limited as long as it is longer than the accommodation hole 25 .
  • the needle-like portion 20 is made of a material that dissolves in water.
  • a main component of the needle-like portion 20 is a water-soluble polymer.
  • the needle-like portion 20 is made of a material such that the needle-like portion 20 has a strength that allows it to pierce the tissue in which the implant is placed, and that the needle-like portion 20 dissolves in the tissue after it pierces the tissue.
  • the material is selected from materials capable of forming the needle-like portion 20 in
  • the implant may come out of the housing portion 26 due to the movement of the living body or the like before the dissolution of the needle-like portion 20 is completed. It can happen. From the viewpoint of suppressing detachment of the implant, it is preferable that dissolution of the needle-like portion 20 in the tissue in which the implant is placed be completed within 48 hours.
  • Examples of water-soluble polymers contained in the material of the needle-like portion 20 include carboxymethylcellulose, methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylcellulose, hydroxyethylcellulose, polyvinyl alcohol, polyacrylic acid-based polymer, polyacrylamide, polyethylene oxide, pullulan, alginate, starch, pectin, chitosan, chitosan succinamide, oligochitosan, chondroitin sulfate, poly 2-ethyl-2-2 oxazoline, poly 2-methyl-2-oxazoline, carboxyvinyl polymer, dextran, dextrin, Cellulose, chitin, galactan, collagen, atelocollagen, gelatin, leozan, xanthan gum, casein, polyvinylpyrrolidone, hyaluronic acid, glucomannan, polymalic acid, curdlan, and the like.
  • the needle-like portion 20
  • the water-insoluble portion 28 is sparingly soluble in water and deforms in vivo so as to lose its shape.
  • the water-insoluble portion 28 deforms by melting, dissolving, or decomposing in vivo.
  • the water-insoluble portion 28 may have a thickness capable of suppressing permeation of moisture.
  • the thickness of the water-insoluble portion 28 is 20 ⁇ m or more.
  • the main component of the water-insoluble portion 28 is a material that is sparingly soluble in water and undergoes changes such as melting, dissolution, and decomposition in vivo.
  • the material of the water-insoluble portion 28 is biocompatible.
  • the material of the water-insoluble portion 28 is, for example, fat or higher alcohol.
  • fats and oils are saturated fatty acids, olive oil, oleic acid, rapeseed oil, palm oil, cacao butter, petrolatum, liquid lanolin, beeswax, liquid paraffin and the like.
  • higher alcohols are stearyl alcohol, 1-hexadecanol and the like.
  • each material mentioned as the oily material in the first embodiment can also be used.
  • An oily material is an example of a material that is sparingly soluble in water.
  • the main component of the water-insoluble portion 28 is the material with the highest content ratio in the water-insoluble portion 28 .
  • “poorly soluble in water” means that when 1 g of a powdered material is put into 1000 ml of pure water and vigorously shaken for 30 seconds every 5 minutes in an environment of 20 ⁇ 5 ° C, the entire amount will be dissolved within 30 minutes. It means insoluble.
  • the water-insoluble portion 28 preferably has the property of melting at a temperature near body temperature.
  • the melting point of the main component of the water-insoluble portion 28 is preferably 10° C. or higher and 37° C. or lower. If the water-insoluble portion 28 melts in the living body due to the temperature in the living body, it is preferable that the containing device 15 be stored in a cold storage before being inserted into the living body.
  • the non-water-soluble part 28 Before the needle-shaped part 20 is inserted into the living body, the non-water-soluble part 28 may be solid or semi-solid such as cream as long as it maintains its film-like shape. If the non-water-soluble portion 28 is solid, the non-water-soluble portion 28 contacts the inner surface of the receiving hole 25 due to contact between the implant and the non-water-soluble portion 28 when the implant is stored in the receiving portion 26 . It is possible to suppress peeling from the
  • the material of the water-insoluble portion 28 may contain an additive in order to facilitate the coating of the inner surface of the accommodation hole 25 and improve the wettability of the inner surface.
  • additives include polymeric materials such as hydroxypropyl cellulose, ethyl cellulose, zein and shellac, and surfactants such as sucrose fatty acid esters, magnesium stearate and lecithin.
  • the non-water-soluble portion 28 may have a single-layer structure, or may have a multi-layer structure consisting of a plurality of layers formed from mutually different materials. Moreover, a layer for improving the ease of coating may be provided between the water-insoluble portion 28 and the inner surface of the accommodation hole 25 as a layer serving as a base for the water-insoluble portion 28 .
  • the non-water-soluble portion 28 By providing the non-water-soluble portion 28 , the contents including the implant are prevented from coming into contact with the inner surface of the receiving hole 25 . Therefore, when the content contains water, the dissolution of the needle-like portion 20 from the inside is suppressed before the needle-like portion 20 is pierced into the living body.
  • Cell transplantation unit A form in which the containing device 15 is used for cell transplantation will be described with reference to FIG. 13 .
  • the housing device 15 in which the implant is housed is the cell transplantation unit.
  • the cell transplantation unit 16 comprises a containment device 15 and an implant 50 .
  • the implant 50 is housed in the housing 26 .
  • the containing portion 26 contains the auxiliary liquid 51 together with the implant 50 , and surrounds the implant 50 with the auxiliary liquid 51 .
  • Implant 50 and auxiliary fluid 51 are the contents of containment device 15 .
  • a non-water-soluble portion 28 surrounds the stored material.
  • the auxiliary liquid 51 is a fluid that assists in maintaining the activity of the cell group in the housing part 26 and the engraftment of the cell group after being placed in the living body.
  • the auxiliary liquid 51 surrounds the implant 50 to reduce contact between the implant 50 and the inner surface of the container 26, thereby helping to maintain the activity of the cell population.
  • the auxiliary liquid 51 may contain components close to body fluids of the living body to wrap the implant 50 or provide nutrition to the implant 50, thereby assisting the maintenance of cell group activity and engraftment. good.
  • the auxiliary liquid 51 contains an aqueous material as a main component.
  • the main component of the auxiliary liquid 51 is the material with the highest content ratio in the auxiliary liquid 51 .
  • Specific examples of the auxiliary liquid 51 are pure water, physiological saline, and the like.
  • the auxiliary liquid 51 may contain an additive that reduces the vapor pressure of water. If the auxiliary liquid 51 contains such an additive, the needle-shaped portion 20 may dissolve when the auxiliary liquid 51 adheres to the surface of the needle-shaped portion 20 or the like when the auxiliary liquid 51 is stored in the storage portion 26 . suppressed.
  • additives that reduce the vapor pressure of water are gelatin, agar, sodium alginate, pullulan, gellan gum, hydroxypropylcellulose, collagen, and the like.
  • the auxiliary liquid 51 may be composed of a single material, or may be a mixture of multiple materials. Also, the auxiliary liquid 51 may be a low-viscosity fluid or a high-viscosity fluid.
  • the auxiliary liquid 51 does not have to surround the entire circumference of the implant 50 .
  • the implant 50 may be placed at the bottom of the container 26 and the supplemental fluid 51 may cover the implant 50 in the area above the implant 50 to the opening 27 .
  • the containment device 15 may comprise a base portion 23 integrally formed with the needle portion 20 .
  • the substrate portion 23 has a plate shape extending from the base end portion of the needle-like portion 20 in a direction perpendicular to the extending direction of the needle-like portion 20 . In other words, the substrate portion 23 supports the proximal end portion of the needle portion 20 .
  • the substrate portion 23 has a first surface 23F and a second surface 23R opposite to the first surface 23F, and the needle-like portion 20 extends from the first surface 23F.
  • the accommodation hole 25 and the accommodation portion 26 are open to the second surface 23R.
  • the substrate portion 23 is made of the same material as the needle-like portion 20 .
  • the non-water-soluble portion 28 extends continuously from the inner side surface of the accommodation hole 25 to the second surface 23R and covers at least a portion of the second surface 23R.
  • the substrate portion 23 Since the substrate portion 23 is provided, it is easy to hold the containing device 15 by holding the substrate portion 23 with another tool or the like. Therefore, it becomes easier to move the containing device 15 or to pierce the living body with the containing device 15 .
  • the substrate portion 23 prevents the stored material from adhering to the surface of the needle-shaped portion 20 when the stored material is put into the storage portion 26 from the opening 27 . So it can be suppressed. Therefore, dissolution of the needle-like portion 20 is suppressed before the needle-like portion 20 is pierced into the living body.
  • the non-water-soluble portion 28 also covers the second surface 23 ⁇ /b>R of the substrate portion 23 continuously from the inner surface of the accommodation hole 25 . That is, since the substrate portion 23 is covered with the non-water-soluble portion 28 in the vicinity of the opening 27, it is possible to suppress the adhesion of the stored object to the substrate portion 23 when the stored object is put into the storage portion 26 through the opening 27. be done. Therefore, the melting of the substrate portion 23 is also suppressed.
  • the substrate portion 23 is too large, the force applied to the containing device 15 when the needle-like portion 20 is inserted into the living body is likely to escape to the substrate portion 23. Therefore, the substrate portion assigned to one needle-like portion 20
  • the area of the first surface 23F of 23 is preferably 625 mm 2 or less.
  • the substrate portion 23 may be reduced in size by cutting or the like after the contents are accommodated, or the substrate portion 23 and the needle may be separated from the substrate portion 23 so that the needle-like portion 20 can be separated from the substrate portion 23 when the living body is punctured.
  • the boundary with the shaped portion 20 may be processed.
  • the containment device 15 may comprise a seal 40, as shown in FIGS.
  • the sealing portion 40 closes the opening portion 27 in a state in which the storage portion 26 accommodates an object.
  • the sealing portion 40 extends along the surface located at the proximal end of the needle-like portion 20 or along the second surface 23R of the substrate portion 23 .
  • the sealing portion 40 is made of a material that does not dissolve in water.
  • the sealing portion 40 before closing the opening 27 may be managed separately from the needle-like portion 20 and the substrate portion 23, or may be connected to the end portion of the substrate portion 23 or the like.
  • the sealing portion 40 is a resin sheet having an adhesive surface. may be placed above.
  • the sealing portion 40 may be formed by applying an oily sealing material so as to cover the opening 27 .
  • the sealing material is, for example, an oily cream such as vaseline.
  • the seal 40 is preferably capable of adhering to the surface of the tissue in which the implant 50 is placed.
  • the sealing portion 40 By providing the sealing portion 40, the contents can be prevented from leaking out of the storage portion 26 due to vibrations during transportation of the storage device 15, impact when the storage device 15 pierces the living body, or the like. can be done.
  • the needle-like portion 20 is formed by filling a solution containing the material of the needle-like portion 20 into a mold having recesses corresponding to the desired shape of the needle-like portion 20, solidifying the filling by drying, and then releasing the mold. manufactured.
  • the accommodating hole 25, which is the gap can be formed.
  • a pin-shaped structure having a shape corresponding to the receiving hole 25 may be inserted into the central portion of the filling and removed after the filling is solidified. As a result, a gap, which is the receiving hole 25, can be formed in the portion where the pin-shaped structure was positioned.
  • the substrate portion 23 is also formed at the same time as the needle portion 20 .
  • the water-insoluble portion 28 is formed by applying the material of the water-insoluble portion 28 into the receiving hole 25 .
  • the shape of the accommodating portion 26 may be adjusted by inserting a pin-shaped structure corresponding to the desired shape of the accommodating portion 26 into the accommodating hole 25 .
  • the storage of the contents in the storage section 26 may be performed by a method according to the properties of the contents. As an example, a case where a transplant 50 containing a group of cells and an auxiliary liquid 51 are accommodated in the accommodation portion 26 will be described.
  • the storage portion 26 is filled with the auxiliary liquid 51 .
  • the auxiliary liquid 51 may be injected into the container 26 using a nozzle, or after the auxiliary liquid 51 is dropped toward the opening 27, the container 26 may be evacuated or a centrifuge may be used.
  • the storage part 26 may be filled with the auxiliary liquid 51 by using it.
  • the implant 50 is put into the housing portion 26 .
  • the implant 50 will sink into the housing 26 due to gravity.
  • a centrifuge may be used, or a rod-shaped or pipe-shaped instrument may be used to push the implant 50 to move the implant 50 to the bottom of the container 26. You can move it towards
  • the implant 50 does not necessarily need to be submerged near the bottom of the container 26 , the closer the implant 50 is placed to the bottom of the container 26 , the less likely the implant 50 will leak out of the container 26 . preferable. If the needle-like portion 20 and the non-water-soluble portion 28 are transparent, the placement of the implant 50 can proceed while confirming the position of the implant 50 in the storage portion 26 . In the case where the containing device 15 has the sealing portion 40 , the opening portion 27 is covered with the sealing portion 40 after the object is contained in the containing portion 26 .
  • Method of placement of implant A method of placing an implant using containment device 15 will now be described with reference to FIGS. 17-20. That is, the method of placing the transplant is a method of transplanting cells using the cell transplantation unit 16 .
  • the needle-like portion 20 of the cell transplantation unit 16 is pressed against the target tissue Sk where the implant 50 is to be placed, thereby piercing the target tissue Sk with the needle-like portion 20 .
  • the target tissue Sk is, for example, skin.
  • an applicator may be used that assists the needle-like portion 20 to enter the target tissue Sk by adjusting the force applied to the needle-like portion 20 and the direction of the needle-like portion 20 .
  • the housing device 15 has the substrate portion 23, it is easy to hold the cell transplantation unit 16 on the applicator. Note that in a state in which the needle-like portion 20 is stuck in the target tissue Sk, the substrate portion 23 does not enter the target tissue Sk and is arranged on the surface of the target tissue Sk.
  • the needle-like portion 20 when the needle-like portion 20 enters the target tissue Sk, the needle-like portion 20 is dissolved by the contact between the needle-like portion 20 and the moisture in the tissue.
  • the water-insoluble portion 28 also collapses as it is placed inside the target tissue Sk.
  • the non-water-soluble portion 28 melts at a temperature near body temperature
  • the non-water-soluble portion 28 is warmed to a temperature near body temperature as the needle-like portion 20 enters the target tissue Sk. Melt.
  • the water-insoluble portion 28 is deformed, and the implant 50 surrounded by the water-insoluble portion 28 is exposed from the water-insoluble portion 28 .
  • Either the deformation of the needle-like portion 20 or the deformation of the water-insoluble portion 28 may occur first.
  • the speed at which the needle-shaped portion 20 collapses and the speed at which the water-insoluble portion 28 collapses can be adjusted by the materials of the needle-shaped portion 20 and the water-insoluble portion 28 .
  • the wound formed by the needle-like portion 20 piercing the target tissue Sk in other words, the cut portion in the tissue is needle-like.
  • the portion 20 dissolves, it closes.
  • the water-insoluble portion 28 is deformed and exists around the implant 50, and the water-insoluble portion 28 having a larger surface area than the implant 50 is likely to be caught inside the tissue. Therefore, since the implant 50 is caught in the water-insoluble portion 28, the implant 50 is prevented from being pushed out to the tissue surface when the wound is closed.
  • the containing device 15 collapses and disappears, and the contained implant 50 is retained within the target tissue Sk.
  • the components of the needle-like portion 20 and the water-insoluble portion 28 are diffused and absorbed into the living body. This completes the placement of the implant 50 in vivo.
  • the housing device 15 includes the substrate portion 23, the substrate portion 23 is dissolved by coming into contact with water on the surface of the target tissue Sk.
  • the implant 50 is prevented from being pulled out of the living body when the implant 50 is placed in the body, thereby preventing the implant 50 from coming out of the body together with the instrument. Therefore, the efficiency of implant 50 placement is also enhanced. In addition, since the implant 50 is inserted into the living body while being housed in the needle-like portion 20, the implant 50 can be protected from impact during insertion.
  • the sealing portion 40 forms a needle-like shape on the surface of the target tissue Sk after disappearance of the needle-like portion 20 and the water-insoluble portion 28 .
  • the part 20 covers the wound Ct formed by stabbing the target tissue Sk. This can also prevent the implant 50 from coming out of the wound Ct.
  • the shape of the accommodation hole 25 and the shape of the accommodation portion 26 may not be similar.
  • the bottom of the accommodation hole 25 is curved, whereas the bottom of the accommodation portion 26 is flat.
  • the receiving hole 25 has, for example, a cylindrical shape with a curved bottom, and the receiving portion 26 has, for example, a cylindrical shape with a flat bottom surface.
  • any manufacturing method for forming the water-insoluble portion 28 by inserting a pin-shaped structure corresponding to the desired shape of the housing portion 26 into the housing hole 25 can be used.
  • the shape of the hole 25 and the shape of the housing portion 26 can be different.
  • the accommodation hole 25 having a cylindrical shape with a curved bottom can be preferably formed by a manufacturing method of forming the accommodation hole 25 using air bubbles.
  • the housing portion 26 having a cylindrical shape with a flat bottom surface can be preferably formed by the manufacturing method using the pin-shaped structure.
  • the thickness of the water-insoluble portion 28 may not be constant.
  • the non-water-soluble portion 28 on the side surface of the accommodation hole 25 is thicker than the water-insoluble portion 28 on the bottom surface of the accommodation hole 25 .
  • the thickness of the non-water-soluble portion 28 may not be constant.
  • the tip of a tool such as a nozzle or a pipette may be inserted into the receiving portion 26 when the container 26 contains a material. Even if the tip of the instrument contacts the bottom of the housing portion 26 and the non-water-soluble portion 28 is scraped off when it is inserted into the housing portion 26, the inner surface of the housing hole 25 is less likely to be exposed.
  • the non-water-soluble portion 28 may not cover the second surface 23R of the substrate portion 23 and may cover only the inner surface of the receiving hole 25 .
  • the side surface of the accommodation hole 25 and the side surface of the accommodation portion 26 may be inclined with respect to the direction in which the needle-like portion 20 extends.
  • the side surfaces of each of the accommodation hole 25 and the accommodation portion 26 are inclined such that the diameter of each of the accommodation hole 25 and the accommodation portion 26 gradually decreases from the opening 27 toward the bottom.
  • each of the accommodation hole 25 and the accommodation portion 26 has a conical concave shape.
  • the side surface of the accommodation hole 25 is inclined so that the diameter of the accommodation hole 25 decreases toward the bottom, it is easy to apply the material of the non-water-soluble portion 28 to the inner surface of the accommodation hole 25 from the opening of the accommodation hole 25 .
  • the diameter of the accommodating portion 26 is maximized at the opening portion 27, it is easy to accommodate the contents.
  • the thickness of the needle-like portion 20 that is, the thickness from the inner surface of the accommodation hole 25 to the surface of the needle-like portion 20 increases toward the base end portion of the needle-like portion 20 . It's becoming With such a configuration, the strength of the base end portion of the needle-like portion 20 is increased, so that the needle-like portion 20 is less likely to break.
  • the accommodating portion 26 has a shape that maximizes the diameter at the opening 27, it is easy to accommodate the content, but the strength near the proximal end portion of the needle-like portion 20 is weakened. Cheap.
  • the thickness of the needle-like portion 20 increases toward the base end portion, it is possible to suppress a decrease in strength near the base end portion of the needle-like portion 20 due to the shape of the housing portion 26 .
  • the tip portion of the needle-like portion 20 is difficult to deform when the needle-like portion 20 is stuck into the living body. It is preferable that the strength of the tip portion of is high. From this point of view, it is preferable that the accommodation hole 25 does not extend to the tip of the needle-like portion 20 . For example, it is preferable that the accommodation hole 25 is not arranged in a region of 1/10, preferably 1/3 of the total length of the needle-like portion 20 from the tip of the needle-like portion 20 .
  • the diameter of the accommodation hole 25 may be maximum at the central portion of the accommodation hole 25 in the depth direction. It may be maximum in the central part of the direction. With such a form, it is easy to secure a wide space for accommodating the implant.
  • each of the accommodation hole 25 and the accommodation portion 26 may have a funnel shape. That is, the diameter of each of the accommodation hole 25 and the accommodation portion 26 becomes constant after gradually decreasing from the end where the opening 27 is located. In the example shown in FIG. 25, the diameter of each of the accommodation hole 25 and the accommodation portion 26 becomes constant and then decreases toward the bottom.
  • the surface roughness of the inner surface of the accommodation hole 25 and the accommodation portion 26 may be made larger than the surface roughness of the surface of the needle-like portion 20 . If the surface roughness of the inner surface of the accommodation hole 25 is greater than the surface roughness of the surface of the needle-shaped portion 20, compared with the case where the surface roughness of the inner surface of the accommodation hole 25 is equal to the surface of the needle-shaped portion 20. As a result, the non-water-soluble portion 28 is less likely to peel off from the inner surface of the accommodation hole 25 . Further, when the material of the non-water-soluble portion 28 is applied to the inner surface of the accommodation hole 25 , the material tends to adhere to the inner surface of the accommodation hole 25 . Therefore, the degree of freedom in selecting the material for the water-insoluble portion 28 and setting the coating conditions is increased.
  • the surface roughness of the inner surface of the accommodating portion 26 is greater than the surface roughness of the surface of the needle-shaped portion 20, the surface roughness of the inner surface of the accommodating portion 26 is equivalent to the surface of the needle-shaped portion 20. , the implant is more likely to get caught on the inner surface of the housing part 26 . Therefore, the housed implant is prevented from coming out of the housing part 26 .
  • the surface roughness of the inner surface of the accommodation hole 25 and the accommodation portion 26 can be adjusted, for example, by the surface roughness of the pin-shaped structure used in manufacturing and the coating method of the water-insoluble portion 28 .
  • the water-insoluble portion 28 may be fluid and filled in the accommodation hole 25 .
  • the area defined by the accommodation hole 25 is the accommodation portion 26
  • the implant 50 is entirely surrounded by the water-insoluble portion 28 in the accommodation portion 26 and is in contact with the water-insoluble portion 28 .
  • the water-insoluble portion 28 may be filled into the accommodation hole 25 before the implant 50 is accommodated, or may be put into the accommodation hole 25 simultaneously with the implant 50 .
  • the inner surface of the accommodation hole 25 is covered with the non-water-soluble portion 28, so contact between the implant 50 and the inner surface of the accommodation hole 25 can be suppressed. Therefore, when the implant 50 contains moisture, the dissolution of the needle-like portion 20 from the inside is suppressed before the needle-like portion 20 is pierced into the living body. In vivo, deformation of the non-water-soluble portion 28 is a change in the area occupied by the non-water-soluble portion 28 so that the state in which the non-water-soluble portion 28 surrounds the implant 50 is broken.
  • the containment device 15 may comprise a plurality of needles 20 each containing an implant 50 . Thereby, a plurality of implants 50 can be collectively placed in the living body. A plurality of needle-like portions 20 may be connected by one substrate portion 23, for example.
  • the accommodation hole 25 and the accommodation portion 26 may be opened on the side surface of the needle-like portion 20 .
  • the degree of freedom regarding adjustment of the opening area and the placement depth of the implant 50 can be improved.
  • the accommodating part 26 is open at the proximal end of the needle-like part 20, the implant 50 can be easily accommodated, and the strength of the needle-like part 20 can be easily ensured.
  • the containment device 15 has a plurality of needle-like portions 20
  • the implant 50 can be efficiently contained in each needle-like portion 20 . can do.
  • non-water-soluble portion 28 is regarded as a part of the member that constitutes the needle-shaped portion 20
  • the non-water-soluble portion 28 is an example of the oily portion 22 of the second embodiment, and the needle-shaped portion other than the non-water-soluble portion 28 is used.
  • the portion 20 can also be regarded as an example of the water-soluble portion 21 of the second embodiment.
  • the implant 50 is accommodated in the needle-like portion 20, and the needle-like portion 20 piercing the living body dissolves in the living body, and the non-water-soluble portion 28 deforms in the living body to expose the implant 50.
  • the implant 50 is thereby placed in the living body. Therefore, since the device is not pulled out from the living body when the implant 50 is placed in the living body, it is possible to prevent the implant 50 from coming out of the living body together with the device. This also increases the efficiency of implant 50 placement.
  • the non-water-soluble portion 28 has a film-like shape that covers the inner surface of the accommodation hole 25 , and the inside of the water-insoluble portion 28 defines a storage portion 26 that is a region that stores the implant 50 . According to such a configuration, a fluid for protecting the implant 50 or the like can be accommodated together with the implant 50, or an object that is a fluid can be accommodated.
  • the implant 50 desired to be protected by the water-insoluble fluid is placed in the water-insoluble portion 28 functioning as the fluid. It can be contained in an enclosed state.
  • the implant 50 can be easily accommodated, and the strength of the needle portion 20 can be easily ensured. .
  • the implant 50 can be placed in the housing portion 26 immediately before the needle-like portion 20 is pierced into the living body.
  • the containing device 15 is provided with a sealing portion 40 configured to be able to block the openings of the containing hole 25 and the containing portion 26, the contents contained in the containing portion 26 will not leak from the openings. is suppressed.
  • the sealing part 40 closes the wound formed by the entry of the needle-like part 20, so that the implant 50 is prevented from being detached from the living body.
  • the containing device 15 is provided with the substrate portion 23 that supports the base end portion of the needle-like portion 20, other instruments or the like may be used when the containing device 15 is transported or when the needle-like portion 20 pierces the living body. It is easy to hold the containment device 15 with the Moreover, when accommodating the content in the needle-like portion 20 , the content is prevented from adhering to the surface of the needle-like portion 20 . Therefore, even when the content contains water, dissolution of the needle-like portion 20 before the needle-like portion 20 is pierced into the living body can be suppressed.
  • non-water-soluble portion 28 extends continuously from the inner surface of the accommodation hole 25 to the second surface 23R of the substrate portion 23, when the needle-like portion 20 accommodates the content, , the contents are prevented from adhering to the substrate portion 23 . Therefore, even if the content contains water, it is possible to prevent the substrate portion 23 from dissolving before the needle-like portion 20 is pierced into the living body.
  • the water-insoluble portion 28 has the property of being melted in the living body due to the temperature in the living body, the deformation of the water-insoluble portion 28 in the living body proceeds favorably. Therefore, the implant 50 is accurately placed in the living body.
  • the implant 50 containing the cell group contains water. Therefore, the beneficial effect of arranging the water-insoluble portion 28 is highly obtained. In addition, even when fluid containing an aqueous material is accommodated in the accommodation portion 26 together with the implant 50, the effect of arranging the water-insoluble portion 28 is highly beneficial.
  • the object to be housed in the housing device is not limited to the implant 50, and may be a member such as a medicine or an IC chip.
  • the object may be liquid, solid, gel, or a mixture thereof.
  • the containing device containing the object is the containing unit, and the cell transplantation unit is an example of the containing unit.
  • Test Examples 1 to 12 A test example of the needle-shaped portion was produced for the above-described containing device, and a test was conducted to evaluate the moldability and melting speed of the needle-shaped portion.
  • the acicular part of the test example corresponds to the acicular part of the first embodiment.
  • An intaglio plate having quadrangular pyramid-shaped recesses was prepared, and the recesses were filled with the needle-shaped portion forming liquid.
  • the opening surface of the recess has a square shape with one side of 800 ⁇ m, and the depth of the recess is 1.8 mm.
  • the portion corresponding to the support plate portion was formed by spreading the needle-shaped portion forming liquid over the concave portion as well.
  • the intaglio plate filled with the needle-shaped portion forming liquid was dried in an environment of 25° C. temperature and 30% humidity for 72 hours while being ventilated. As a result, the needle-like portion, which is the filling material for the recess, and the support plate portion were formed.
  • Test Example 2 was obtained by holding the support plate portion and releasing the needle-like portion from the intaglio.
  • Test Example 2 Needles of Test Example 2 were obtained using the same materials and processes as those of Test Example 1, except that the proportion of palm oil in the needle-like portion-forming liquid was changed. The proportion of palm oil in the needle-shaped portion-forming liquid in Test Example 2 was 10% by mass.
  • Test Example 3 Needles of Test Example 3 were obtained using the same materials and processes as in Test Example 1, except that the proportion of palm oil in the needle-shaped portion-forming liquid was changed. The proportion of palm oil in the needle-shaped portion-forming liquid in Test Example 3 was 1% by mass.
  • Test Example 4 Needles of Test Example 4 were obtained using the same materials and processes as in Test Example 1, except that a sucrose fatty acid ester, which is a surfactant, was added as an additive to the needle-like portion-forming liquid.
  • the ratio of the sucrose fatty acid ester in the needle-shaped portion-forming liquid in Test Example 4 was 1% by mass.
  • Test Example 5 Needles of Test Example 5 were obtained using the same materials and processes as in Test Example 1, except that a surfactant, sucrose fatty acid ester, was added as an additive to the needle-like portion-forming solution. The ratio of the sucrose fatty acid ester in the needle-shaped portion-forming liquid in Test Example 5 was 0.1% by mass.
  • Test Example 6 was performed using the same materials and processes as in Test Example 1, except that petrolatum was used as the oily material, and sucrose fatty acid ester, which is a surfactant, was added as an additive to the needle-shaped portion-forming liquid. needles were obtained. In the needle-shaped portion-forming liquid of Test Example 6, the percentage of petroleum jelly was 67% by mass, and the percentage of sucrose fatty acid ester was 1% by mass.
  • Test Example 7 A needle-like portion of Test Example 7 was obtained using the same material and process as in Test Example 6, except that the proportion of petroleum jelly in the needle-like portion-forming liquid was changed. The proportion of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 7 was 50% by mass.
  • Test Example 8 A needle-shaped portion of Test Example 8 was obtained using the same material and process as in Test Example 6, except that the proportion of petroleum jelly in the needle-shaped portion-forming liquid was changed.
  • the ratio of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 8 was 33% by mass.
  • Test Example 9 A needle-shaped portion of Test Example 9 was obtained using the same material and process as in Test Example 6, except that the proportion of petrolatum in the needle-shaped portion-forming liquid was changed.
  • the proportion of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 9 was 10% by mass.
  • Test Example 10 Needles of Test Example 10 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 10, the percentage of petroleum jelly was 50% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
  • Test Example 11 Needles of Test Example 11 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 11, the percentage of petrolatum was 30% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
  • Test Example 12 Needles of Test Example 12 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 12, the percentage of petroleum jelly was 10% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
  • ⁇ Followability> For each test example, the shape of the needle-like portion was observed, and the followability of the shape of the needle-like portion to the shape of the concave portion was evaluated in three stages. In the evaluation, 1 point was obtained when the needle-shaped part-forming liquid did not enter the concave part, and a sample in which the needle-shaped part was not formed was formed. A score of 2 was given when it occurred at a rate exceeding 3, and a score of 3 was given when a needle-like portion having a shape matching the shape of the concave portion was obtained for 90% or more of the samples.
  • the needle-shaped portion different from the shape of the recess includes a needle-shaped portion that is smaller or larger than the recess, and a needle-shaped portion that has unevenness on the surface due to the inclusion of air bubbles or the like and does not have a surface along the recess. part is included.
  • ⁇ Stability> For each test example, the shape of the needle-like portion was observed, and the stability of the shape in a plurality of samples was evaluated on a three-grade scale. In the evaluation, in a plurality of samples, 1 point when the ratio of needle-like portions formed in the desired shape is less than 50%, and in a plurality of samples, the ratio of needle-like portions formed in the desired shape is 50. % or more and less than 85% was given 2 points, and a case where the ratio of needle-like portions formed in a desired shape in a plurality of samples was 85% or more was given 3 points.
  • the desired shape of the needle-like portion is a needle-like portion that has no chipping and matches the shape of the recess.
  • a needle-like portion was produced by the same process as in Test Example 1 using an aqueous pullulan solution as a needle-like portion-forming liquid.
  • the needle-shaped portion of the reference example does not contain an oily material or additives, and is formed only from a water-soluble material.
  • the measurement result was about 1 minute.
  • Table 1 shows the type of oily material, the proportion of oily material, the proportion of additive, evaluation results of formability evaluation and shape disappearance rate evaluation, and overall evaluation for each test example.
  • Comprehensive evaluation is the sum of the points of each evaluation.
  • the easiness of forming the needle-like portion varies depending on the ratio of the oily material and whether or not the surfactant is added and the amount of surfactant added. As a whole, there is a tendency that the smaller the ratio of the oily material, the higher the formability of the needle-shaped portion.
  • the oily material was palm oil, the contribution of the sucrose fatty acid ester to the improvement of moldability could not be confirmed.
  • the oily material is petrolatum
  • the addition of the sucrose fatty acid ester facilitates the mixing of the petrolatum with the needle-like portion-forming liquid, and the addition ratio of the sucrose fatty acid ester of about 1% by mass is favorable. It was confirmed that there is a tendency that good moldability is easily obtained.
  • the time required for the disappearance of the shape was longer than that of the needle-shaped portion of the reference example made of only the water-soluble material. It was confirmed that the melting speed of the part slowed down. A total evaluation of 8 points or more is preferable because it can be said that the acicular portion has well-balanced characteristics related to each evaluation.
  • Example 1 The accommodation device and cell transplantation unit of the third embodiment will be described using specific examples.
  • a mold having quadrangular pyramid-shaped concave portions was prepared, and an aqueous pullulan solution was dropped into the concave portions as a solution for forming the needle-like portions. Then, the mold filled with the pullulan aqueous solution was dried in an environment of temperature 25° C. and humidity 30% for 72 hours while being ventilated. As drying progresses, cavities grow inside the filling of the recesses due to the balance between the wettability of the mold and the surface tension of the aqueous pullulan solution. After the drying was completed, the filling was released from the mold to obtain a needle-like portion having the above-mentioned hollow accommodation hole.
  • the face located at the proximal end of the needle-like portion has a square shape with a side of 500 ⁇ m, and the length of the needle-like portion is 1.8 mm.
  • a film-like water-insoluble portion was formed by applying fatty acid glyceride inside the accommodation hole.
  • storage portions partitioned by water-insoluble portions were formed, and the storage device of Example 1 was obtained.
  • the diameter of the opening of the container was measured using a microscope. As a result, the diameter of the opening was 300 ⁇ m.
  • a phosphate buffer solution was injected as an auxiliary liquid into the housing portion of the housing device of Example 1 using a tube. Furthermore, using a micropipette, the cell mass was dropped into the opening of the container. When the containing device was left with the opening facing upward, the cell clusters sank into the containing part due to gravity. Since cell masses larger than the diameter of the opening do not enter the storage unit by the action of gravity alone, the storage device was subjected to centrifugation using a desktop centrifuge to sink the cell masses into the storage unit. . The centrifugation speed is 5000 rpm, and the treatment time is 60 seconds.
  • Cell clusters were placed in 10 storage devices by the above method, and each storage device was observed from the outside with a microscope. Since the acicular part and the water-insoluble part of Example 1 are transparent, the position of the cell mass can be confirmed from the outside. As a result of observation, it was confirmed that in 90% or more of the containing devices, the cell mass was contained near the bottom of the containing portion.
  • the storage device containing the cell mass was immersed in a liquid medium kept at 37°C to liquefy the needle-shaped part and the water-insoluble part, and the cell mass was recovered.
  • the sizes of the cell aggregates before and after accommodation in the needle-like portion were compared.
  • the size comparison was carried out by comparing the areas of the cell clusters projected onto a predetermined surface by observation using an epi-illumination microscope. As a result, 80% or more of the cell aggregate area was maintained for all cell aggregates. Therefore, it can be concluded that the cell aggregates were not damaged due to accommodation in the needle-like portion.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A storage device that is to be used for placement of an object in a living body. The storage device comprises a needle-shaped body equipped with a needle-shaped part which is shaped so as to be capable of piercing a living body. The needle-shaped body is configured to hold an object inside the needle-shaped part. Materials of the needle-shaped body include a water-soluble material and a material hardly soluble in water.

Description

収容デバイスcontainment device
 本開示は、生体内へ対象物を配置するために用いられる収容デバイスに関する。 The present disclosure relates to a containment device used to place an object in vivo.
 細胞群を生体内へ移植する技術の活用が進んでいる。例えば、毛を作り出す毛包器官の形成に寄与する細胞群を培養し、この細胞群を皮内へ移植することによって、毛髪を再生させることが試みられている。毛髪の良好な再生のためには、移植された細胞群から、正常な組織構造を有して良好な毛髪の形成能力を有する毛包器官が生じることが望ましい。そこで、こうした毛包器官を形成可能な細胞群の製造方法について、様々な研究開発が行われている(例えば、特許文献1~3参照)。 The use of technology for transplanting cell groups into the body is progressing. For example, attempts have been made to regenerate hair by culturing a group of cells that contribute to the formation of hair-producing organs of the hair follicle and intradermally transplanting this group of cells. For good hair regeneration, it is desirable that the transplanted cell population yields a follicular organ with a normal tissue structure and good hair-forming ability. Therefore, various researches and developments have been conducted on methods for producing cell groups capable of forming such hair follicle organs (see, for example, Patent Documents 1 to 3).
国際公開第2017/073625号WO2017/073625 国際公開第2012/108069号WO2012/108069 特開2008-29331号公報Japanese Unexamined Patent Application Publication No. 2008-29331
 細胞群を生体内に配置する際には、ピンセットや注射器等の器具で細胞群を保持し、生体の組織表面を切って器具を組織内に挿入する。そして、細胞群の配置後に、器具を組織から引き抜く。しかしながら、こうした細胞群の移植方法では、器具を組織から引き抜くときに、器具と共に細胞群が組織から抜け出てしまうことが起こる場合があり、このことが、移植効率の低下を招いている。 When placing the cell group in the body, the cell group is held with instruments such as tweezers and syringes, the surface of the tissue of the body is cut, and the instrument is inserted into the tissue. After placement of the cell population, the instrument is then withdrawn from the tissue. However, in such a cell group transplantation method, when the instrument is pulled out from the tissue, the cell group may sometimes come out of the tissue together with the instrument, which leads to a decrease in transplantation efficiency.
 なお、こうした問題は細胞群の移植に限らず、皮膚等の組織の表面から生体内に対象物を配置する場合に共通する。 It should be noted that such problems are not limited to the transplantation of cell groups, but are common when placing an object in vivo from the surface of a tissue such as skin.
 上記課題を解決するための収容デバイスは、生体内への対象物の配置に用いられる収容デバイスであり、生体を刺すことが可能な形状を有する針状部を備えた針状体であって、前記対象物を前記針状部の内部に保持するように構成された前記針状体を備え、前記針状体の材料には、水溶性材料と水に対して難溶な材料とが含まれる。 A storage device for solving the above problems is a storage device used for arranging an object in a living body, and is a needle-like body having a needle-like portion having a shape capable of piercing the living body, The needle-shaped body is configured to hold the object inside the needle-shaped portion, and the material of the needle-shaped body includes a water-soluble material and a poorly water-soluble material. .
第1実施形態における細胞移植ユニットの断面構造を示す図。The figure which shows the cross-section of the cell transplantation unit in 1st Embodiment. 第1実施形態における細胞移植ユニットの断面構造の他の例を示す図。FIG. 4 is a diagram showing another example of the cross-sectional structure of the cell transplantation unit according to the first embodiment; 第1実施形態における複数の針状部を備える細胞移植ユニットの断面構造を示す図。FIG. 2 is a diagram showing a cross-sectional structure of a cell transplantation unit having a plurality of needle-like portions according to the first embodiment; 第1実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment; 第1実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment; 第1実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 2 shows a procedure for placement of a transplant using the cell transplantation unit of the first embodiment; 第1実施形態の細胞移植ユニットの製造工程を示す図。FIG. 4 is a diagram showing a manufacturing process of the cell transplantation unit of the first embodiment; 第1実施形態の細胞移植ユニットの製造工程を示す図。FIG. 4 is a diagram showing a manufacturing process of the cell transplantation unit of the first embodiment; 第2実施形態における第1例の細胞移植ユニットの断面構造を示す図。The figure which shows the cross-section of the cell transplantation unit of the 1st example in 2nd Embodiment. 第2実施形態における第2例の細胞移植ユニットの断面構造を示す図。The figure which shows the cross-section of the cell transplantation unit of the 2nd example in 2nd Embodiment. 第2実施形態における第3例の細胞移植ユニットの断面構造を示す図。The figure which shows the cross-section of the cell transplantation unit of the 3rd example in 2nd Embodiment. 第3実施形態の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of 3rd Embodiment. 第3実施形態の細胞移植ユニットの断面構造を示す図。The figure which shows the cross-section of the cell transplantation unit of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment; 第3実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment; 第3実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment; 第3実施形態の細胞移植ユニットを用いた移植物の配置の手順を示す図。FIG. 11 shows a procedure for placement of a transplant using the cell transplantation unit of the third embodiment; 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment. 第3実施形態の変形例の収容デバイスの断面構造を示す図。The figure which shows the cross-section of the accommodation device of the modification of 3rd Embodiment.
 (第1実施形態)
 図1~図8を参照して、収容デバイス、細胞移植ユニット、および、収容デバイスの製造方法の第1実施形態を説明する。本実施形態の細胞移植ユニットは、細胞群等の対象物を生体内に配置するために用いられる。対象物が配置される領域は、生体の組織内であり、例えば、皮内および皮下の少なくとも一方、あるいは、臓器等である。本実施形態において「生体」には、生物の身体や組織だけでなく、生物の身体や組織を模した人工的な製造物である生体モデルが含まれる。すなわち、本実施形態の細胞移植ユニットは、生物に対する対象物の配置に限らず、生体モデルに対する対象物の配置にも用いられ得る。
 なお、本明細書における記述「AおよびBの少なくとも一つ」は、「Aのみ、または、Bのみ、または、AとBの両方」を意味するものとして理解されたい。
(First embodiment)
A first embodiment of a containing device, a cell transplantation unit, and a method for manufacturing the containing device will be described with reference to FIGS. 1 to 8. FIG. The cell transplantation unit of the present embodiment is used for placing an object such as a group of cells in vivo. The area in which the object is placed is within the tissue of the living body, for example, at least one of intradermal and subcutaneous, or an organ or the like. In the present embodiment, the term “living body” includes not only the body and tissues of living organisms, but also biological models, which are artificial products simulating the bodies and tissues of living organisms. That is, the cell transplantation unit of the present embodiment can be used not only for arranging an object on an organism, but also for arranging an object on a biological model.
In this specification, the statement "at least one of A and B" should be understood to mean "only A, or only B, or both A and B."
 [細胞移植ユニットの構造]
 図1が示すように、細胞移植ユニット10は、生体を刺すことが可能な形状に延びる針状部20を備えている。針状部20は、その内部に、対象物の一例である移植物50を保持している。針状部20は、針状体の一例である。さらに、細胞移植ユニット10は、針状部20の基端を支持する支持板部30を備えていることが好ましい。支持板部30は、板状であって、第1面31Fと、第1面31Fとは反対側の面である第2面31Rとを有している。そして、第1面31Fから針状部20が延びている。針状部20、もしくは、針状部20および支持板部30を備える構造体は、対象物を収容可能に構成された収容デバイスの一例である。
[Structure of Cell Transplantation Unit]
As shown in FIG. 1, the cell transplantation unit 10 has a needle-like portion 20 extending into a shape capable of being pierced into a living body. The needle-like portion 20 holds an implant 50, which is an example of an object, inside thereof. Needle-like part 20 is an example of a needle-like object. Furthermore, the cell transplantation unit 10 preferably includes a support plate portion 30 that supports the proximal end of the needlelike portion 20 . The support plate portion 30 is plate-shaped and has a first surface 31F and a second surface 31R opposite to the first surface 31F. And the needle-like part 20 is extended from the 1st surface 31F. The needle-like portion 20 or the structure including the needle-like portion 20 and the support plate portion 30 is an example of a containing device configured to be able to contain an object.
 針状部20の形状は、移植物50の配置される組織を刺すことの可能な形状であればよい。生体に対する針状部20の刺さりやすさを高める観点では、針状部20は1つの方向に沿って延びる形状を有し、針状部20の先端部は尖っていることが好ましい。針状部20の延びる方向は、支持板部30の第1面31Fに直交する方向であってもよいし、第1面31Fに対して傾斜する方向であってもよい。 The needle-like portion 20 may have any shape as long as it can pierce the tissue in which the implant 50 is placed. From the viewpoint of increasing the ease with which the needle-like portion 20 can be stuck into the living body, it is preferable that the needle-like portion 20 has a shape that extends along one direction and that the tip of the needle-like portion 20 is sharp. The direction in which the needle-like portion 20 extends may be a direction orthogonal to the first surface 31F of the support plate portion 30, or may be a direction inclined with respect to the first surface 31F.
 例えば、針状部20は、円錐状や角錐状のように、基端から先端に向けて断面積が小さくなる形状を有していてもよい。また例えば、針状部20は、円柱をその延びる方向に対して斜めに切断した形状や、円柱の上面から円錐が延びる形状のように、基端から一定の断面積を有するように延びた後、先端に向けて断面積が小さくなる形状を有していてもよい。あるいは、針状部20は、先端部に刃状の構造を有していてもよい。 For example, the needle-like portion 20 may have a shape such as a conical shape or a pyramidal shape in which the cross-sectional area decreases from the proximal end to the distal end. Further, for example, the needle-like portion 20 has a shape obtained by cutting a cylinder obliquely to the direction in which it extends, or a shape in which a cone extends from the upper surface of the cylinder. , may have a shape in which the cross-sectional area decreases toward the tip. Alternatively, the needle-like portion 20 may have a blade-like structure at its tip.
 ただし、針状部20が移植物50の配置される組織を刺すことが可能であれば、針状部20の先端部は曲率を有する形状であってもよいし、針状部20は、円柱状や角柱状のように、先端部が尖っていない形状を有していてもよい。
 針状部20の長さは、例えば、200μm以上2mm以下であり、針状部20の外径の最大値は、例えば、100μm以上1mm以下である。
However, as long as the needle-like portion 20 can pierce the tissue in which the implant 50 is placed, the distal end portion of the needle-like portion 20 may have a curved shape, or the needle-like portion 20 may have a circular shape. It may have a shape with a blunt tip, such as a columnar shape or a prismatic shape.
The length of the needle portion 20 is, for example, 200 μm or more and 2 mm or less, and the maximum value of the outer diameter of the needle portion 20 is, for example, 100 μm or more and 1 mm or less.
 針状部20と支持板部30とは、同一の材料から一体に形成されていてもよいし、別々に形成されて接合されていてもよい。さらに、支持板部30は、針状部20と一体に形成されて針状部20の基端から連続する第1の板状部と、第1の板状部に接合された第2の板状部とを備える積層体であってもよい。 The needle-like portion 20 and the support plate portion 30 may be integrally formed from the same material, or may be formed separately and joined together. Further, the support plate portion 30 includes a first plate-like portion integrally formed with the needle-like portion 20 and continuing from the proximal end of the needle-like portion 20, and a second plate joined to the first plate-like portion. It may be a laminate comprising a shape portion.
 細胞移植ユニット10の一例である図1の細胞移植ユニット10Aでは、移植物50は、針状部20の内部に埋め込まれている。あるいは、細胞移植ユニット10の他の例である図2の細胞移植ユニット10Bのように、針状部20は、針状部20の基端から内部に向けて窪む孔である収容孔25を有し、収容孔25内に移植物50が収容されていてもよい。 In the cell transplantation unit 10A of FIG. 1, which is an example of the cell transplantation unit 10, the transplant 50 is embedded inside the needle-like portion 20. Alternatively, like the cell transplantation unit 10B of FIG. 2, which is another example of the cell transplantation unit 10, the needle-like portion 20 has a receiving hole 25 which is a hole recessed inward from the proximal end of the needle-like portion 20. and the implant 50 may be accommodated in the accommodation hole 25 .
 収容孔25は、針状部20の基端に開口している。収容孔25の開口は、支持板部30によって塞がれている。収容孔25の形状や大きさは、移植物50を収容可能であれば特に限定されない。図2に示す例では、収容孔25は、針状部20の基端に位置する開口から一定の内径で延びた後、収容孔25の底部に向けて縮径する。針状部20の延びる方向と直交する方向に沿った収容孔25の断面形状は円形であり、収容孔25の底部は曲面である。これに限らず、収容孔25の側面が傾斜面であって、収容孔25の内径は開口から徐々に変化してもよい。また、収容孔25の底面は平面であってもよい。 The housing hole 25 opens at the proximal end of the needle-like portion 20 . The opening of the accommodation hole 25 is closed by the support plate portion 30 . The shape and size of the accommodation hole 25 are not particularly limited as long as the implant 50 can be accommodated therein. In the example shown in FIG. 2 , the accommodating hole 25 extends with a constant inner diameter from the opening located at the proximal end of the needle-like portion 20 and then decreases in diameter toward the bottom of the accommodating hole 25 . The sectional shape of the receiving hole 25 along the direction perpendicular to the extending direction of the needle-like portion 20 is circular, and the bottom of the receiving hole 25 is a curved surface. Alternatively, the side surface of the accommodation hole 25 may be an inclined surface, and the inner diameter of the accommodation hole 25 may gradually change from the opening. Also, the bottom surface of the accommodation hole 25 may be flat.
 収容孔25には、移植物50に加えて、収容孔25内での細胞の活性の維持や、生体内に配置された後の細胞の生着を補助する流体である補助液51が収容されてもよい。収容孔25内において、移植物50は補助液51に囲まれている。なお、補助液51は、移植物50の全周を取り囲んでいなくてもよく、例えば、移植物50は収容孔25の底部に配置され、移植物50上から開口までの領域において補助液51が移植物50を覆っていてもよい。 In addition to the implant 50, the accommodation hole 25 accommodates an auxiliary liquid 51, which is a fluid for maintaining the activity of cells in the accommodation hole 25 and assisting the engraftment of the cells after being placed in the living body. may The implant 50 is surrounded by an auxiliary liquid 51 within the receiving hole 25 . The auxiliary liquid 51 does not have to surround the entire periphery of the implant 50. For example, the implant 50 is arranged at the bottom of the receiving hole 25, and the auxiliary liquid 51 is not present in the region from the top of the implant 50 to the opening. may cover the implant 50 .
 図3は、細胞移植ユニット10の他の例である細胞移植ユニット10Cを示す。図3が示すように、細胞移植ユニット10は、複数の針状部20を備えていてもよい。各針状部20に移植物50が保持される。互いに隣り合う針状部20において支持板部30が繋がっていることにより、複数の針状部20の集合体が形成される。すなわち、複数の針状部20に対し、共通する1つの支持板部30が配置されている。 FIG. 3 shows a cell transplantation unit 10C, which is another example of the cell transplantation unit 10. FIG. As shown in FIG. 3 , the cell transplantation unit 10 may have multiple needle-like parts 20 . An implant 50 is held in each needle 20 . By connecting the support plate portions 30 of the needle-like portions 20 adjacent to each other, an assembly of the plurality of needle-like portions 20 is formed. That is, one common support plate portion 30 is arranged for a plurality of needle-like portions 20 .
 細胞移植ユニット10が複数の針状部20を備えている場合、複数の針状部20は規則的に配列されていてもよいし、不規則に配置されていてもよい。例えば、複数の針状部20は、1列に並んでいてもよいし、正方格子や三角格子の各格子点に針状部20が位置するように複数の列に並んでいてもよい。また、複数の針状部20の並びにおいて、互いに隣り合う針状部20の間隔は、一定であってもよいし、一定でなくてもよい。
 細胞移植ユニット10が複数の針状部20を備えていることにより、複数の移植物50をまとめて生体内に配置することができる。
When the cell transplantation unit 10 includes a plurality of needle-like portions 20, the needle-like portions 20 may be arranged regularly or may be arranged irregularly. For example, the plurality of needle-like portions 20 may be arranged in one row, or may be arranged in a plurality of rows so that each needle-like portion 20 is positioned at each lattice point of a square lattice or a triangular lattice. Moreover, in the arrangement of the plurality of needle-like portions 20, the intervals between the needle-like portions 20 adjacent to each other may be constant or may not be constant.
Since the cell transplantation unit 10 has a plurality of needle-like portions 20, a plurality of transplants 50 can be collectively placed in the living body.
 [移植物の構成]
 移植物50は、細胞群を含む。細胞群は、複数の細胞を含む。例えば、細胞群は、1または複数の細胞塊を含む。細胞塊は複数の細胞の集合体である。細胞塊は、凝集された複数の細胞の集合体であってもよいし、細胞間結合により結合した複数の細胞の集合体であってもよい。あるいは、細胞群は、分散した複数の細胞から構成されてもよい。また、細胞群を構成する細胞は、未分化の細胞であってもよいし、分化が完了した細胞であってもよいし、細胞群は、未分化の細胞と分化した細胞とを含んでいてもよい。細胞群は、例えば、スフェロイドである細胞塊、原基、組織、器官、オルガノイド、ミニサイズの臓器等である。
[Configuration of implant]
Implant 50 includes a group of cells. A cell group contains a plurality of cells. For example, a population of cells includes one or more clusters of cells. A cell mass is an aggregate of multiple cells. A cell cluster may be an aggregate of a plurality of aggregated cells, or an aggregate of a plurality of cells bound by intercellular junctions. Alternatively, the cell population may consist of a plurality of dispersed cells. In addition, the cells that constitute the cell group may be undifferentiated cells or cells that have completed differentiation, and the cell group includes undifferentiated cells and differentiated cells. good too. The cell group is, for example, a cell cluster that is a spheroid, an primordium, a tissue, an organ, an organoid, a mini-sized organ, or the like.
 細胞群は、生体内に配置されることによって、生体における組織形成に作用する能力を有する。こうした細胞群の一例は、幹細胞性を有する細胞を含んだ細胞凝集体である。細胞群は、例えば、皮内または皮下に配置されることにより、発毛または育毛に寄与する。具体的には、細胞群は、毛包器官として機能する能力、毛包器官へ分化する能力、毛包器官の形成を誘導もしくは促進する能力、あるいは、毛包器官における毛の形成を誘導もしくは促進する能力等を有する。また、細胞群は、色素細胞もしくは色素細胞に分化する幹細胞等のように、毛色の制御に寄与する細胞を含んでいてもよい。また、細胞群は、血管系細胞を含んでいてもよい。 A group of cells has the ability to affect tissue formation in the body by being placed in the body. One example of such cell populations are cell aggregates containing cells with stemness. The cell group contributes to hair growth or growth, for example, by being placed intradermally or subcutaneously. Specifically, the cell group has the ability to function as a hair follicle organ, the ability to differentiate into the hair follicle organ, the ability to induce or promote the formation of the hair follicle organ, or the ability to induce or promote the formation of hair in the hair follicle organ. have the ability to The cell group may also contain cells that contribute to the control of coat color, such as pigment cells or stem cells that differentiate into pigment cells. In addition, the cell group may contain vascular cells.
 細胞群の具体例は、器官原基である。器官原基は、間葉系細胞と上皮系細胞とを含む。器官原基の例は、毛包器官に分化する毛包原基、肝臓の原基、腎臓の原基、膵臓の原基、神経系の原基細胞や血管系の原基細胞等の細胞群である。 A specific example of a cell group is an organ primordium. The organ primordium contains mesenchymal and epithelial cells. Examples of organ primordium include cell groups such as hair follicle primordium that differentiates into hair follicle organ, liver primordium, kidney primordium, pancreatic primordium, nervous system primordium cells, and vascular system primordium cells. is.
 例えば、毛包原基は、間葉系細胞からなる細胞塊と上皮系細胞からなる細胞塊とを含み、これらの2種類の細胞塊は互いに接触している。毛包器官では、間葉系の細胞塊に含まれる毛乳頭細胞が、上皮系の細胞塊に含まれる毛包上皮幹細胞の分化を誘導し、これによって形成された毛球部にて毛母細胞が分裂を繰り返すことにより、毛が形成される。毛包原基は、こうした毛包器官に分化する細胞群である。 For example, the hair follicle primordium contains a cell mass composed of mesenchymal cells and a cell mass composed of epithelial cells, and these two types of cell masses are in contact with each other. In the hair follicle organ, dermal papilla cells contained in the mesenchymal cell mass induce differentiation of hair follicle epithelial stem cells contained in the epithelial cell mass, and hair matrix cells are formed in the hair bulb formed by this. Hair is formed by repeated division of . A hair follicle primordium is a group of cells that differentiate into such hair follicle organs.
 毛包原基は、例えば、毛乳頭等の間葉組織に由来する間葉系細胞と、バルジ領域や毛球基部等に位置する上皮組織に由来する上皮系細胞とを、それぞれ所定の条件で培養することによって細胞塊を形成し、これらの細胞塊を接触させることで形成される。ただし、毛包原基の製造方法は上述の例に限定されない。また、毛包原基の製造に用いられる間葉系細胞と上皮系細胞との由来も限定されず、これらの細胞は、毛包器官由来の細胞であってもよいし、毛包器官とは異なる器官由来の細胞であってもよいし、多能性幹細胞から誘導された細胞であってもよい。 For the hair follicle primordium, for example, mesenchymal cells derived from mesenchymal tissue such as dermal papilla, and epithelial cells derived from epithelial tissue located in the bulge region, hair bulb base, etc. It is formed by forming cell clusters by culturing and bringing these cell clusters into contact. However, the method for producing the hair follicle primordia is not limited to the above examples. In addition, the origin of the mesenchymal cells and epithelial cells used for the production of the hair follicle primordium is not limited, and these cells may be cells derived from the hair follicle organ. Cells derived from different organs may be used, or cells derived from pluripotent stem cells may be used.
 また、細胞群は、間葉系の細胞塊と上皮系の細胞塊に加えて、生着や機能の向上に寄与する細胞塊を含んでいてもよい。こうした細胞塊の例は、毛色に関わる細胞塊、血管系細胞を含む細胞塊、成長因子を放出する細胞塊等である。 In addition to mesenchymal cell masses and epithelial cell masses, the cell masses may also contain cell masses that contribute to engraftment and functional improvement. Examples of such cell clusters are cell clusters involved in hair color, cell clusters containing vascular cells, and cell clusters that release growth factors.
 なお、移植物50は、細胞群に加えて、細胞群の移植や生着を補助する部材や、細胞群を保護するゲル状体を含んでいてもよい。細胞群の移植や生着を補助する部材の例は、成長因子を徐放するゲルビーズである。 In addition to the cell group, the implant 50 may contain a member that assists the transplantation and engraftment of the cell group, and a gel-like body that protects the cell group. An example of a member that assists transplantation or engraftment of cell groups is gel beads that slowly release growth factors.
 補助液51は、細胞の生存を阻害し難い成分であればよく、また、生体に注入された場合に生体に与える影響の小さい成分であることが好ましい。補助液51は、移植物50を取り囲んで移植物50と収容孔25の内側面との接触や摩擦を抑えることで、移植物50の活性の維持を補助する。あるいは、移植物50は、生体の体液に近しい成分を含有して移植物50を包むことや移植物50に対して栄養を提供することで移植物50の活性の維持や生着を補助してもよい。 The auxiliary liquid 51 may be a component that does not easily inhibit the survival of cells, and is preferably a component that has a small effect on the living body when injected into the living body. The auxiliary liquid 51 surrounds the implant 50 and suppresses contact and friction between the implant 50 and the inner surface of the receiving hole 25 , thereby helping to maintain the activity of the implant 50 . Alternatively, the implant 50 contains a component close to the body fluid of the living body to wrap the implant 50 or provide nutrition to the implant 50, thereby assisting the maintenance of the activity of the implant 50 and engraftment. good too.
 補助液51は、例えば、生理食塩水、ワセリンや化粧水等の皮膚を保護する物質、あるいは、これらの混合物である。また、補助液51は、栄養成分や、細胞の生存に必要な酸素等の成分を含んでいてもよい。また、補助液51は、細胞の培養のための培地であってもよい。補助液51は、低粘度の流体、あるいは、高粘度の流体であり得る。補助液51は、ゾル状体、あるいは、ゲル状体であってもよい。 The auxiliary liquid 51 is, for example, a physiological saline solution, a substance that protects the skin such as vaseline or lotion, or a mixture thereof. In addition, the auxiliary liquid 51 may contain nutritional components and components such as oxygen necessary for cell survival. Also, the auxiliary liquid 51 may be a medium for culturing cells. The auxiliary liquid 51 can be a low viscosity fluid or a high viscosity fluid. The auxiliary liquid 51 may be a sol or gel.
 [細胞移植ユニットの材料]
 細胞移植ユニット10の各部の材料について詳細に説明する。
 針状部20は、水溶性材料と油性材料とを含み、生体内でこれらの材料の溶解、融解、あるいは、分解により、その形状を失う。言い換えれば、針状部20は生体内で溶ける。針状部20において、水溶性材料と油性材料とは均一に混合されている。言い換えれば、針状部20の材料は、水溶性材料と油性材料との混合物である。
[Materials for Cell Transplantation Unit]
Materials for each part of the cell transplantation unit 10 will be described in detail.
The needle-like portion 20 contains a water-soluble material and an oily material, and loses its shape due to dissolution, melting, or decomposition of these materials in vivo. In other words, the needle-like portion 20 dissolves in vivo. In the needle-like portion 20, the water-soluble material and the oily material are uniformly mixed. In other words, the material of needle 20 is a mixture of water-soluble material and oily material.
 水溶性材料は、生体適合性を有していることが好ましい。水溶性材料の具体例は、水溶性高分子である。水溶性材料の主成分として用いられる水溶性高分子は、例えば、ヒドロキシプロピルセルロース、プルラン、ペクチン、コンドロイチン硫酸ナトリウム、デキストラン、コラーゲン、アテロコラーゲン、ヒアルロン酸、ヒアルロン酸ナトリウムである。針状部20は、複数の種類の水溶性材料を含んでいてもよい。 The water-soluble material preferably has biocompatibility. A specific example of a water-soluble material is a water-soluble polymer. Water-soluble polymers used as main components of water-soluble materials are, for example, hydroxypropylcellulose, pullulan, pectin, sodium chondroitin sulfate, dextran, collagen, atelocollagen, hyaluronic acid, and sodium hyaluronate. Needles 20 may contain more than one type of water-soluble material.
 油性材料は、非水溶性である。油性材料の具体例は、植物油脂、動物油脂、鉱油、これらを原料として合成された油脂である。油性材料は、生体に害を与え難い材料であること、すなわち、生体に接触した際に重度の炎症等の障害を引き起こし難く、かつ、臓器等の組織に対する深刻な毒性を有さない材料であることが好ましい。 The oily material is water-insoluble. Specific examples of oily materials are vegetable oils, animal oils, mineral oils, and oils synthesized using these as raw materials. The oily material should be a material that is unlikely to harm the living body, that is, a material that is unlikely to cause damage such as severe inflammation when in contact with the living body, and that does not have serious toxicity to tissues such as organs. is preferred.
 油性材料は、例えば、オリーブ油、ナタネ油、パーム油、スクワラン、ワセリン、パラフィン、ハードファットである。針状部20は、複数の種類の油性材料を含んでいてもよい。 Oily materials are, for example, olive oil, rapeseed oil, palm oil, squalane, vaseline, paraffin, and hard fat. Needle 20 may contain more than one type of oily material.
 油性材料は、室温において、固体状、または、クリーム状のように半固形状であることが好ましい。油性材料の融点は、例えば、15℃以上70℃以下であることが好ましく、30℃以上40℃以下であることがより好ましい。油性材料の融点が上記範囲であれば、室温で油性材料が液状になることが抑えられるため、使用前において針状部20が所望の形状に保たれやすくなる。一方で、生体内の温度によって油性材料が液状になりやすくなるため、生体内に針状部20が長期に残留することが抑えられる。 The oily material is preferably solid or semi-solid such as cream at room temperature. The melting point of the oily material is, for example, preferably 15° C. or higher and 70° C. or lower, and more preferably 30° C. or higher and 40° C. or lower. If the melting point of the oil-based material is within the above range, the oil-based material is prevented from becoming liquid at room temperature, and thus the needle-like portion 20 can be easily maintained in a desired shape before use. On the other hand, since the temperature in the living body makes the oily material more likely to be liquefied, it is possible to prevent the needle-like portion 20 from remaining in the living body for a long period of time.
 針状部20の総質量に対する油性材料の割合は、1質量%以上60質量%以下であることが好ましい。また、針状部20の総質量に対する水溶性材料の割合は、40質量%以上99質量%以下であることが好ましい。油性材料の割合が60質量%以下、かつ、水溶性材料の割合が40質量%以上であれば、針状部20の強度が適度に得られる。また、水溶性材料と油性材料との混合が容易になるとともに、針状部20を所望の形状に形成しやすくなる。また、油性材料の割合が1質量%以上、かつ、水溶性材料の割合が99質量%以下であれば、生体と針状部20との接触時に針状部20が急速に溶けることが抑えられる。 The ratio of the oily material to the total mass of the needle-like portion 20 is preferably 1% by mass or more and 60% by mass or less. Moreover, the ratio of the water-soluble material to the total mass of the needle-like portion 20 is preferably 40% by mass or more and 99% by mass or less. If the ratio of the oil-based material is 60% by mass or less and the ratio of the water-soluble material is 40% by mass or more, the strength of the needle-like portion 20 can be appropriately obtained. In addition, it becomes easier to mix the water-soluble material and the oily material, and it becomes easier to form the needle-like portion 20 into a desired shape. Further, when the ratio of the oily material is 1% by mass or more and the ratio of the water-soluble material is 99% by mass or less, rapid dissolution of the needle-like portion 20 upon contact between the living body and the needle-like portion 20 can be suppressed. .
 針状部20は、さらに、針状部20の成形、あるいは、細胞の活性の維持や生着に寄与する成分を有する添加剤を含んでいてもよい。例えば、針状部20は、針状部20の形成を容易にするための添加剤として、界面活性剤や乳化剤を含んでいてもよい。具体的には、油性材料がワセリンのように融点の高い材料である場合、界面活性剤の添加によって、水溶性材料と油性材料とを混和しやすくなる。界面活性剤としては、例えば、ショ糖脂肪酸エステルが好適に用いられる。針状部20の総質量に対する界面活性剤の割合は、0.1質量%以上5質量%以下であることが好ましい。 The needle-like portion 20 may further contain an additive having a component that contributes to shaping of the needle-like portion 20 or maintenance of cell activity and engraftment. For example, the needle-like portion 20 may contain a surfactant or an emulsifier as an additive for facilitating the formation of the needle-like portion 20 . Specifically, when the oil-based material is a material with a high melting point, such as vaseline, the addition of a surfactant makes it easier to mix the water-soluble material and the oil-based material. As the surfactant, for example, sucrose fatty acid ester is preferably used. A ratio of the surfactant to the total mass of the needle-like portion 20 is preferably 0.1% by mass or more and 5% by mass or less.
 例えば、油性材料としてパーム油を用いる場合、針状部20において、パーム油の含有量は1質量%以上30質量%以下であることが好ましい。また、油性材料としてワセリンを用いる場合、針状部20は、ワセリンとショ糖脂肪酸エステルとを含み、針状部20において、ワセリンの含有量が5質量%以上40質量%以下、かつ、ショ糖脂肪酸エステルの含有量が0.5質量%以上2質量%以下であることが好ましい。こうした構成によれば、針状部20を所望の形状に形成しやすくなる。 For example, when palm oil is used as the oily material, the content of palm oil in the needle-like portion 20 is preferably 1% by mass or more and 30% by mass or less. Further, when petrolatum is used as the oily material, the needle-like portion 20 contains petrolatum and sucrose fatty acid ester, and the content of petroleum jelly in the needle-like portion 20 is 5% by mass or more and 40% by mass or less, and sucrose It is preferable that the content of the fatty acid ester is 0.5% by mass or more and 2% by mass or less. Such a configuration makes it easier to form the needle-like portion 20 into a desired shape.
 上述した材料以外に針状部20が含有し得る材料は、例えば、ヒドロキシプロピルメチルセルロース、デキストリン、でんぷん、セルロース、キトサン、ペクチン酸、ガラクタン、コンドロイチン硫酸、カルボキシメチルセルロース、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ポリビニルアルコール、ポリアクリル酸系ポリマー、ポリアクリルアミド、ポリエチレンオキシド、アルギン酸塩、コンドロイチン硫酸塩、ポリ2-エチル-2-2オキサゾリン、ポリ2-メチル-2-オキサゾリン、カルボキシビニルポリマー、ガラクタン、レオザン、キサンタンガム、カゼイン、ポリビニルピロリドン、グルコマンナン、ポリリンゴ酸、カードランである。
 なお、針状部20が透明であると、外部から針状部20内の移植物50の状態を確認しやすいため好ましい。
Materials that the needle-like portion 20 may contain in addition to the materials described above include, for example, hydroxypropylmethylcellulose, dextrin, starch, cellulose, chitosan, pectic acid, galactan, chondroitin sulfate, carboxymethylcellulose, methylcellulose, ethylcellulose, hydroxyethylcellulose, and polyvinyl alcohol. , polyacrylic acid-based polymer, polyacrylamide, polyethylene oxide, alginate, chondroitin sulfate, poly 2-ethyl-2-2 oxazoline, poly 2-methyl-2-oxazoline, carboxyvinyl polymer, galactan, leozan, xanthan gum, casein , polyvinylpyrrolidone, glucomannan, polymalic acid, and curdlan.
In addition, it is preferable that the needle-like portion 20 is transparent because the state of the implant 50 in the needle-like portion 20 can be easily confirmed from the outside.
 支持板部30の材料は、針状部20と同一であってもよいし、針状部20とは異なっていてもよい。また、支持板部30は、水に溶ける性質を有していてもよいし、有していなくてもよい。例えば、支持板部30は、水溶性材料と油性材料のうち、水溶性材料のみを含んでもよいし、水溶性材料および油性材料の両方を含んでもよい。あるいは、支持板部30は、水溶性材料および油性材料のいずれとも異なる材料から形成されていてもよい。 The material of the support plate portion 30 may be the same as that of the needle-like portion 20 or may be different from that of the needle-like portion 20 . Further, the support plate portion 30 may or may not have the property of dissolving in water. For example, the support plate portion 30 may contain only the water-soluble material or both the water-soluble material and the oil-based material, out of the water-soluble material and the oil-based material. Alternatively, the support plate portion 30 may be made of a material different from both the water-soluble material and the oil-based material.
 支持板部30の材料としては、例えば、針状部20の材料として例示した上述の各種の材料が用いられる。また、支持板部30として、生体適合性樹脂からなる樹脂シートが用いられてもよい。 As the material of the support plate portion 30, for example, the above various materials exemplified as the material of the needle portion 20 are used. Moreover, a resin sheet made of a biocompatible resin may be used as the support plate portion 30 .
 なお、本実施形態において、針状部20は水に溶ける。針状部20や支持板部30である対象物が水に溶けるとは、撹拌している25℃の水に対象物を浸けて5分間経過した場合に、水中にある対象物の質量の内、0.05%以上が溶出することを意味する。 It should be noted that in the present embodiment, the needle-like portion 20 dissolves in water. An object such as the needle-like portion 20 or the support plate portion 30 dissolves in water means that when the object is immersed in stirring water at 25° C. for 5 minutes, the weight of the object in the water is reduced. , means that 0.05% or more is eluted.
 [移植物の配置方法]
 図4~図6を参照して、細胞移植ユニット10を用いた生体内への移植物50の配置方法、すなわち移植物50の移植方法を説明する。移植物50の配置方法は、言い換えれば、細胞移植ユニット10の使用方法である。
[Method of placement of implant]
A method of placing the implant 50 in vivo using the cell transplantation unit 10, that is, a method of implanting the implant 50 will be described with reference to FIGS. 4 to 6. FIG. The method of placing the implant 50 is, in other words, the method of using the cell transplantation unit 10 .
 図4が示すように、まず、細胞移植ユニット10の針状部20を、移植物50の配置の対象組織Skに押し付けることによって、針状部20を対象組織Skに刺す。対象組織Skは例えば皮膚である。このとき、針状部20にかかる力や針状部20の向きを調整することで対象組織Skへの針状部20の進入を補助するアプリケーターが用いられてもよい。なお、針状部20が対象組織Skに刺さっている状態において、支持板部30は対象組織Skの内部に入り込まず、対象組織Skの表面上に配置される。 As shown in FIG. 4, first, the needle-like portion 20 of the cell transplantation unit 10 is pressed against the target tissue Sk in which the implant 50 is to be placed, thereby piercing the target tissue Sk with the needle-like portion 20 . The target tissue Sk is, for example, skin. At this time, an applicator may be used that assists the needle-like portion 20 to enter the target tissue Sk by adjusting the force applied to the needle-like portion 20 and the direction of the needle-like portion 20 . In addition, in a state in which the needle-like portion 20 is stuck in the target tissue Sk, the support plate portion 30 is arranged on the surface of the target tissue Sk without entering the inside of the target tissue Sk.
 図5が示すように、針状部20が対象組織Skの内部に入ると、針状部20と組織内の水分とが接触することや、針状部20が生体の体温付近の温度にまで温められることに起因して、針状部20が溶けていく。 As shown in FIG. 5, when the needle-like portion 20 enters the target tissue Sk, the needle-like portion 20 comes into contact with moisture in the tissue, and the needle-like portion 20 reaches a temperature close to the body temperature of the living body. Due to being warmed, the needle-like portion 20 melts.
 支持板部30が水に溶ける性質を有している場合、支持板部30と対象組織Skの表面の水分とが接触することによって、支持板部30も溶ける。支持板部30が水に溶ける性質を有していない場合、支持板部30は対象組織Skの表面から剥離される。支持板部30の剥離は、針状部20が完全に溶ける前に行われてもよいし、針状部20が完全に溶けた後に行われてもよい。支持板部30が溶ける形態であれば、支持板部30の剥離が不要となるため、細胞移植ユニット10の使用に要する手間が軽減される。 When the support plate portion 30 has the property of dissolving in water, the support plate portion 30 also dissolves due to the contact between the support plate portion 30 and the moisture on the surface of the target tissue Sk. If the support plate portion 30 does not have the property of dissolving in water, the support plate portion 30 is peeled off from the surface of the target tissue Sk. The peeling of the support plate portion 30 may be performed before the needle-like portion 20 is completely melted, or may be performed after the needle-like portion 20 is completely melted. If the support plate portion 30 is in a form that dissolves, the support plate portion 30 does not need to be peeled off, and the labor required for using the cell transplantation unit 10 is reduced.
 図6が示すように、針状部20が溶けて変形が進行すると、針状部20が崩れて消失し、針状部20の内部に保持されていた移植物50が露出されて対象組織Sk内に留め置かれる。また、移植物50と共に補助液51が収容されていた場合、補助液51も移植物50の周囲の組織に浸透する。針状部20の成分は生体内に拡散や吸収される。これにより、生体内への移植物50の配置が完了する。 As shown in FIG. 6 , when the needle-like portion 20 melts and deforms, the needle-like portion 20 collapses and disappears, exposing the implant 50 held inside the needle-like portion 20 to expose the target tissue Sk. kept inside. Moreover, when the auxiliary liquid 51 is contained together with the implant 50 , the auxiliary liquid 51 also permeates the tissue around the implant 50 . Components of the needle-like portion 20 are diffused and absorbed in the living body. This completes the placement of the implant 50 in vivo.
 以上のように、本実施形態の移植物50の配置方法によれば、移植物50は、針状部20に保持された状態で生体内に挿入され、針状部20の消失によって生体内に配置される。したがって、生体内への移植物50の配置に際して生体内からのピンセット等の器具の引き抜きが発生しないため、移植物50が器具と共に生体内から抜け出ることが抑えられる。それゆえ、移植物50の配置の効率が高められ、また、生体の組織内における移植物50の配置の深さを所望の深さに制御しやすくなる。 As described above, according to the placement method of the implant 50 of the present embodiment, the implant 50 is inserted into the living body while being held by the needle-like portion 20, and the needle-like portion 20 disappears into the living body. placed. Therefore, since an instrument such as tweezers is not pulled out of the living body when the implant 50 is placed in the living body, the implant 50 is prevented from coming out of the living body together with the instrument. Therefore, the placement efficiency of the implant 50 is enhanced, and the placement depth of the implant 50 within the tissue of the living body can be easily controlled to a desired depth.
 また、移植物50が針状部20の内部に保持された状態で生体内に挿入されるため、挿入時の衝撃から移植物50を保護することが可能であり、さらに、移植物50のみが生体内に挿入される場合と比較して、外部から見て移植物50の移植箇所も把握しやすくなる。 In addition, since the implant 50 is inserted into the living body while being held inside the needle-like portion 20, it is possible to protect the implant 50 from impact during insertion. Compared to the case where the implant is inserted into the living body, it becomes easier to grasp the implantation site of the implant 50 when viewed from the outside.
 ここで、針状部20が水溶性材料のみから形成されている場合、生体の表面に針状部20が接した時点から針状部20の溶解が急速に進行する。そして、こうした針状部20の溶解は、生体に最初に接する針状部20の先端部から進行する。それゆえ、針状部20の先端部が所望の深さまで到達する前に、先端部の形状が崩れて、針状部20が組織内に進入し難くなることが起こり得る。また、針状部20の基部が溶解すると、細胞移植ユニット10を押圧する力が針状部20に伝わりにくくなるため、これによっても、針状部20が組織内に進入し難くなることが起こり得る。結果として、針状部20が所望の深さまで刺さらず、生体内への移植物50の配置が阻害される場合がある。 Here, when the needle-like portion 20 is formed only from a water-soluble material, dissolution of the needle-like portion 20 progresses rapidly from the time the needle-like portion 20 comes into contact with the surface of the living body. Such dissolution of the needle-like portion 20 progresses from the tip portion of the needle-like portion 20 that first comes into contact with the living body. Therefore, before the distal end of the needle-like portion 20 reaches a desired depth, the shape of the distal end may be lost, making it difficult for the needle-like portion 20 to enter the tissue. Further, when the base of the needle-like portion 20 dissolves, the force that presses the cell transplantation unit 10 is less likely to be transmitted to the needle-like portion 20, which also makes it difficult for the needle-like portion 20 to enter the tissue. obtain. As a result, the needle-like portion 20 may not penetrate to the desired depth, and placement of the implant 50 into the living body may be hindered.
 これに対し、本実施形態では、針状部20が水溶性材料に加えて油性材料を含んでいるため、針状部20が水溶性材料のみからなる場合と比較して、針状部20の形状の崩れが緩やかに進行する。例えば、針状部20における油性材料の割合が、50質量%程度であるとき、針状部20の形状が完全に失われるまでに要する時間は、針状部20が水溶性材料のみからなる場合の1.2倍~10倍程度になる。したがって、針状部20が生体内に進入した初期においては、針状部20の形状が保たれやすくなるため、針状部20が所望の深さまで刺さりやすくなる。それゆえ、移植物50が所望の深さに配置されやすくなる。なお、針状部20が溶ける速さは、水溶性材料および油性材料の種類と、油性材料の割合とによって調整できる。 On the other hand, in the present embodiment, since the needle-like portion 20 contains an oil-based material in addition to the water-soluble material, the needle-like portion 20 is more dense than the case where the needle-like portion 20 is made of only the water-soluble material. The collapse of the shape progresses gently. For example, when the ratio of the oil-based material in the needle-like portion 20 is about 50% by mass, the time required for the needle-like portion 20 to completely lose its shape is 1.2 times to 10 times of Therefore, at the initial stage when the needle-like part 20 enters the living body, the shape of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stabbed to a desired depth. Therefore, it becomes easier to place the implant 50 at the desired depth. In addition, the speed at which the needle-like portion 20 dissolves can be adjusted by the types of the water-soluble material and the oil-based material, and the ratio of the oil-based material.
 また、支持板部30の液状化が、針状部20が溶けた後に完了する場合や、針状部20が溶けた後に支持板部30が剥離される場合、針状部20が溶けている途中には、対象組織Skにおいて針状部20が刺さっている箇所の表面が支持板部30によって覆われる。それゆえ、外部からの衝撃を受けた場合であっても、針状部20や移植物50が対象組織Skから抜け出ることが抑えられる。 Further, when the liquefaction of the support plate portion 30 is completed after the needle portion 20 is melted, or when the support plate portion 30 is peeled off after the needle portion 20 is melted, the needle portion 20 is melted. On the way, the surface of the target tissue Sk where the needle-like portion 20 is stuck is covered with the support plate portion 30 . Therefore, the needle-like portion 20 and the implant 50 are prevented from slipping out of the target tissue Sk even when receiving an external impact.
 一方、支持板部30の液状化が、針状部20が溶ける前に完了する場合や、針状部20が溶ける前に支持板部30が剥離される場合、針状部20が刺さっている位置を視認しやすくなる。したがって、針状部20が刺さっている位置の保護やこの位置に対する薬剤の塗布等の追加の処理を容易に行うことができる。 On the other hand, when the liquefaction of the support plate portion 30 is completed before the needle portion 20 melts, or when the support plate portion 30 is peeled off before the needle portion 20 melts, the needle portion 20 is stuck. Makes it easier to see the position. Therefore, additional processing such as protection of the position where the needle-like portion 20 is stuck and application of medicine to this position can be easily performed.
 支持板部30が水に溶ける性質を有する場合、支持板部30が溶ける速さは、支持板部30の材料によって調整できる。例えば、支持板部30が、針状部20と同一の種類の水溶性材料と油性材料とを含み、かつ、支持板部30における油性材料の割合と、針状部20における油性材料の割合とが互いに異なっていれば、支持板部30の溶ける速度と針状部20の溶ける速度とを異ならせることができる。 When the support plate portion 30 has the property of dissolving in water, the speed at which the support plate portion 30 dissolves can be adjusted by the material of the support plate portion 30 . For example, the support plate portion 30 contains the same types of water-soluble material and oily material as the needle-like portion 20, and the ratio of the oily material in the support plate portion 30 and the ratio of the oily material in the needle-like portion 20 are different from each other, the melting speed of the support plate portion 30 and the melting speed of the needle-like portion 20 can be made different.
 なお、細胞移植ユニット10が複数の針状部20を備える場合、各針状部20における油性材料の割合は一定でなくてもよい。すなわち、複数の針状部20に第1の針状部20と第2の針状部20とが含まれ、第1の針状部20における油性材料の割合と、第2の針状部20における油性材料の割合とが互いに異なっていてもよい。こうした構成によれば、第1の針状部20と第2の針状部20とにおいて、形状の消失に要する時間を異ならせることができる。さらに、第1の針状部20が含む油性材料と、第2の針状部20が含む油性材料とは、互いに異なっていてもよい。また、細胞移植ユニット10は、油性材料を含まない針状部を備えていてもよい。 In addition, when the cell transplantation unit 10 includes a plurality of needle-like portions 20, the proportion of the oily material in each needle-like portion 20 may not be constant. That is, the first needle-like portion 20 and the second needle-like portion 20 are included in the plurality of needle-like portions 20, and the ratio of the oily material in the first needle-like portion 20 and the second needle-like portion 20 may differ from each other. According to such a configuration, the first needle-like portion 20 and the second needle-like portion 20 can have different times required for the shape to disappear. Furthermore, the oily material contained in the first needle-like portion 20 and the oily material contained in the second needle-like portion 20 may be different from each other. Moreover, the cell transplantation unit 10 may have a needle-like portion that does not contain an oily material.
 [細胞移植ユニットの製造方法]
 図7および図8を参照して、細胞移植ユニット10の製造方法を説明する。
 図7が示すように、針状部20は、所望の針状部20の形状に対応する凹部81を有する凹版80に、針状部20の材料を含む液体である針状部形成液を充填し、充填物を固化させることによって形成される。移植物50は、充填物の固化の後に、培養容器等のトレイから、針状部20の内部に入れられる。
[Method for producing cell transplantation unit]
A method for manufacturing the cell transplantation unit 10 will be described with reference to FIGS. 7 and 8. FIG.
As shown in FIG. 7, the needle-shaped portion 20 is formed by filling an intaglio 80 having recesses 81 corresponding to the desired shape of the needle-shaped portion 20 with a needle-shaped portion forming liquid, which is a liquid containing the material of the needle-shaped portion 20 . and formed by solidifying the filling. The implant 50 is placed inside the needle 20 from a tray such as a culture vessel after solidification of the filler.
 針状部形成液は、例えば、水等の溶媒に水溶性材料が溶かされた後、この溶液に油性材料が混合されることにより生成される。針状部形成液の生成に際しては、材料の加熱が行われてもよい。充填物の固化は、乾燥により行われてもよいし、紫外線や熱が用いられてもよい。 The needle-shaped portion forming liquid is produced by, for example, dissolving a water-soluble material in a solvent such as water, and then mixing the solution with an oily material. The material may be heated when generating the needle-shaped portion forming liquid. Solidification of the filling may be performed by drying, or ultraviolet rays or heat may be used.
 収容孔25を形成する場合には、針状部20となる充填物の中央部に気泡が集まるように針状部形成液の充填および固化を制御することで、針状部20の内部に空隙が形成される。これによって当該空隙である収容孔25を形成することができる。あるいは、収容孔25に対応する形状のピン状の構造体が充填物の中央部に挿入された状態で充填物が固化された後、当該構造体が取り除かれてもよい。これにより、ピン状の構造体が位置していた部分に収容孔25である空隙を形成することができる。 When forming the accommodation hole 25 , by controlling the filling and solidification of the needle-shaped portion forming liquid so that air bubbles gather in the central portion of the filling that becomes the needle-shaped portion 20 , a void is formed inside the needle-shaped portion 20 . is formed. Accordingly, the accommodating hole 25, which is the gap, can be formed. Alternatively, a pin-shaped structure having a shape corresponding to the receiving hole 25 may be inserted into the central portion of the filling and removed after the filling is solidified. As a result, a gap, which is the receiving hole 25, can be formed in the portion where the pin-shaped structure was positioned.
 図8が示すように、針状部20の基端に位置する面上に、支持板部30が配置され、針状部20と支持板部30とが接合される。支持板部30は、例えば、2つの板状部材の間に支持板部30の材料が挟まれ、当該材料が固化されることによって形成される。 As shown in FIG. 8, the support plate portion 30 is arranged on the surface positioned at the proximal end of the needle portion 20, and the needle portion 20 and the support plate portion 30 are joined. The support plate portion 30 is formed, for example, by sandwiching the material of the support plate portion 30 between two plate-like members and solidifying the material.
 支持板部30は、接着剤によって接合されてもよいし、熱溶着や超音波振動を利用した溶着によって接合されてもよい。また、支持板部30の接合に際して針状部20が熱等により軟化されてもよい。
 針状部20を凹版80から離型することで、細胞移植ユニット10が得られる。離型は、支持板部30の接合前に行われてもよい。
The support plate portion 30 may be joined with an adhesive, or may be joined by heat welding or welding using ultrasonic vibration. Moreover, the needle-like portion 20 may be softened by heat or the like when the support plate portion 30 is joined.
By releasing the needle-like portion 20 from the intaglio 80, the cell transplantation unit 10 is obtained. The release may be performed before the support plate portion 30 is joined.
 なお、針状部20の内部に移植物50を保持した細胞移植ユニット10が形成可能であれば、細胞移植ユニット10の製造方法は、上述の製造方法とは異なっていてもよい。例えば、支持板部30に対応する凹部が凹版80に設けられ、当該凹部に対する支持板部30の材料の充填と固化によって、支持板部30が形成されてもよい。 As long as the cell transplantation unit 10 holding the implant 50 inside the needle-like portion 20 can be formed, the manufacturing method of the cell transplantation unit 10 may be different from the manufacturing method described above. For example, a concave portion corresponding to the support plate portion 30 may be provided in the intaglio 80, and the support plate portion 30 may be formed by filling the concave portion with the material of the support plate portion 30 and solidifying the material.
 以上、第1実施形態によれば、以下に列挙する効果を得ることができる。
 (1)移植物50が、針状部20に保持された状態で生体内に挿入され、針状部20が溶けることによって生体内に配置される。したがって、移植物50が生体内から抜け出ることが抑えられるため、移植物50の配置の効率が高められ、また、生体の組織内における移植物50の配置の深さを所望の深さに制御しやすくなる
 (2)針状部20が水溶性材料と油性材料とを含むため、針状部20が急速に溶解することが抑えられる。したがって、針状部20が生体内に進入した初期においては、針状部20の形状が保たれやすくなるため、針状部20が所望の深さまで刺さりやすくなる。それゆえ、移植物50が所望の深さに配置されやすくなる。
As described above, according to the first embodiment, the following effects can be obtained.
(1) The implant 50 is inserted into the living body while being held by the needle-like portion 20, and is arranged in the living body by the needle-like portion 20 melting. Therefore, since the implant 50 is prevented from coming out of the living body, the placement efficiency of the implant 50 is enhanced, and the placement depth of the implant 50 in the tissue of the living body can be controlled to a desired depth. (2) Since needle-like portion 20 contains a water-soluble material and an oily material, rapid dissolution of needle-like portion 20 is suppressed. Therefore, at the initial stage when the needle-like part 20 enters the living body, the shape of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stabbed to a desired depth. Therefore, it becomes easier to place the implant 50 at the desired depth.
 (3)水溶性材料が、水溶性高分子を含み、油性材料が、植物油脂、動物油脂、鉱油、および、これらを原料として合成された油脂の少なくとも1つを含む。こうした構成によれば、生体内で緩やかに溶ける針状部20が好適に実現される。 (3) The water-soluble material contains a water-soluble polymer, and the oily material contains at least one of vegetable oil, animal oil, mineral oil, and oil synthesized using these as raw materials. According to such a configuration, the needle-like portion 20 that is gently dissolved in the living body is preferably realized.
 (4)針状部20における油性材料の割合が60質量%以下であると、針状部20の強度が適度に得られる。また、水溶性材料と油性材料とを混合して針状部20を所望の形状に形成することが容易になる。 (4) When the ratio of the oily material in the needle-like portion 20 is 60% by mass or less, the strength of the needle-like portion 20 can be appropriately obtained. Further, it becomes easy to mix the water-soluble material and the oil-based material to form the needle-like portion 20 into a desired shape.
 (5)針状部20にて、水溶性材料と油性材料とが均一に混合されているため、針状部20の全体において、針状部20の急速な溶解を抑えることができる。
 (6)針状部20の材料に界面活性剤が含まれていれば、油溶性材料の融点が高い場合であっても、水溶性材料と油溶性材料とを混和しやすくなる。
(5) Since the water-soluble material and the oily material are uniformly mixed in the needle-like portion 20, rapid dissolution of the needle-like portion 20 can be suppressed in the entire needle-like portion 20.
(6) If the material of the needle-like portion 20 contains a surfactant, the water-soluble material and the oil-soluble material can easily be mixed even when the melting point of the oil-soluble material is high.
 (7)支持板部30が水溶性材料と油性材料とを含んでいることにより、支持板部30が生体の表面に接したときに、支持板部30が溶ける。これにより、支持板部30の剥離が不要になるため、細胞移植ユニット10の使用に要する手間が軽減される。また、油性材料の含有により、支持板部30の溶ける速さの調整が可能である。 (7) Since the support plate portion 30 contains a water-soluble material and an oily material, the support plate portion 30 melts when the support plate portion 30 comes into contact with the surface of the living body. This eliminates the need to peel off the support plate portion 30 , thereby reducing the labor required for using the cell transplantation unit 10 . In addition, the melting speed of the support plate portion 30 can be adjusted by containing the oily material.
 (8)支持板部30における油性材料の割合が、針状部20における油性材料の割合と異なっていれば、支持板部30の溶ける速さを針状部20の溶ける速さと異ならせることができる。 (8) If the ratio of the oil-based material in the support plate portion 30 is different from the ratio of the oil-based material in the needle-like portion 20, the dissolving speed of the support plate portion 30 can be made different from the dissolving speed of the needle-like portion 20. can.
 (9)細胞移植ユニット10が、複数の針状部20を備え、第1の針状部20における油性材料の割合が、第2の針状部20における油性材料の割合と異なっていれば、第1の針状部20の溶ける速さを第2の針状部20の溶ける速さと異ならせることができる。 (9) If the cell transplantation unit 10 has a plurality of needle-like portions 20 and the ratio of the oily material in the first needle-like portion 20 is different from the ratio of the oily material in the second needle-like portion 20, The melting speed of the first needle-like portion 20 can be made different from the melting speed of the second needle-like portion 20 .
 (第2実施形態)
 図9~図11を参照して、収容デバイス、細胞移植ユニット、および、収容デバイスの製造方法の第2実施形態を説明する。第2実施形態では、針状部の構成が第1実施形態と異なる。第2実施形態における移植物の構成および移植物の配置の対象は、第1実施形態と同様である。以下では、第2実施形態と第1実施形態との相違点を中心に説明し、第1実施形態と同様の構成については同じ符号を付してその説明を省略する。
(Second embodiment)
A second embodiment of the containing device, the cell transplantation unit, and the manufacturing method of the containing device will be described with reference to FIGS. 9 to 11. FIG. In the second embodiment, the configuration of the needle-like portion is different from that in the first embodiment. The configuration of the implant and the placement of the implant in the second embodiment are the same as in the first embodiment. In the following, the differences between the second embodiment and the first embodiment will be mainly described, and the same reference numerals will be given to the same configurations as in the first embodiment, and the description thereof will be omitted.
 第2実施形態の細胞移植ユニット11の針状部20においては、油性材料の濃度が偏っている。具体的には、針状部20は、水溶性部21と油性部22とを有する。針状部20は、針状体の一例である。水溶性部21は水溶性材料を含み、油性部22は油性材料を含む。水溶性材料および油性材料としては、第1実施形態で例示した材料が用いられる。支持板部30の構成は第1実施形態と同様である。また、第2実施形態の細胞移植ユニット11を用いた生体内への移植物50の配置は、第1実施形態と同様の手順で行われる。 The concentration of the oily material is uneven in the needle-like portion 20 of the cell transplantation unit 11 of the second embodiment. Specifically, the needle-like portion 20 has a water-soluble portion 21 and an oily portion 22 . Needle-like part 20 is an example of a needle-like object. The water-soluble part 21 contains a water-soluble material, and the oily part 22 contains an oily material. Materials exemplified in the first embodiment are used as the water-soluble material and the oily material. The configuration of the support plate portion 30 is the same as that of the first embodiment. Also, placement of the transplant 50 in vivo using the cell transplantation unit 11 of the second embodiment is performed in the same procedure as in the first embodiment.
 図9が示す第1例の細胞移植ユニット11Aは、針状部20の表層に油性部22を備える。言い換えれば、油性部22は、水溶性部21の表面を覆っている。水溶性部21は、第1実施形態の針状部20と同様に、生体を刺すことの可能な形状を有する。移植物50は、水溶性部21に保持されている。なお、第1実施形態の細胞移植ユニット10Bと同様に、水溶性部21に形成された収容孔に移植物50が収容されていてもよい。 A cell transplantation unit 11A of the first example shown in FIG. In other words, the oily part 22 covers the surface of the water-soluble part 21 . The water-soluble portion 21 has a shape capable of piercing a living body, like the needle-like portion 20 of the first embodiment. The implant 50 is held in the water-soluble portion 21 . The transplant 50 may be housed in the housing hole formed in the water-soluble portion 21, as in the cell transplantation unit 10B of the first embodiment.
 第1例の細胞移植ユニット11Aによれば、針状部20を生体に刺したときに、油性部22が溶けるまで、水溶性部21が水分に接し難くなる。そのため、針状部20の全体が水溶性部21である場合と比較して、水溶性部21の溶解の開始を遅らせることができる。したがって、針状部20が生体内に進入した初期においては、生体に刺さりやすい形状が保たれやすくなるため、針状部20が所望の深さまで刺さりやすくなる。それゆえ、移植物50が所望の深さに配置されやすくなる。 According to the cell transplantation unit 11A of the first example, when the needle-shaped part 20 is pierced into the living body, the water-soluble part 21 becomes difficult to come into contact with water until the oily part 22 dissolves. Therefore, the start of dissolution of the water-soluble portion 21 can be delayed compared to the case where the entire needle-like portion 20 is the water-soluble portion 21 . Therefore, in the initial period after the needle-like portion 20 has entered the living body, the needle-like portion 20 can easily stick to the living body to a desired depth because the shape of the needle-like portion 20 can easily be maintained. Therefore, it becomes easier to place the implant 50 at the desired depth.
 なお、油性部22は、水溶性部21の表面の一部のみを覆っていてもよい。例えば、油性部22が水溶性部21の先端部のみを覆う形態であっても、針状部20の先端部の形状が保たれやすくなるため、針状部20が所望の深さまで刺さりやすくなる。 Note that the oily part 22 may cover only part of the surface of the water-soluble part 21 . For example, even if the oily part 22 covers only the tip of the water-soluble part 21, the shape of the tip of the needle-like part 20 is easily maintained, so that the needle-like part 20 can be easily stuck to a desired depth. .
 第1例の細胞移植ユニット11Aは、例えば、凹版における針状部20の形状に対応する凹部の内側面に油性部22の材料を塗布して油性部22を形成した後に、水溶性部21の材料を充填して水溶性部21を形成することによって形成できる。あるいは、凹版を用いて水溶性部21を形成した後に、水溶性部21の表面に油性部22の材料を塗布することによって油性部22を形成してもよい。 In the cell transplantation unit 11A of the first example, for example, after forming the oily portion 22 by applying the material of the oily portion 22 to the inner surface of the concave portion corresponding to the shape of the needle-like portion 20 in the intaglio, the water-soluble portion 21 is formed. It can be formed by filling the material to form the water-soluble portion 21 . Alternatively, after the water-soluble portion 21 is formed using an intaglio, the oily portion 22 may be formed by coating the surface of the water-soluble portion 21 with the material for the oily portion 22 .
 図10が示す第2例の細胞移植ユニット11Bは、針状部20の基部に油性部22を備える。油性部22以外の部分は水溶性部21であり、針状部20の先端部は水溶性部21に含まれる。油性部22は、支持板部30に接していてもよいし、針状部20の基部において水溶性部21に囲まれていてもよい。また、図10では、油性部22が水溶性部21と支持板部30とで囲まれている形態を示しているが、油性部22の強度が十分に得られる場合には、針状部20の基部の全体が油性部22であって、油性部22は針状部20の表面に露出していてもよい。 A cell transplantation unit 11B of the second example shown in FIG. The portion other than the oily portion 22 is the water-soluble portion 21 , and the tip portion of the needle-like portion 20 is included in the water-soluble portion 21 . The oily portion 22 may be in contact with the support plate portion 30 or may be surrounded by the water-soluble portion 21 at the base of the needle-like portion 20 . FIG. 10 shows a configuration in which the oily portion 22 is surrounded by the water-soluble portion 21 and the support plate portion 30. The entire base of is the oily part 22 , and the oily part 22 may be exposed on the surface of the needle-like part 20 .
 移植物50は、水溶性部21に保持されていてもよいし、油性部22に保持されていてもよい。また、第1実施形態の細胞移植ユニット10Bと同様に、水溶性部21および油性部22に形成された収容孔、もしくは、油性部22に形成された収容孔に、移植物50が収容されていてもよい。 The implant 50 may be held by the water-soluble portion 21 or may be held by the oily portion 22 . In addition, similarly to the cell transplantation unit 10B of the first embodiment, the implant 50 is accommodated in the accommodation hole formed in the water-soluble portion 21 and the oily portion 22 or the accommodation hole formed in the oily portion 22. may
 第2例の細胞移植ユニット11Bによれば、針状部20の全体が水溶性部21である場合と比較して、針状部20を生体に刺したときに、針状部20の基部が溶けるまでに要する時間が長くなる。したがって、針状部20の基部が急速に溶解して細胞移植ユニット11を押圧する力が針状部20に伝わりにくくなることが抑えられる。そのため、針状部20が所望の深さまで刺さりやすくなる。 According to the cell transplantation unit 11B of the second example, compared to the case where the needle-like portion 20 is entirely water-soluble portion 21, when the needle-like portion 20 is pierced into the living body, the base of the needle-like portion 20 is It takes longer to dissolve. Therefore, it is suppressed that the base portion of the needle-like portion 20 rapidly dissolves and the force that presses the cell transplantation unit 11 is less likely to be transmitted to the needle-like portion 20 . Therefore, the needle-like portion 20 can easily stick to a desired depth.
 また、針状部20の基部が急速に溶解すると、溶解した基部である液体から移植物50が圧力を受ける場合がある。針状部20の基部に油性部22が含まれることで、このように移植物50に急な圧力がかかることも抑えられる。さらに、針状部20の基部の形状が保たれやすいため、支持板部30の液状化や剥離によって、針状部20が刺さっている位置を視認しやすくなる。 Also, if the base of the needle-like portion 20 rapidly dissolves, the implant 50 may receive pressure from the liquid that is the dissolved base. By including the oily part 22 in the base of the needle-like part 20, such sudden pressure on the implant 50 is also suppressed. Furthermore, since the shape of the base portion of the needle-like portion 20 is easily maintained, the position where the needle-like portion 20 is stuck can be easily visually recognized due to liquefaction or peeling of the support plate portion 30 .
 第2例の細胞移植ユニット11Bは、例えば、凹版における針状部20の形状に対応する凹部に、水溶性部21の材料を充填して水溶性部21を形成した後、油性部22の材料を充填して油性部22を形成することによって形成できる。 In the cell transplantation unit 11B of the second example, for example, after filling the material of the water-soluble portion 21 into the concave portion corresponding to the shape of the needle-like portion 20 in the intaglio to form the water-soluble portion 21, the material of the oily portion 22 is formed. to form the oily part 22 .
 図11は、第3例の細胞移植ユニット11Cを示す。油性部22の強度が十分に得られる場合には、図11が示すように、細胞移植ユニット11Cは、針状部20の先端部に油性部22を備えてもよい。油性部22以外の部分は水溶性部21であり、針状部20の基部は水溶性部21に含まれる。 FIG. 11 shows a cell transplantation unit 11C of the third example. When sufficient strength of the oily part 22 can be obtained, the cell transplantation unit 11C may include the oily part 22 at the distal end of the needle-like part 20, as shown in FIG. The portion other than the oily portion 22 is the water-soluble portion 21 , and the base portion of the needle-like portion 20 is included in the water-soluble portion 21 .
 移植物50は、水溶性部21に保持されていてもよいし、油性部22に保持されていてもよい。また、第1実施形態の細胞移植ユニット10Bと同様に、水溶性部21に形成された収容孔、もしくは、水溶性部21および油性部22に形成された収容孔に、移植物50が収容されていてもよい。 The implant 50 may be held by the water-soluble portion 21 or may be held by the oily portion 22 . In addition, similarly to the cell transplantation unit 10B of the first embodiment, the implant 50 is accommodated in the accommodation hole formed in the water-soluble portion 21 or the accommodation hole formed in the water-soluble portion 21 and the oily portion 22. may be
 第3例の細胞移植ユニット11Cによれば、針状部20の全体が水溶性部21である場合と比較して、針状部20を生体に刺したときに、針状部20の先端部の形状が保たれやすくなる。したがって、針状部20が所望の深さまで刺さりやすくなるため、移植物50が所望の深さに配置されやすくなる。 According to the cell transplantation unit 11C of the third example, compared to the case where the entire needle-like portion 20 is the water-soluble portion 21, when the needle-like portion 20 is pierced into the living body, the tip portion of the needle-like portion 20 It becomes easy to keep the shape of Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
 第3例の細胞移植ユニット11Cは、例えば、凹版における針状部20の形状に対応する凹部に、油性部22の材料を充填して油性部22を形成した後に、水溶性部21の材料を充填して水溶性部21を形成することによって形成できる。 In the cell transplantation unit 11C of the third example, for example, after forming the oily portion 22 by filling the concave portion corresponding to the shape of the needle-like portion 20 in the intaglio to form the oily portion 22, the material for the water-soluble portion 21 is added. It can be formed by filling to form the water-soluble portion 21 .
 [変形例]
 第2実施形態の細胞移植ユニット11においては、針状部20が水溶性部21と油性部22とを有していれば、油性部22の位置は、上述した第1例~第3例とは異なっていてもよい。例えば、針状部20の中央部に油性部22が位置していてもよいし、針状部20は、針状部20内において互いに離れた複数の油性部22を有していてもよい。
[Modification]
In the cell transplantation unit 11 of the second embodiment, if the needle-like portion 20 has the water-soluble portion 21 and the oily portion 22, the position of the oily portion 22 is the same as in the first to third examples described above. can be different. For example, the oily part 22 may be located in the central part of the needle-like part 20 , or the needle-like part 20 may have a plurality of oily parts 22 separated from each other within the needle-like part 20 .
 また、第1例~第3例に示したように、水溶性部21と油性部22との境界面が存在してもよいし、あるいは、水溶性部21と油性部22との境界面が存在せず、水溶性部21と油性部22との間で油性材料の濃度が徐々に変化してもよい。 In addition, as shown in the first to third examples, there may be a boundary surface between the water-soluble portion 21 and the oil-based portion 22, or the boundary surface between the water-soluble portion 21 and the oil-based portion 22 may be It may not be present, and the concentration of the oily material may gradually change between the water-soluble portion 21 and the oily portion 22 .
 なお、水溶性部21は、油性材料を含まなくてもよいし、水溶性材料に混合された状態で油性材料を含んでもよい。また、油性部22は、水溶性材料を含まなくてもよいし、油性材料に混合された状態で水溶性材料を含んでもよい。ただし、油性部22における油性材料の質量割合は、水溶性部21における油性材料の質量割合よりも大きい。すなわち、水溶性部21よりも油性部22の方が、油性材料の濃度が大きい。また、水溶性部21および油性部22の各々は、水溶性材料および油性材料以外に、第1実施形態で例示した添加剤等の各種の材料を含んでいてもよい。第1実施形態と同様、針状部20の全体に対する油性材料の割合は、1質量%以上60質量%以下であることが好ましく、針状部20の全体に対する水溶性材料の割合は、40質量%以上99質量%以下であることが好ましい。 The water-soluble part 21 may not contain an oily material, or may contain an oily material mixed with a water-soluble material. Moreover, the oily part 22 may not contain a water-soluble material, or may contain a water-soluble material in a state of being mixed with the oily material. However, the mass ratio of the oily material in the oily portion 22 is greater than the mass ratio of the oily material in the water-soluble portion 21 . That is, the concentration of the oily material is higher in the oily part 22 than in the water-soluble part 21 . Moreover, each of the water-soluble portion 21 and the oil-based portion 22 may contain various materials such as the additives exemplified in the first embodiment, in addition to the water-soluble material and the oil-based material. As in the first embodiment, the ratio of the oil-based material to the entire needle-like portion 20 is preferably 1% by mass or more and 60% by mass or less, and the ratio of the water-soluble material to the entire needle-like portion 20 is 40% by mass. % or more and 99 mass % or less.
 また、第1実施形態と同様、細胞移植ユニット11は、複数の針状部20を備えていてもよい。この場合、複数の針状部20において、油性部22の配置は一致していてもよいし、一致していなくてもよい。例えば、複数の針状部20に第1の針状部20と第2の針状部20とが含まれ、第1の針状部20における油性部22の位置と、第2の針状部20における油性部22の位置とは異なっていてもよい。さらに、第1の針状部20が含む油性材料と第2の針状部20が含む油性材料との割合や種類は、互いに異なっていてもよい。また、細胞移植ユニット11は、第1実施形態の針状部20と第2実施形態の針状部20とを備えていてもよいし、油性材料を含まない針状部を備えていてもよい。 Also, the cell transplantation unit 11 may include a plurality of needle-like parts 20, as in the first embodiment. In this case, the arrangement of the oily portions 22 may or may not be the same among the plurality of needle-like portions 20 . For example, the plurality of needle-like portions 20 include the first needle-like portion 20 and the second needle-like portion 20, and the position of the oily portion 22 in the first needle-like portion 20 and the second needle-like portion The position of the oily part 22 in 20 may be different. Furthermore, the ratio and type of the oily material contained in the first needle-like portion 20 and the oily material contained in the second needle-like portion 20 may be different from each other. Moreover, the cell transplantation unit 11 may include the needle-like portion 20 of the first embodiment and the needle-like portion 20 of the second embodiment, or may include a needle-like portion that does not contain an oily material. .
 以上、第2実施形態によれば、第1実施形態の(1)~(4),(7)~(9)の効果に加えて、以下に列挙する効果を得ることができる。
 (11)針状部20における油性材料の濃度が、針状部20内において偏りを有するため、針状部20の溶ける速さを部分的に遅くすることができる。
As described above, according to the second embodiment, in addition to the effects (1) to (4) and (7) to (9) of the first embodiment, the following effects can be obtained.
(11) Since the concentration of the oily material in the needle-like portion 20 is uneven within the needle-like portion 20, the dissolving speed of the needle-like portion 20 can be partially slowed down.
 (12)針状部20が水溶性部21と油性部22とを有することにより、油性材料の濃度が部分的に異なる針状部20が好適に実現される。
 (13)油性部22が針状部20の表層に位置していれば、水溶性部21の溶解の開始を遅らせることができるため、針状部20が生体内に進入した初期において、生体に刺さりやすい形状が保たれやすくなる。したがって、針状部20が所望の深さまで刺さりやすくなるため、移植物50が所望の深さに配置されやすくなる。
(12) The needle-like portion 20 having the water-soluble portion 21 and the oil-based portion 22 suitably realizes the needle-like portion 20 having partially different concentrations of the oil-based material.
(13) If the oily part 22 is located on the surface layer of the needle-shaped part 20, the start of dissolution of the water-soluble part 21 can be delayed. It becomes easy to keep the shape that is easy to stab. Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
 (14)油性部22が針状部20の基部に位置していれば、針状部20の基部が急速に溶解して細胞移植ユニット11を押圧する力が針状部20に伝わりにくくなることや、溶解した基部である液体から移植物50が圧力を受けることが抑えられる。また、針状部20の基部の形状が保たれやすいため、支持板部30の液状化や剥離によって、針状部20が刺さっている位置を視認しやすくなる。 (14) If the oily part 22 is positioned at the base of the needle-shaped part 20 , the base of the needle-shaped part 20 dissolves rapidly, and the force that presses the cell transplantation unit 11 is less likely to be transmitted to the needle-shaped part 20 . Also, pressure on the implant 50 from the dissolved base fluid is reduced. In addition, since the shape of the base of the needle-like portion 20 is easily maintained, the position where the needle-like portion 20 is stuck can be easily recognized visually by the liquefaction or peeling of the support plate portion 30 .
 (15)油性部22が針状部20の先端部に位置していれば、針状部20が生体内に進入した初期において、針状部20の先端部の形状が保たれやすくなる。したがって、針状部20が所望の深さまで刺さりやすくなるため、移植物50が所望の深さに配置されやすくなる。 (15) If the oily part 22 is positioned at the distal end of the needle-shaped part 20, the shape of the distal end of the needle-shaped part 20 is easily maintained at the initial stage when the needle-shaped part 20 enters the living body. Therefore, the needle-like portion 20 can easily be inserted to the desired depth, and the implant 50 can be easily arranged at the desired depth.
 (第3実施形態)
 図12~図27を参照して、収容デバイス、細胞移植ユニット、および、収容デバイスの製造方法の第3実施形態を説明する。第3実施形態では、針状部の構成が第1実施形態および第2実施形態と異なる。第3実施形態における移植物の構成および移植物の配置の対象は、第1実施形態と同様である。以下では、第3実施形態と第1実施形態および第2実施形態との相違点を中心に説明し、第1実施形態および第2実施形態と同様の構成については同じ符号を付してその説明を省略する。
(Third embodiment)
A third embodiment of a containing device, a cell transplantation unit, and a method for manufacturing the containing device will be described with reference to FIGS. 12 to 27. FIG. The third embodiment differs from the first and second embodiments in the configuration of the needle-like portion. The configuration of the implant and the target of placement of the implant in the third embodiment are the same as in the first embodiment. The following description will focus on the differences between the third embodiment and the first and second embodiments, and the same reference numerals will be assigned to the same configurations as in the first and second embodiments. omitted.
 [収容デバイス]
 図12が示すように、収容デバイス15は、1つの方向に沿って延びる針状部20を備えている。針状部20は、移植物を収容するための空間を針状部20の内部に区画するための孔である収容孔25を有している。収容孔25は、針状部20の基端に開口している。さらに、収容デバイス15は、収容孔25の内側面を覆う非水溶部28を備えている。第3実施形態では、針状部20と非水溶部28とから針状体が構成される。
[Accommodating device]
As FIG. 12 shows, the containment device 15 comprises needles 20 extending along one direction. The needle-like portion 20 has an accommodation hole 25 that is a hole for partitioning the interior of the needle-like portion 20 into a space for accommodating an implant. The receiving hole 25 opens at the proximal end of the needle-like portion 20 . Furthermore, the containment device 15 comprises a water-impermeable portion 28 that covers the inner surface of the containment hole 25 . In the third embodiment, the needle-shaped body is composed of the needle-shaped portion 20 and the non-water-soluble portion 28 .
 非水溶部28は、収容孔25の内側面に沿った膜状を有する。非水溶部28の内側に区画される領域が、移植物が収容される収容部26である。すなわち、非水溶部28は収容孔25内で移植物が配置される領域を囲む。収容部26は、収容孔25と略相似形状を有し、針状部20の基端に開口している。なお、収容部26に収容される収容物には、移植物に加えて、移植物の保護等のための物質も含まれ得る。 The non-water-soluble portion 28 has a film shape along the inner surface of the accommodation hole 25 . A region defined inside the non-water-soluble portion 28 is a storage portion 26 in which the implant is stored. That is, the water-impervious portion 28 surrounds the area within the receiving cavity 25 where the implant is to be placed. The housing portion 26 has a shape substantially similar to that of the housing hole 25 and opens at the proximal end of the needle-like portion 20 . In addition to the implant, the material to be stored in the storage unit 26 may also include a substance for protecting the implant.
 針状部20の先端部が、移植物の配置される組織を刺すことの可能な形状を有していれば、針状部20の形状は特に限定されない。生体に対する針状部20の刺さりやすさを高める観点では、針状部20の先端部は尖っていることが好ましい。例えば、針状部20は、円錐状や角錐状のように、基端から先端に向けて幅が小さくなる形状を有していてもよい。あるいは、針状部20は、円柱をその延びる方向に対して斜めに切断した形状や、円柱の上面から円錐が延びる形状のように、基端から一定の幅で延びた後、先端に向けて幅が小さくなる形状を有していてもよい。 The shape of the needle-like part 20 is not particularly limited as long as the tip of the needle-like part 20 has a shape that can pierce the tissue in which the implant is placed. From the viewpoint of increasing the ease with which the needle-like portion 20 sticks into the living body, the tip of the needle-like portion 20 is preferably sharp. For example, the needle-like portion 20 may have a shape such as a conical shape or a pyramidal shape in which the width decreases from the proximal end to the distal end. Alternatively, the needle-like portion 20 may have a shape obtained by cutting a cylinder obliquely to the direction in which it extends, or a shape in which a cone extends from the upper surface of the cylinder. It may have a shape with a narrower width.
 針状部20が細い方が、生体に針状部20を刺したときに形成される痕を小さくできる一方で、針状部20が太い方が、収容孔25の大きさについての自由度が高められ、すなわち、収容できる移植物の大きさや量の自由度が高められる。上記痕の拡大を抑えつつ、収容できる移植物についての制限が大きくなることを抑える観点では、針状部20の幅が最も大きくなる位置での幅方向の断面において、針状部20の外形に内接する仮想的な円を基準円とするとき、基準円の半径は、50μm以上2000μm以下であることが好ましく、400μm以上800μm以下であることがより好ましい。なお、幅方向は、針状部20の延びる方向と直交する方向であり、針状部20の幅は、幅方向における針状部20の長さである。 The thinner needle portion 20 can reduce the scar formed when the needle portion 20 is pierced into the living body, while the thicker needle portion 20 increases the degree of freedom regarding the size of the accommodation hole 25. Increased, ie greater flexibility in the size and amount of implants that can be accommodated. From the viewpoint of suppressing the enlargement of the scar while suppressing the limitation on the implant that can be accommodated, in the cross section in the width direction at the position where the width of the needle-like part 20 is the largest, the outer shape of the needle-like part 20 When a virtual inscribed circle is used as a reference circle, the radius of the reference circle is preferably 50 μm or more and 2000 μm or less, more preferably 400 μm or more and 800 μm or less. The width direction is a direction perpendicular to the direction in which the needle-like portion 20 extends, and the width of the needle-like portion 20 is the length of the needle-like portion 20 in the width direction.
 収容孔25の形状や大きさは、移植物を収容可能な収容部26を区画可能であれば特に限定されない。収容孔25の形状や大きさは、針状部20の強度を過度に低下させない範囲で、移植物の大きさや量に応じて選択されればよい。図12に示す例では、収容孔25および収容部26の各々は、針状部20の基端に位置する開口から一定の径で延びた後、収容孔25および収容部26の底部に向けて縮径する。収容孔25および収容部26の底部は、上記開口と反対側の端部であって、言い換えれば、収容孔25および収容部26における針状部20の先端に近い端部である。針状部20の幅方向に沿った収容孔25および収容部26の各々の断面形状は円形であり、収容孔25および収容部26の各々の底部は曲面である。すなわち、収容孔25および収容部26の各々は、円筒の底部が曲面状になった形状を有するとも言える。 The shape and size of the accommodation hole 25 are not particularly limited as long as the accommodation section 26 capable of accommodating the implant can be defined. The shape and size of the accommodation hole 25 may be selected according to the size and amount of the implant within a range that does not excessively reduce the strength of the needle-like portion 20 . In the example shown in FIG. 12 , each of accommodation hole 25 and accommodation portion 26 extends from an opening located at the proximal end of needle-like portion 20 with a constant diameter, and then toward the bottom of accommodation hole 25 and accommodation portion 26 . shrink. The bottoms of the accommodation hole 25 and the accommodation portion 26 are the ends opposite to the opening, in other words, the ends of the accommodation hole 25 and the accommodation portion 26 near the tip of the needle-like portion 20 . The cross-sectional shape of each of the accommodation hole 25 and the accommodation portion 26 along the width direction of the needle-like portion 20 is circular, and the bottom of each of the accommodation hole 25 and the accommodation portion 26 is a curved surface. That is, it can be said that each of the accommodation hole 25 and the accommodation portion 26 has a cylindrical shape with a curved bottom.
 例えば、移植物が毛包原基等の細胞塊であるとき、針状部20の基端にて収容部26が有する開口部27から、収容部26内に移植物を円滑に入れるためには、開口部27の径は、30μm以上1800μm以下であることが好ましく、300μm以上700μm以下であることがより好ましい。 For example, when the transplant is a cell mass such as a hair follicle primordium, in order to smoothly insert the transplant into the housing portion 26 from the opening 27 of the housing portion 26 at the proximal end of the needle-like portion 20, , the diameter of the opening 27 is preferably 30 μm or more and 1800 μm or less, more preferably 300 μm or more and 700 μm or less.
 収容孔25および収容部26の各々の深さは、移植物を配置する目標の深さに応じて選択されればよい。ただし、収容後の移植物が開口部27から出ることを抑える観点では、収容部26の深さは50μm以上であることが好ましく、収容部26の底部付近にまで移植物を入れることを容易にする観点では、収容部26の深さは3000μm以下であることが好ましい。なお、針状部20の長さは、収容孔25よりも長ければ、特に限定されない。 The depth of each of the receiving hole 25 and the receiving portion 26 may be selected according to the target depth of placement of the implant. However, from the viewpoint of suppressing the transplanted material from coming out of the opening 27 after being housed, the depth of the housing part 26 is preferably 50 μm or more, which facilitates the insertion of the transplanted material into the vicinity of the bottom of the housing part 26. In view of this, it is preferable that the depth of the accommodating portion 26 is 3000 μm or less. Note that the length of the needle-like portion 20 is not particularly limited as long as it is longer than the accommodation hole 25 .
 針状部20は、水に溶解する材料から形成されている。針状部20の主成分は水溶性高分子である。針状部20の材料は、移植物の配置される組織を刺すことが可能な強度を針状部20が有し、かつ、当該組織を刺した後に組織内で針状部20が溶解するように針状部20を形成可能な材料から選択される。 The needle-like portion 20 is made of a material that dissolves in water. A main component of the needle-like portion 20 is a water-soluble polymer. The needle-like portion 20 is made of a material such that the needle-like portion 20 has a strength that allows it to pierce the tissue in which the implant is placed, and that the needle-like portion 20 dissolves in the tissue after it pierces the tissue. The material is selected from materials capable of forming the needle-like portion 20 in
 ただし、組織内での針状部20の溶解に時間がかかりすぎると、針状部20の溶解が完了する前に生体の動き等に起因して移植物が収容部26から出てしまうことが起こり得る。こうした移植物の脱離を抑える観点では、移植物の配置される組織中で針状部20の溶解が48時間以内に完了することが好ましい。 However, if the dissolution of the needle-like portion 20 in the tissue takes too long, the implant may come out of the housing portion 26 due to the movement of the living body or the like before the dissolution of the needle-like portion 20 is completed. It can happen. From the viewpoint of suppressing detachment of the implant, it is preferable that dissolution of the needle-like portion 20 in the tissue in which the implant is placed be completed within 48 hours.
 針状部20の材料に含まれる水溶性高分子の例は、カルボキシメチルセルロース、メチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ポリビニルアルコール、ポリアクリル酸系ポリマー、ポリアクリルアミド、ポリエチレンオキシド、プルラン、アルギン酸塩、デンプン、ペクチン、キトサン、キトサンサクシナミド、オリゴキトサン、コンドロイチン硫酸塩、ポリ2-エチル-2-2オキサゾリン、ポリ2-メチル-2-オキサゾリン、カルボキシビニルポリマー、デキストラン、デキストリン、セルロース、キチン、ガラクタン、コラーゲン、アテロコラーゲン、ゼラチン、レオザン、キサンタンガム、カゼイン、ポリビニルピロリドン、ヒアルロン酸、グルコマンナン、ポリリンゴ酸、カードラン等である。針状部20は、これらの材料のうち単一の材料から形成されていてもよいし、複数の材料の混合により形成されていてもよい。針状部20の主成分は、針状部20において最も含有割合の高い材料である。 Examples of water-soluble polymers contained in the material of the needle-like portion 20 include carboxymethylcellulose, methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylcellulose, hydroxyethylcellulose, polyvinyl alcohol, polyacrylic acid-based polymer, polyacrylamide, polyethylene oxide, pullulan, alginate, starch, pectin, chitosan, chitosan succinamide, oligochitosan, chondroitin sulfate, poly 2-ethyl-2-2 oxazoline, poly 2-methyl-2-oxazoline, carboxyvinyl polymer, dextran, dextrin, Cellulose, chitin, galactan, collagen, atelocollagen, gelatin, leozan, xanthan gum, casein, polyvinylpyrrolidone, hyaluronic acid, glucomannan, polymalic acid, curdlan, and the like. The needle-like portion 20 may be made of a single material among these materials, or may be made of a mixture of a plurality of materials. The main component of the needle-like portion 20 is the material with the highest content ratio in the needle-like portion 20 .
 非水溶部28は、水に対して難溶であって、かつ、その形状が崩れるように生体内で変形する。例えば、非水溶部28は、生体内で、融解、溶解、あるいは、分解することにより変形する。非水溶部28は、水分の透過を抑えることのできる厚さを有していればよい。例えば、非水溶部28の厚さは20μm以上である。 The water-insoluble portion 28 is sparingly soluble in water and deforms in vivo so as to lose its shape. For example, the water-insoluble portion 28 deforms by melting, dissolving, or decomposing in vivo. The water-insoluble portion 28 may have a thickness capable of suppressing permeation of moisture. For example, the thickness of the water-insoluble portion 28 is 20 μm or more.
 非水溶部28の主成分は、水に対して難溶であって、生体内で融解、溶解、分解等の変化を生じる材料である。非水溶部28の材料は生体適合性を有することが好ましい。非水溶部28の材料は、例えば、油脂や高級アルコールである。油脂の例は、飽和脂肪酸、オリーブ油、オレイン酸、ナタネ油、パーム油、カカオ脂、ワセリン、流動ラノリン、ミツロウ、流動パラフィン等である。高級アルコールの例は、ステアリルアルコール、1-ヘキサデカノール等である。非水溶部28の材料として、第1実施形態で油性材料として挙げた各材料を用いることもできる。油性材料は、水に対して難溶な材料の一例である。非水溶部28の主成分は、非水溶部28において最も含有割合の高い材料である。また、水に対して難溶とは、粉末状にした材料1gを1000mlの純水中に入れ、20±5℃の環境で5分ごとに強く30秒間振り混ぜるとき、30分以内に全量が溶けきらないことを指す。 The main component of the water-insoluble portion 28 is a material that is sparingly soluble in water and undergoes changes such as melting, dissolution, and decomposition in vivo. Preferably, the material of the water-insoluble portion 28 is biocompatible. The material of the water-insoluble portion 28 is, for example, fat or higher alcohol. Examples of fats and oils are saturated fatty acids, olive oil, oleic acid, rapeseed oil, palm oil, cacao butter, petrolatum, liquid lanolin, beeswax, liquid paraffin and the like. Examples of higher alcohols are stearyl alcohol, 1-hexadecanol and the like. As the material of the water-insoluble portion 28, each material mentioned as the oily material in the first embodiment can also be used. An oily material is an example of a material that is sparingly soluble in water. The main component of the water-insoluble portion 28 is the material with the highest content ratio in the water-insoluble portion 28 . In addition, "poorly soluble in water" means that when 1 g of a powdered material is put into 1000 ml of pure water and vigorously shaken for 30 seconds every 5 minutes in an environment of 20 ± 5 ° C, the entire amount will be dissolved within 30 minutes. It means insoluble.
 生体内での非水溶部28の速やかな崩壊のためには、非水溶部28は、体温付近の温度で融解する性質を有することが好ましい。例えば、非水溶部28の主成分の融点は、10℃以上37℃以下であることが好ましい。非水溶部28が生体内の温度に起因して生体内で融解する場合、生体を刺す前の収容デバイス15は、冷蔵保存されることが好ましい。 For rapid disintegration of the water-insoluble portion 28 in vivo, the water-insoluble portion 28 preferably has the property of melting at a temperature near body temperature. For example, the melting point of the main component of the water-insoluble portion 28 is preferably 10° C. or higher and 37° C. or lower. If the water-insoluble portion 28 melts in the living body due to the temperature in the living body, it is preferable that the containing device 15 be stored in a cold storage before being inserted into the living body.
 針状部20を生体に刺す前において、非水溶部28は、膜状を維持できていれば、固体状であってもよいし、クリーム状のように半固形状であってもよい。非水溶部28が固体状であると、移植物を収容部26に収容する際等に移植物と非水溶部28とが接触することに起因して非水溶部28が収容孔25の内側面から剥がれることが抑えられる。 Before the needle-shaped part 20 is inserted into the living body, the non-water-soluble part 28 may be solid or semi-solid such as cream as long as it maintains its film-like shape. If the non-water-soluble portion 28 is solid, the non-water-soluble portion 28 contacts the inner surface of the receiving hole 25 due to contact between the implant and the non-water-soluble portion 28 when the implant is stored in the receiving portion 26 . It is possible to suppress peeling from the
 非水溶部28の材料には、収容孔25の内側面へのコーティングの容易性や当該内側面に対する濡れ性の向上のために、添加剤が含まれていてもよい。添加剤は、例えば、ヒドロキシプロピルセルロース、エチルセルロース、ツェイン、シェラック等の高分子材料や、ショ糖脂肪酸エステル、ステアリン酸マグネシウム、レシチン等の界面活性剤である。 The material of the water-insoluble portion 28 may contain an additive in order to facilitate the coating of the inner surface of the accommodation hole 25 and improve the wettability of the inner surface. Examples of additives include polymeric materials such as hydroxypropyl cellulose, ethyl cellulose, zein and shellac, and surfactants such as sucrose fatty acid esters, magnesium stearate and lecithin.
 非水溶部28は、単層構造を有していてもよいし、互いに異なる材料から形成された複数の層からなる多層構造を有していてもよい。また、非水溶部28と収容孔25の内側面との間に、非水溶部28の下地となる層として、コーティングの容易性を高めるための層が設けられていてもよい。 The non-water-soluble portion 28 may have a single-layer structure, or may have a multi-layer structure consisting of a plurality of layers formed from mutually different materials. Moreover, a layer for improving the ease of coating may be provided between the water-insoluble portion 28 and the inner surface of the accommodation hole 25 as a layer serving as a base for the water-insoluble portion 28 .
 非水溶部28が設けられていることにより、移植物を含む収容物が、収容孔25の内側面に接触することが抑えられる。したがって、収容物が水分を含んでいる場合に、針状部20を生体に刺す前に針状部20が内側から溶解してしまうことが抑えられる。 By providing the non-water-soluble portion 28 , the contents including the implant are prevented from coming into contact with the inner surface of the receiving hole 25 . Therefore, when the content contains water, the dissolution of the needle-like portion 20 from the inside is suppressed before the needle-like portion 20 is pierced into the living body.
 [細胞移植ユニット]
 図13を参照して、収容デバイス15が細胞移植に用いられる形態について説明する。移植物が収容された状態の収容デバイス15が、細胞移植ユニットである。
[Cell transplantation unit]
A form in which the containing device 15 is used for cell transplantation will be described with reference to FIG. 13 . The housing device 15 in which the implant is housed is the cell transplantation unit.
 図13が示すように、細胞移植ユニット16は、収容デバイス15と移植物50とを備えている。移植物50は収容部26に収容されている。また、収容部26には、移植物50と共に補助液51も収容されており、移植物50を補助液51が取り囲んでいる。移植物50および補助液51が収容デバイス15の収容物である。そして、収容物を非水溶部28が囲んでいる。 As shown in FIG. 13, the cell transplantation unit 16 comprises a containment device 15 and an implant 50 . The implant 50 is housed in the housing 26 . In addition, the containing portion 26 contains the auxiliary liquid 51 together with the implant 50 , and surrounds the implant 50 with the auxiliary liquid 51 . Implant 50 and auxiliary fluid 51 are the contents of containment device 15 . A non-water-soluble portion 28 surrounds the stored material.
 補助液51は、収容部26内での細胞群の活性の維持や、生体内に配置された後の細胞群の生着を補助する流体である。例えば、補助液51は、移植物50を取り囲んで移植物50と収容部26の内側面との接触を抑えることで、細胞群の活性の維持を補助する。あるいは、補助液51は、生体の体液に近しい成分を含有して移植物50を包むことや移植物50に対して栄養を提供することで細胞群の活性の維持や生着を補助してもよい。 The auxiliary liquid 51 is a fluid that assists in maintaining the activity of the cell group in the housing part 26 and the engraftment of the cell group after being placed in the living body. For example, the auxiliary liquid 51 surrounds the implant 50 to reduce contact between the implant 50 and the inner surface of the container 26, thereby helping to maintain the activity of the cell population. Alternatively, the auxiliary liquid 51 may contain components close to body fluids of the living body to wrap the implant 50 or provide nutrition to the implant 50, thereby assisting the maintenance of cell group activity and engraftment. good.
 補助液51は水性材料を主成分として含む。補助液51の主成分は、補助液51において最も含有割合の高い材料である。補助液51の具体例は、純水、生理食塩水等である。
 また、補助液51は、水の蒸気圧を低下させる添加物を含んでいてもよい。補助液51がこうした添加物を含んでいると、収容部26への補助液51の収容時に補助液51が針状部20の表面等に付着した場合に、針状部20が溶解することが抑えられる。水の蒸気圧を低下させる添加物の例は、ゼラチン、寒天、アルギン酸ナトリウム、プルラン、ジェランガム、ヒドロキシプロピルセルロース、コラーゲン等である。
The auxiliary liquid 51 contains an aqueous material as a main component. The main component of the auxiliary liquid 51 is the material with the highest content ratio in the auxiliary liquid 51 . Specific examples of the auxiliary liquid 51 are pure water, physiological saline, and the like.
Also, the auxiliary liquid 51 may contain an additive that reduces the vapor pressure of water. If the auxiliary liquid 51 contains such an additive, the needle-shaped portion 20 may dissolve when the auxiliary liquid 51 adheres to the surface of the needle-shaped portion 20 or the like when the auxiliary liquid 51 is stored in the storage portion 26 . suppressed. Examples of additives that reduce the vapor pressure of water are gelatin, agar, sodium alginate, pullulan, gellan gum, hydroxypropylcellulose, collagen, and the like.
 補助液51は、単一の材料から構成されていてもよいし、複数の材料の混合物であってもよい。また、補助液51は、低粘度の流体であってもよいし、高粘度の流体であってもよい。 The auxiliary liquid 51 may be composed of a single material, or may be a mixture of multiple materials. Also, the auxiliary liquid 51 may be a low-viscosity fluid or a high-viscosity fluid.
 なお、補助液51は、移植物50の全周を取り囲んでいなくてもよい。例えば、移植物50は収容部26の底部に配置され、移植物50上から開口部27までの領域において補助液51が移植物50を覆っていてもよい。 It should be noted that the auxiliary liquid 51 does not have to surround the entire circumference of the implant 50 . For example, the implant 50 may be placed at the bottom of the container 26 and the supplemental fluid 51 may cover the implant 50 in the area above the implant 50 to the opening 27 .
 [収容デバイスおよび細胞移植ユニットの変形例]
 図14が示すように、収容デバイス15は、針状部20と一体に形成された基板部23を備えていてもよい。基板部23は、針状部20の基端部から、針状部20の延びる方向と直交する方向に広がる板状を有する。言い換えれば、基板部23は、針状部20の基端部を支持している。
[Modified example of housing device and cell transplantation unit]
As FIG. 14 shows, the containment device 15 may comprise a base portion 23 integrally formed with the needle portion 20 . The substrate portion 23 has a plate shape extending from the base end portion of the needle-like portion 20 in a direction perpendicular to the extending direction of the needle-like portion 20 . In other words, the substrate portion 23 supports the proximal end portion of the needle portion 20 .
 詳細には、基板部23は、第1面23Fと、第1面23Fとは反対側の面である第2面23Rとを有し、第1面23Fから針状部20が延びている。収容孔25および収容部26は第2面23Rに開口している。 Specifically, the substrate portion 23 has a first surface 23F and a second surface 23R opposite to the first surface 23F, and the needle-like portion 20 extends from the first surface 23F. The accommodation hole 25 and the accommodation portion 26 are open to the second surface 23R.
 基板部23は、針状部20と同一の材料から形成されている。非水溶部28は、収容孔25の内側面上から第2面23R上へ連続して広がり、第2面23Rの少なくとも一部を覆っている。 The substrate portion 23 is made of the same material as the needle-like portion 20 . The non-water-soluble portion 28 extends continuously from the inner side surface of the accommodation hole 25 to the second surface 23R and covers at least a portion of the second surface 23R.
 基板部23が設けられていることにより、他の器具等で基板部23を保持することで収容デバイス15を保持することが容易である。そのため、収容デバイス15の移動や生体に収容デバイス15を刺す動作を行いやすくなる。 Since the substrate portion 23 is provided, it is easy to hold the containing device 15 by holding the substrate portion 23 with another tool or the like. Therefore, it becomes easier to move the containing device 15 or to pierce the living body with the containing device 15 .
 また、基板部23が設けられていることにより、収容物を開口部27から収容部26に入れる際に、収容物が針状部20の表面に付着することが、基板部23によって遮られることで、抑えられる。したがって、針状部20を生体に刺す前に針状部20が溶解することが抑えられる。また、非水溶部28が、収容孔25の内側面上から連続して基板部23の第2面23Rも覆っている。すなわち、開口部27の付近で基板部23が非水溶部28に覆われているため、収容物を開口部27から収容部26に入れる際に、収容物が基板部23に付着することも抑えられる。したがって、基板部23が溶解することも抑えられる。 In addition, since the substrate portion 23 is provided, the substrate portion 23 prevents the stored material from adhering to the surface of the needle-shaped portion 20 when the stored material is put into the storage portion 26 from the opening 27 . So it can be suppressed. Therefore, dissolution of the needle-like portion 20 is suppressed before the needle-like portion 20 is pierced into the living body. In addition, the non-water-soluble portion 28 also covers the second surface 23</b>R of the substrate portion 23 continuously from the inner surface of the accommodation hole 25 . That is, since the substrate portion 23 is covered with the non-water-soluble portion 28 in the vicinity of the opening 27, it is possible to suppress the adhesion of the stored object to the substrate portion 23 when the stored object is put into the storage portion 26 through the opening 27. be done. Therefore, the melting of the substrate portion 23 is also suppressed.
 特に、補助液51のような水性の流体が収容物に含まれる場合には、収容物の収容時に収容物からの飛沫が周囲に飛散して収容デバイス15に付着しやすい。そのため、上述のように、基板部23および基板部23上の非水溶部28により針状部20と基板部23との溶解を抑えることの有益性が大きい。 In particular, when a water-based fluid such as the auxiliary liquid 51 is contained in the content, droplets from the content tend to scatter around and adhere to the storage device 15 when the content is stored. Therefore, as described above, it is highly beneficial to suppress the dissolution of the needle-shaped portion 20 and the substrate portion 23 by the substrate portion 23 and the water-insoluble portion 28 on the substrate portion 23 .
 なお、基板部23が大きすぎると、針状部20を生体に刺す際に、収容デバイス15にかかる力が基板部23に逃げやすくなるため、1つの針状部20に対して割り当てられる基板部23の第1面23Fの面積は、625mm以下であることが好ましい。あるいは、収容物の収容後に、切り抜き等によって基板部23が縮小されてもよいし、生体を刺す際に、基板部23から針状部20を切り離すことが可能なように、基板部23と針状部20との境界に加工が施されていてもよい。 If the substrate portion 23 is too large, the force applied to the containing device 15 when the needle-like portion 20 is inserted into the living body is likely to escape to the substrate portion 23. Therefore, the substrate portion assigned to one needle-like portion 20 The area of the first surface 23F of 23 is preferably 625 mm 2 or less. Alternatively, the substrate portion 23 may be reduced in size by cutting or the like after the contents are accommodated, or the substrate portion 23 and the needle may be separated from the substrate portion 23 so that the needle-like portion 20 can be separated from the substrate portion 23 when the living body is punctured. The boundary with the shaped portion 20 may be processed.
 図15および図16が示すように、収容デバイス15は、封止部40を備えていてもよい。封止部40は、収容部26に収容物が収容されている状態で、開口部27を塞ぐ。封止部40は、針状部20の基端に位置する面、あるいは、基板部23の第2面23Rに沿って広がる。封止部40は、水に溶解しない材料から形成されている。 The containment device 15 may comprise a seal 40, as shown in FIGS. The sealing portion 40 closes the opening portion 27 in a state in which the storage portion 26 accommodates an object. The sealing portion 40 extends along the surface located at the proximal end of the needle-like portion 20 or along the second surface 23R of the substrate portion 23 . The sealing portion 40 is made of a material that does not dissolve in water.
 開口部27を塞ぐ前の封止部40は、針状部20や基板部23とは別に管理されていてもよいし、基板部23の端部等に接続されていてもよい。
 例えば、封止部40は、粘着面を有する樹脂シートであり、樹脂シートが開口部27を覆うように針状部20や基板部23に貼り付けられることによって、封止部40が開口部27上に配置されてもよい。あるいは、油性の封止材が開口部27を覆うように塗布されることにより、封止部40が形成されてもよい。封止材は、例えば、ワセリン等の油性クリームである。封止部40は、移植物50が配置される組織の表面に密着可能であることが好ましい。
The sealing portion 40 before closing the opening 27 may be managed separately from the needle-like portion 20 and the substrate portion 23, or may be connected to the end portion of the substrate portion 23 or the like.
For example, the sealing portion 40 is a resin sheet having an adhesive surface. may be placed above. Alternatively, the sealing portion 40 may be formed by applying an oily sealing material so as to cover the opening 27 . The sealing material is, for example, an oily cream such as vaseline. The seal 40 is preferably capable of adhering to the surface of the tissue in which the implant 50 is placed.
 封止部40が設けられていることにより、収容デバイス15の運搬中の振動や収容デバイス15が生体を刺したときの衝撃等に起因して収容物が収容部26から漏出することを抑えることができる。 By providing the sealing portion 40, the contents can be prevented from leaking out of the storage portion 26 due to vibrations during transportation of the storage device 15, impact when the storage device 15 pierces the living body, or the like. can be done.
 [収容デバイスおよび細胞移植ユニットの製造方法]
 針状部20は、所望の針状部20の形状に対応する凹部を有する型に、針状部20の材料を含む溶液を充填し、充填物を乾燥により固化させた後に離型することによって製造される。
[Manufacturing method of storage device and cell transplantation unit]
The needle-like portion 20 is formed by filling a solution containing the material of the needle-like portion 20 into a mold having recesses corresponding to the desired shape of the needle-like portion 20, solidifying the filling by drying, and then releasing the mold. manufactured.
 針状部20となる充填物の中央部に気泡が集まるように溶液の充填および乾燥を制御することで、針状部20の内部に空隙が形成される。これによって当該空隙である収容孔25を形成することができる。あるいは、収容孔25に対応する形状のピン状の構造体が充填物の中央部に挿入された状態で充填物が固化された後、当該構造体が取り除かれてもよい。これにより、ピン状の構造体が位置していた部分に収容孔25である空隙を形成することができる。 By controlling the filling and drying of the solution so that air bubbles gather in the central portion of the filling that will become the needle-like portion 20 , a void is formed inside the needle-like portion 20 . Accordingly, the accommodating hole 25, which is the gap, can be formed. Alternatively, a pin-shaped structure having a shape corresponding to the receiving hole 25 may be inserted into the central portion of the filling and removed after the filling is solidified. As a result, a gap, which is the receiving hole 25, can be formed in the portion where the pin-shaped structure was positioned.
 なお、収容デバイス15が基板部23を備える場合には、基板部23も針状部20と同時に形成される。
 非水溶部28は、非水溶部28の材料を収容孔25内に塗布することによって形成される。非水溶部28の形成時に、所望の収容部26の形状に対応するピン状の構造体を収容孔25に挿入することで、収容部26の形状を整えてもよい。
In addition, in the case where the containing device 15 includes the substrate portion 23 , the substrate portion 23 is also formed at the same time as the needle portion 20 .
The water-insoluble portion 28 is formed by applying the material of the water-insoluble portion 28 into the receiving hole 25 . When forming the water-insoluble portion 28 , the shape of the accommodating portion 26 may be adjusted by inserting a pin-shaped structure corresponding to the desired shape of the accommodating portion 26 into the accommodating hole 25 .
 収容部26への収容物の収容は、収容物の性状に応じた方法で行われればよい。一例として、細胞群を含む移植物50および補助液51を収容部26に収容する場合について説明する。 The storage of the contents in the storage section 26 may be performed by a method according to the properties of the contents. As an example, a case where a transplant 50 containing a group of cells and an auxiliary liquid 51 are accommodated in the accommodation portion 26 will be described.
 まず、収容部26に補助液51を充填する。例えば、ノズルを使用して補助液51を収容部26に注入してもよいし、開口部27に向けて補助液51を適下した後に、収容部26を真空状態にすることや遠心機を利用することで収容部26に補助液51を充填してもよい。 First, the storage portion 26 is filled with the auxiliary liquid 51 . For example, the auxiliary liquid 51 may be injected into the container 26 using a nozzle, or after the auxiliary liquid 51 is dropped toward the opening 27, the container 26 may be evacuated or a centrifuge may be used. The storage part 26 may be filled with the auxiliary liquid 51 by using it.
 続いて、収容部26に移植物50を入れる。例えば、移植物50を開口部27に向けて落とすと、移植物50は重力によって収容部26内に沈む。このとき、収容部26への移植物50の収容を促進するために、遠心機を利用してもよいし、棒状やパイプ状の器具で移植物50を押して移植物50を収容部26の底部に向けて移動させてもよい。 Then, the implant 50 is put into the housing portion 26 . For example, if the implant 50 is dropped toward the opening 27, the implant 50 will sink into the housing 26 due to gravity. At this time, in order to facilitate accommodation of the implant 50 in the container 26, a centrifuge may be used, or a rod-shaped or pipe-shaped instrument may be used to push the implant 50 to move the implant 50 to the bottom of the container 26. You can move it towards
 移植物50は、必ずしも収容部26の底部付近まで沈められる必要はないが、移植物50が収容部26の底部の近くに配置されるほど、移植物50が収容部26から漏出し難くなるため好ましい。針状部20および非水溶部28が透明であると、収容部26内における移植物50の位置を確認しながら、移植物50の収容を進めることができる。
 収容デバイス15が封止部40を備える場合には、収容物が収容部26に収容された後に、開口部27が封止部40で覆われる。
Although the implant 50 does not necessarily need to be submerged near the bottom of the container 26 , the closer the implant 50 is placed to the bottom of the container 26 , the less likely the implant 50 will leak out of the container 26 . preferable. If the needle-like portion 20 and the non-water-soluble portion 28 are transparent, the placement of the implant 50 can proceed while confirming the position of the implant 50 in the storage portion 26 .
In the case where the containing device 15 has the sealing portion 40 , the opening portion 27 is covered with the sealing portion 40 after the object is contained in the containing portion 26 .
 [移植物の配置方法]
 図17~図20を参照して、収容デバイス15を用いた移植物の配置方法を説明する。すなわち、上記移植物の配置方法は、細胞移植ユニット16を用いた細胞の移植方法である。
[Method of placement of implant]
A method of placing an implant using containment device 15 will now be described with reference to FIGS. 17-20. That is, the method of placing the transplant is a method of transplanting cells using the cell transplantation unit 16 .
 図17が示すように、まず、細胞移植ユニット16の針状部20を、移植物50の配置の対象組織Skに押し付けることによって、針状部20を対象組織Skに刺す。対象組織Skは例えば皮膚である。このとき、針状部20にかかる力や針状部20の向きを調整することで対象組織Skへの針状部20への進入を補助するアプリケーターが用いられてもよい。収容デバイス15が基板部23を有していると、アプリケーターに細胞移植ユニット16を保持させることが容易である。なお、針状部20が対象組織Skに刺さっている状態において、基板部23は対象組織Skの内部に入り込まず、対象組織Skの表面上に配置される。 As shown in FIG. 17, first, the needle-like portion 20 of the cell transplantation unit 16 is pressed against the target tissue Sk where the implant 50 is to be placed, thereby piercing the target tissue Sk with the needle-like portion 20 . The target tissue Sk is, for example, skin. At this time, an applicator may be used that assists the needle-like portion 20 to enter the target tissue Sk by adjusting the force applied to the needle-like portion 20 and the direction of the needle-like portion 20 . If the housing device 15 has the substrate portion 23, it is easy to hold the cell transplantation unit 16 on the applicator. Note that in a state in which the needle-like portion 20 is stuck in the target tissue Sk, the substrate portion 23 does not enter the target tissue Sk and is arranged on the surface of the target tissue Sk.
 図18が示すように、針状部20が対象組織Skの内部に入ると、針状部20と組織内の水分とが接触することによって針状部20は溶解する。また、非水溶部28も対象組織Skの内部に配置されることによって崩れていく。例えば、非水溶部28が体温付近の温度で融解する場合、針状部20が対象組織Skの内部に入ることで非水溶部28が体温付近の温度にまで温められるため、非水溶部28が融解する。これにより非水溶部28が変形し、非水溶部28に囲まれていた移植物50は非水溶部28から露出する。 As shown in FIG. 18, when the needle-like portion 20 enters the target tissue Sk, the needle-like portion 20 is dissolved by the contact between the needle-like portion 20 and the moisture in the tissue. In addition, the water-insoluble portion 28 also collapses as it is placed inside the target tissue Sk. For example, when the non-water-soluble portion 28 melts at a temperature near body temperature, the non-water-soluble portion 28 is warmed to a temperature near body temperature as the needle-like portion 20 enters the target tissue Sk. Melt. As a result, the water-insoluble portion 28 is deformed, and the implant 50 surrounded by the water-insoluble portion 28 is exposed from the water-insoluble portion 28 .
 なお、針状部20の変形と、非水溶部28の変形とは、いずれが先に生じてもよい。針状部20が崩れる速さと、非水溶部28が崩れる速さとは、針状部20および非水溶部28の材料によって調整できる。例えば、非水溶部28よりも針状部20が先に崩れる場合、針状部20が対象組織Skを刺すことで形成された傷、言い換えれば、組織内にて切断された箇所は、針状部20の溶解に伴い塞がっていく。このとき、非水溶部28は変形しつつ移植物50の周囲に存在しており、移植物50よりも表面積の大きい非水溶部28は組織内部に引っ掛りやすい。そのため、移植物50が非水溶部28に捕らわれていることで、上記傷が塞がるときに移植物50が組織表面に押し出されることが抑えられる。 Either the deformation of the needle-like portion 20 or the deformation of the water-insoluble portion 28 may occur first. The speed at which the needle-shaped portion 20 collapses and the speed at which the water-insoluble portion 28 collapses can be adjusted by the materials of the needle-shaped portion 20 and the water-insoluble portion 28 . For example, when the needle-like portion 20 collapses before the non-water-soluble portion 28, the wound formed by the needle-like portion 20 piercing the target tissue Sk, in other words, the cut portion in the tissue is needle-like. As the portion 20 dissolves, it closes. At this time, the water-insoluble portion 28 is deformed and exists around the implant 50, and the water-insoluble portion 28 having a larger surface area than the implant 50 is likely to be caught inside the tissue. Therefore, since the implant 50 is caught in the water-insoluble portion 28, the implant 50 is prevented from being pushed out to the tissue surface when the wound is closed.
 図19が示すように、針状部20および非水溶部28の変形が進行すると、収容デバイス15が崩れて消失し、収容されていた移植物50が対象組織Sk内に留め置かれる。針状部20および非水溶部28の成分は生体内に拡散や吸収される。これにより、生体内への移植物50の配置が完了する。なお、収容デバイス15が基板部23を備える場合には、基板部23は、対象組織Skの表面の水分に接することによって、溶解する。 As shown in FIG. 19, as the deformation of the needle-like portion 20 and the water-insoluble portion 28 progresses, the containing device 15 collapses and disappears, and the contained implant 50 is retained within the target tissue Sk. The components of the needle-like portion 20 and the water-insoluble portion 28 are diffused and absorbed into the living body. This completes the placement of the implant 50 in vivo. It should be noted that in the case where the housing device 15 includes the substrate portion 23, the substrate portion 23 is dissolved by coming into contact with water on the surface of the target tissue Sk.
 本実施形態の収容デバイス15を用いることにより、生体内への移植物50の配置に際して生体内からの器具の引き抜きが発生しないため、移植物50が器具と共に生体内から抜け出ることが抑えられる。したがって、移植物50の配置の効率も高められる。また、移植物50は、針状部20に収容された状態で生体内に挿入されるため、挿入時の衝撃から移植物50を保護することもできる。 By using the housing device 15 of the present embodiment, the implant 50 is prevented from being pulled out of the living body when the implant 50 is placed in the body, thereby preventing the implant 50 from coming out of the body together with the instrument. Therefore, the efficiency of implant 50 placement is also enhanced. In addition, since the implant 50 is inserted into the living body while being housed in the needle-like portion 20, the implant 50 can be protected from impact during insertion.
 図20が示すように、収容デバイス15が封止部40を備えている場合、針状部20および非水溶部28の消失後、封止部40は、対象組織Skの表面上において、針状部20が対象組織Skを刺すことで形成された傷Ctを覆う。これによっても、傷Ctから移植物50が出ることを抑えることができる。 As shown in FIG. 20 , when the containment device 15 is provided with a sealing portion 40 , the sealing portion 40 forms a needle-like shape on the surface of the target tissue Sk after disappearance of the needle-like portion 20 and the water-insoluble portion 28 . The part 20 covers the wound Ct formed by stabbing the target tissue Sk. This can also prevent the implant 50 from coming out of the wound Ct.
 [収容孔および収容部の変形例]
 図21が示すように、収容孔25の形状と、収容部26の形状とは、相似形状でなくてもよい。図21に示す例では、収容孔25の底部が曲面であることに対し、収容部26の底部は平面である。収容孔25は、例えば、円筒の底部が曲面状になった形状を有しており、収容部26は、例えば、平面の底面を有する円筒形状を有している。
[Modified Example of Accommodating Hole and Accommodating Portion]
As shown in FIG. 21, the shape of the accommodation hole 25 and the shape of the accommodation portion 26 may not be similar. In the example shown in FIG. 21, the bottom of the accommodation hole 25 is curved, whereas the bottom of the accommodation portion 26 is flat. The receiving hole 25 has, for example, a cylindrical shape with a curved bottom, and the receiving portion 26 has, for example, a cylindrical shape with a flat bottom surface.
 収容デバイス15の製造方法にて述べたように、所望の収容部26の形状に対応するピン状の構造体を収容孔25に挿入して非水溶部28を形成する製造方法であれば、収容孔25の形状と収容部26の形状とを異ならせることが可能である。 As described in the manufacturing method of the housing device 15, any manufacturing method for forming the water-insoluble portion 28 by inserting a pin-shaped structure corresponding to the desired shape of the housing portion 26 into the housing hole 25 can be used. The shape of the hole 25 and the shape of the housing portion 26 can be different.
 円筒の底部が曲面状になった形状を有する収容孔25は、気泡を利用して収容孔25を形成する製造方法によって好適に形成することができる。一方、平面の底面を有する円筒形状を有した収容部26は、上記ピン状の構造体を利用した製造方法によって好適に形成することができる。 The accommodation hole 25 having a cylindrical shape with a curved bottom can be preferably formed by a manufacturing method of forming the accommodation hole 25 using air bubbles. On the other hand, the housing portion 26 having a cylindrical shape with a flat bottom surface can be preferably formed by the manufacturing method using the pin-shaped structure.
 また、非水溶部28の厚さは一定でなくてもよい。例えば、図21に示す例では、収容孔25の側面上の非水溶部28の厚さよりも、収容孔25の底面上の非水溶部28の厚さの方が大きい。図22が示すように、収容孔25と収容部26とが、略相似形状を有する場合にも、非水溶部28の厚さは一定でなくてもよい。 Also, the thickness of the water-insoluble portion 28 may not be constant. For example, in the example shown in FIG. 21 , the non-water-soluble portion 28 on the side surface of the accommodation hole 25 is thicker than the water-insoluble portion 28 on the bottom surface of the accommodation hole 25 . As shown in FIG. 22, even when the accommodation hole 25 and the accommodation portion 26 have substantially similar shapes, the thickness of the non-water-soluble portion 28 may not be constant.
 非水溶部28の厚さが、収容孔25の側面上よりも底面上にて厚ければ、収容部26に収容物を収容する際に、ノズルやピペット等の器具の先端を収容部26の中に挿入する場合であって、器具の先端が収容部26の底部に接触して非水溶部28が削れた場合であっても、収容孔25の内側面が露出し難くなる。 If the non-water-soluble portion 28 is thicker on the bottom surface than on the side surface of the receiving hole 25, the tip of a tool such as a nozzle or a pipette may be inserted into the receiving portion 26 when the container 26 contains a material. Even if the tip of the instrument contacts the bottom of the housing portion 26 and the non-water-soluble portion 28 is scraped off when it is inserted into the housing portion 26, the inner surface of the housing hole 25 is less likely to be exposed.
 また、収容孔25の側面上にて非水溶部28の厚さを変化させることで、収容部26の径を変化させることが可能であり、これによって、収容部26内において移植物が引っ掛かって留められる深さを制御することも可能である。同様に、収容孔25の底面上における非水溶部28の厚さを調整することによっても、収容孔25内で移植物が留められる深さを制御することができる。収容された移植物が留められる深さの制御が可能であれば、生体の組織内にて移植物が配置される深さをより精密に制御することができる。
 なお、図21および図22が示すように、非水溶部28は、基板部23の第2面23Rを覆わず、収容孔25の内側面のみを覆っていてもよい。
In addition, by varying the thickness of the water-insoluble portion 28 on the side surface of the receiving hole 25, it is possible to change the diameter of the receiving portion 26, thereby preventing the implant from being caught in the receiving portion 26. It is also possible to control the depth to which it is clipped. Similarly, by adjusting the thickness of the water-impermeable portion 28 on the bottom surface of the receiving hole 25, the depth to which the implant is anchored within the receiving hole 25 can be controlled. The ability to control the depth at which a contained implant is anchored allows for more precise control over the depth at which the implant is placed within the tissue of the body.
In addition, as shown in FIGS. 21 and 22 , the non-water-soluble portion 28 may not cover the second surface 23R of the substrate portion 23 and may cover only the inner surface of the receiving hole 25 .
 図23が示すように、収容孔25の側面や収容部26の側面は、針状部20の延びる方向に対して傾斜していてもよい。図23が示す例では、収容孔25および収容部26の各々の径が、開口部27から底部に向けて徐々に小さくなるように、収容孔25および収容部26の各々の側面が傾斜している。例えば、収容孔25および収容部26の各々は、円錐形状に窪む形状を有している。 As shown in FIG. 23, the side surface of the accommodation hole 25 and the side surface of the accommodation portion 26 may be inclined with respect to the direction in which the needle-like portion 20 extends. In the example shown in FIG. 23, the side surfaces of each of the accommodation hole 25 and the accommodation portion 26 are inclined such that the diameter of each of the accommodation hole 25 and the accommodation portion 26 gradually decreases from the opening 27 toward the bottom. there is For example, each of the accommodation hole 25 and the accommodation portion 26 has a conical concave shape.
 収容孔25の径が底部に向けて小さくなるように収容孔25の側面が傾斜していると、収容孔25の開口から非水溶部28の材料を収容孔25の内側面に塗布しやすい。また、収容部26の径が、開口部27にて最大になっているため、収容物の収容が容易である。 If the side surface of the accommodation hole 25 is inclined so that the diameter of the accommodation hole 25 decreases toward the bottom, it is easy to apply the material of the non-water-soluble portion 28 to the inner surface of the accommodation hole 25 from the opening of the accommodation hole 25 . In addition, since the diameter of the accommodating portion 26 is maximized at the opening portion 27, it is easy to accommodate the contents.
 さらに、図23が示す例では、針状部20の厚さ、すなわち、収容孔25の内側面から針状部20の表面までの厚さが、針状部20の基端部に向けて大きくなっている。こうした構成であれば、針状部20の基端部の強度が高められるため、針状部20が折れにくくなる。特に、収容部26が、開口部27にて径が最大になる形状を有している場合、収容物の収容が容易である一方で、針状部20の基端部付近の強度が弱くなりやすい。これに対し、針状部20の厚さが基端部に向けて大きくなれば、収容部26の形状に起因した針状部20の基端部付近の強度の低下を抑えることができる。 Furthermore, in the example shown in FIG. 23 , the thickness of the needle-like portion 20 , that is, the thickness from the inner surface of the accommodation hole 25 to the surface of the needle-like portion 20 increases toward the base end portion of the needle-like portion 20 . It's becoming With such a configuration, the strength of the base end portion of the needle-like portion 20 is increased, so that the needle-like portion 20 is less likely to break. In particular, when the accommodating portion 26 has a shape that maximizes the diameter at the opening 27, it is easy to accommodate the content, but the strength near the proximal end portion of the needle-like portion 20 is weakened. Cheap. On the other hand, if the thickness of the needle-like portion 20 increases toward the base end portion, it is possible to suppress a decrease in strength near the base end portion of the needle-like portion 20 due to the shape of the housing portion 26 .
 一方、生体への針状部20の刺さりやすさを高める観点では、針状部20を生体に刺したときに針状部20の先端部が変形し難いことが好ましく、すなわち、針状部20の先端部の強度が高いことが好ましい。こうした観点では、収容孔25は、針状部20の先端部まで延びていないことが好ましい。例えば、針状部20の先端から、針状部20の全長の1/10、望ましくは1/3の領域には、収容孔25が配置されていないことが好ましい。 On the other hand, from the viewpoint of increasing the ease with which the needle-like portion 20 sticks into the living body, it is preferable that the tip portion of the needle-like portion 20 is difficult to deform when the needle-like portion 20 is stuck into the living body. It is preferable that the strength of the tip portion of is high. From this point of view, it is preferable that the accommodation hole 25 does not extend to the tip of the needle-like portion 20 . For example, it is preferable that the accommodation hole 25 is not arranged in a region of 1/10, preferably 1/3 of the total length of the needle-like portion 20 from the tip of the needle-like portion 20 .
 図24が示すように、収容孔25の径は、収容孔25の深さ方向の中央部にて最大になっていてもよく、同様に、収容部26の径は、収容部26の深さ方向の中央部にて最大になっていてもよい。こうした形態であれば、移植物の収容される空間を広く確保しやすい。 As shown in FIG. 24 , the diameter of the accommodation hole 25 may be maximum at the central portion of the accommodation hole 25 in the depth direction. It may be maximum in the central part of the direction. With such a form, it is easy to secure a wide space for accommodating the implant.
 図25が示すように、収容孔25および収容部26の各々は、漏斗状の形状を有していてもよい。すなわち、収容孔25および収容部26の各々の径は、開口部27の位置する端部から徐々に小さくなった後、一定となる。図25が示す例では、収容孔25および収容部26の各々の径は、一定となった後、さらに、底部に向けて小さくなる。 As shown in FIG. 25, each of the accommodation hole 25 and the accommodation portion 26 may have a funnel shape. That is, the diameter of each of the accommodation hole 25 and the accommodation portion 26 becomes constant after gradually decreasing from the end where the opening 27 is located. In the example shown in FIG. 25, the diameter of each of the accommodation hole 25 and the accommodation portion 26 becomes constant and then decreases toward the bottom.
 こうした形態であれば、図26が示すように、ノズルやピペット等の注入器具60を用いて収容物を収容部26に入れる場合に、収容部26内における開口部27の付近に注入器具60の先端を向けて収容物を注入することにより、収容物の飛散が抑えられ、収容物を収容部26に円滑に収容することができる。 With such a configuration, as shown in FIG. 26 , when an injection device 60 such as a nozzle or a pipette is used to put a contained object into the container 26 , the injection device 60 is placed near the opening 27 in the container 26 . By injecting the content with the tip pointed, scattering of the content can be suppressed and the content can be smoothly accommodated in the accommodation section 26 .
 また、収容孔25や収容部26の内側面の表面粗さが、針状部20の表面の表面粗さよりも大きくされていてもよい。収容孔25の内側面の表面粗さが、針状部20の表面の表面粗さよりも大きければ、収容孔25の内側面の表面粗さが針状部20の表面と同等である場合と比較して、非水溶部28が収容孔25の内側面から剥がれにくくなる。また、非水溶部28の材料を収容孔25の内側面に塗布した場合に、収容孔25の内側面に材料が付きやすくなる。それゆえ、非水溶部28の材料の選択やコーティングの条件の設定の自由度が高められる。 Further, the surface roughness of the inner surface of the accommodation hole 25 and the accommodation portion 26 may be made larger than the surface roughness of the surface of the needle-like portion 20 . If the surface roughness of the inner surface of the accommodation hole 25 is greater than the surface roughness of the surface of the needle-shaped portion 20, compared with the case where the surface roughness of the inner surface of the accommodation hole 25 is equal to the surface of the needle-shaped portion 20. As a result, the non-water-soluble portion 28 is less likely to peel off from the inner surface of the accommodation hole 25 . Further, when the material of the non-water-soluble portion 28 is applied to the inner surface of the accommodation hole 25 , the material tends to adhere to the inner surface of the accommodation hole 25 . Therefore, the degree of freedom in selecting the material for the water-insoluble portion 28 and setting the coating conditions is increased.
 また、収容部26の内側面の表面粗さが、針状部20の表面の表面粗さよりも大きければ、収容部26の内側面の表面粗さが針状部20の表面と同等である場合と比較して、移植物が収容部26の内側面に引っ掛りやすくなる。したがって、収容された移植物が収容部26から外部へ出ることが抑えられる。 Further, if the surface roughness of the inner surface of the accommodating portion 26 is greater than the surface roughness of the surface of the needle-shaped portion 20, the surface roughness of the inner surface of the accommodating portion 26 is equivalent to the surface of the needle-shaped portion 20. , the implant is more likely to get caught on the inner surface of the housing part 26 . Therefore, the housed implant is prevented from coming out of the housing part 26 .
 収容孔25や収容部26の内側面の表面粗さは、例えば、製造時に使用するピン状の構造体の表面粗さや、非水溶部28の塗布方法によって調整することができる。
 図27が示すように、非水溶部28は、流体であって、収容孔25内に充填されていてもよい。この場合、収容孔25によって区画される領域が収容部26であり、移植物50は、収容部26内において非水溶部28にその全体を取り囲まれ、非水溶部28に接している。非水溶部28は、移植物50の収容前に収容孔25に充填されていてもよいし、移植物50と同時に収容孔25内に入れられてもよい。
The surface roughness of the inner surface of the accommodation hole 25 and the accommodation portion 26 can be adjusted, for example, by the surface roughness of the pin-shaped structure used in manufacturing and the coating method of the water-insoluble portion 28 .
As shown in FIG. 27 , the water-insoluble portion 28 may be fluid and filled in the accommodation hole 25 . In this case, the area defined by the accommodation hole 25 is the accommodation portion 26 , and the implant 50 is entirely surrounded by the water-insoluble portion 28 in the accommodation portion 26 and is in contact with the water-insoluble portion 28 . The water-insoluble portion 28 may be filled into the accommodation hole 25 before the implant 50 is accommodated, or may be put into the accommodation hole 25 simultaneously with the implant 50 .
 こうした形態においても、収容孔25の内側面は、非水溶部28によって覆われているため、移植物50と収容孔25の内側面との接触を抑えることができる。したがって、移植物50に水分が含まれる場合に、針状部20を生体に刺す前に針状部20が内側から溶解してしまうことが抑えられる。生体内において、非水溶部28が移植物50を囲んでいる状態が崩れるように非水溶部28の占有領域が変化することが、非水溶部28の変形である。 Even in this form, the inner surface of the accommodation hole 25 is covered with the non-water-soluble portion 28, so contact between the implant 50 and the inner surface of the accommodation hole 25 can be suppressed. Therefore, when the implant 50 contains moisture, the dissolution of the needle-like portion 20 from the inside is suppressed before the needle-like portion 20 is pierced into the living body. In vivo, deformation of the non-water-soluble portion 28 is a change in the area occupied by the non-water-soluble portion 28 so that the state in which the non-water-soluble portion 28 surrounds the implant 50 is broken.
 [その他の変形例]
 収容デバイス15は、複数の針状部20を備え、各針状部20に移植物50が収容されてもよい。これにより、複数の移植物50をまとめて生体内に配置することができる。複数の針状部20は、例えば、1つの基板部23によって繋がれていてもよい。
[Other Modifications]
The containment device 15 may comprise a plurality of needles 20 each containing an implant 50 . Thereby, a plurality of implants 50 can be collectively placed in the living body. A plurality of needle-like portions 20 may be connected by one substrate portion 23, for example.
 収容孔25および収容部26は、針状部20の側面に開口していてもよい。収容部26が針状部20の側面に開口していると、開口面積や移植物50の配置深さの調整に関する自由度の向上が可能である。一方、収容部26が針状部20の基端に開口していれば、移植物50の収容が容易であり、また、針状部20の強度を確保しやすい。特に、収容デバイス15が複数の針状部20を備える場合には、収容部26が針状部20の基端に開口していると、各針状部20に移植物50を効率的に収容することができる。 The accommodation hole 25 and the accommodation portion 26 may be opened on the side surface of the needle-like portion 20 . When the receiving portion 26 is open on the side surface of the needle-like portion 20, the degree of freedom regarding adjustment of the opening area and the placement depth of the implant 50 can be improved. On the other hand, if the accommodating part 26 is open at the proximal end of the needle-like part 20, the implant 50 can be easily accommodated, and the strength of the needle-like part 20 can be easily ensured. In particular, when the containment device 15 has a plurality of needle-like portions 20 , if the containment portion 26 is open at the proximal end of the needle-like portion 20 , the implant 50 can be efficiently contained in each needle-like portion 20 . can do.
 なお、非水溶部28を針状部20を構成する部材の一部と捉える場合、非水溶部28は、第2実施形態の油性部22の一例であり、非水溶部28以外の針状部20の部分は、第2実施形態の水溶性部21の一例であると捉えることもできる。 Note that when the non-water-soluble portion 28 is regarded as a part of the member that constitutes the needle-shaped portion 20, the non-water-soluble portion 28 is an example of the oily portion 22 of the second embodiment, and the needle-shaped portion other than the non-water-soluble portion 28 is used. The portion 20 can also be regarded as an example of the water-soluble portion 21 of the second embodiment.
 以上、第3実施形態によれば、以下に列挙する効果を得ることができる。
 (21)針状部20内に移植物50が収容され、生体を刺した針状部20が生体内で溶解するとともに、非水溶部28が生体内で変形して移植物50が露出されることにより、生体内に移植物50が配置される。したがって、生体内への移植物50の配置に際して生体内からの器具の引き抜きが発生しないため、移植物50が器具と共に生体内から抜け出ることが抑えられる。これにより、移植物50の配置の効率も高められる。
As described above, according to the third embodiment, the following effects can be obtained.
(21) The implant 50 is accommodated in the needle-like portion 20, and the needle-like portion 20 piercing the living body dissolves in the living body, and the non-water-soluble portion 28 deforms in the living body to expose the implant 50. The implant 50 is thereby placed in the living body. Therefore, since the device is not pulled out from the living body when the implant 50 is placed in the living body, it is possible to prevent the implant 50 from coming out of the living body together with the device. This also increases the efficiency of implant 50 placement.
 (22)収容孔25の内側面が非水溶部28で覆われており、移植物50が非水溶部28で囲まれるため、移植物50を含む収容部26への収容物が収容孔25の内側面に接触することが抑えられる。そのため、収容物が水分を含んでいる場合であっても、生体へ針状部20を刺す前に針状部20が内側から溶解することを抑えることができる。 (22) Since the inner surface of the accommodation hole 25 is covered with the water-insoluble portion 28 and the implant 50 is surrounded by the water-insoluble portion 28, the contents of the accommodation portion 26 including the implant 50 are Contact with the inner surface is suppressed. Therefore, even when the content contains water, it is possible to prevent needle-like portion 20 from dissolving from the inside before stabbing needle-like portion 20 into the living body.
 (23)非水溶部28が、収容孔25の内側面を被覆する膜状を有し、非水溶部28の内側に、移植物50を収容する領域である収容部26が区画される。こうした構成によれば、移植物50の保護等のための流体を移植物50と共に収容することや、流体である対象物を収容することができる。 (23) The non-water-soluble portion 28 has a film-like shape that covers the inner surface of the accommodation hole 25 , and the inside of the water-insoluble portion 28 defines a storage portion 26 that is a region that stores the implant 50 . According to such a configuration, a fluid for protecting the implant 50 or the like can be accommodated together with the implant 50, or an object that is a fluid can be accommodated.
 (24)非水溶部28が収容孔25内に充填されている形態であれば、非水溶性の流体によって保護されることの望まれる移植物50を、当該流体として機能する非水溶部28に囲まれた状態で収容することができる。 (24) If the water-insoluble portion 28 is filled in the accommodation hole 25, the implant 50 desired to be protected by the water-insoluble fluid is placed in the water-insoluble portion 28 functioning as the fluid. It can be contained in an enclosed state.
 (25)収容孔25および収容部26が針状部20の基端に開口している形態であれば、移植物50の収容が容易であり、また、針状部20の強度を確保しやすい。また、針状部20を生体に刺す直前に、移植物50を収容部26に入れることもできる。 (25) If the accommodating hole 25 and the accommodating portion 26 are open at the proximal end of the needle portion 20, the implant 50 can be easily accommodated, and the strength of the needle portion 20 can be easily ensured. . Alternatively, the implant 50 can be placed in the housing portion 26 immediately before the needle-like portion 20 is pierced into the living body.
 (26)収容デバイス15が、収容孔25および収容部26の開口を閉塞可能に構成された封止部40を備える形態であれば、収容部26に収容された収容物が開口から漏れ出ることが抑えられる。また、生体内への移植物50の配置後にも、針状部20の進入により形成された傷が封止部40によって塞がれるため、生体内からの移植物50の脱離が抑えられる。 (26) If the containing device 15 is provided with a sealing portion 40 configured to be able to block the openings of the containing hole 25 and the containing portion 26, the contents contained in the containing portion 26 will not leak from the openings. is suppressed. In addition, even after the implant 50 is placed in the living body, the sealing part 40 closes the wound formed by the entry of the needle-like part 20, so that the implant 50 is prevented from being detached from the living body.
 (27)収容デバイス15が、針状部20の基端部を支持する基板部23を備える形態であれば、収容デバイス15の運搬時や針状部20が生体を刺す際に他の器具等で収容デバイス15を保持することが容易である。また、針状部20に収容物を収容する際に、収容物が針状部20の表面に付着することが抑えられる。したがって、収容物が水分を含んでいる場合であっても、生体へ針状部20を刺す前に針状部20が溶解することを抑えることができる。 (27) If the containing device 15 is provided with the substrate portion 23 that supports the base end portion of the needle-like portion 20, other instruments or the like may be used when the containing device 15 is transported or when the needle-like portion 20 pierces the living body. It is easy to hold the containment device 15 with the Moreover, when accommodating the content in the needle-like portion 20 , the content is prevented from adhering to the surface of the needle-like portion 20 . Therefore, even when the content contains water, dissolution of the needle-like portion 20 before the needle-like portion 20 is pierced into the living body can be suppressed.
 (28)非水溶部28が、収容孔25の内側面上から基板部23の第2面23R上に連続して広がっている形態であれば、針状部20に収容物を収容する際に、収容物が基板部23に付着することが抑えられる。したがって、収容物が水分を含んでいる場合であっても、生体へ針状部20を刺す前に基板部23が溶解することを抑えることができる。 (28) If the non-water-soluble portion 28 extends continuously from the inner surface of the accommodation hole 25 to the second surface 23R of the substrate portion 23, when the needle-like portion 20 accommodates the content, , the contents are prevented from adhering to the substrate portion 23 . Therefore, even if the content contains water, it is possible to prevent the substrate portion 23 from dissolving before the needle-like portion 20 is pierced into the living body.
 (29)非水溶部28が、生体内の温度に起因して生体内で融解する性質を有していれば、生体内での非水溶部28の変形が好適に進む。したがって、生体内に移植物50が的確に配置される。 (29) If the water-insoluble portion 28 has the property of being melted in the living body due to the temperature in the living body, the deformation of the water-insoluble portion 28 in the living body proceeds favorably. Therefore, the implant 50 is accurately placed in the living body.
 (30)細胞群を含む移植物50には、水分が含まれる。したがって、非水溶部28を配置することによる効果の有益性が高く得られる。また、収容部26に、移植物50と共に水性材料を含む流体が収容される場合にも、非水溶部28を配置することによる効果の有益性が高く得られる。 (30) The implant 50 containing the cell group contains water. Therefore, the beneficial effect of arranging the water-insoluble portion 28 is highly obtained. In addition, even when fluid containing an aqueous material is accommodated in the accommodation portion 26 together with the implant 50, the effect of arranging the water-insoluble portion 28 is highly beneficial.
 (第1~第3実施形態の変形例)
 上記各実施形態において、収容デバイスに収容される対象物は、移植物50に限らず、薬剤や、ICチップ等の部材であってもよい。また、対象物は、液体、固体、ゲル状物のいずれであってもよいし、これらの混合物であってもよい。なお、対象物が収容された収容デバイスが収容ユニットであり、細胞移植ユニットは収容ユニットの一例である。
(Modifications of the first to third embodiments)
In each of the above embodiments, the object to be housed in the housing device is not limited to the implant 50, and may be a member such as a medicine or an IC chip. The object may be liquid, solid, gel, or a mixture thereof. The containing device containing the object is the containing unit, and the cell transplantation unit is an example of the containing unit.
 (実施例)
 [試験例1~12]
 上述した収容デバイスについて、針状部の試験例を作製し、針状部の成形性および溶ける速さを評価する試験を実施した。なお、試験例の針状部は、第1実施形態の針状部に対応する。
(Example)
[Test Examples 1 to 12]
A test example of the needle-shaped portion was produced for the above-described containing device, and a test was conducted to evaluate the moldability and melting speed of the needle-shaped portion. In addition, the acicular part of the test example corresponds to the acicular part of the first embodiment.
 (試験例1)
 40℃に温めたマグネチックスターラー上にて、熱導電性のある容器に入れたプルラン水溶液にパーム油を添加し、スターラーバーを用いて10分間混合することにより、針状部の形成のための液体である針状部形成液を作製した。プルランが水溶性材料であり、パーム油が油性材料である。針状部形成液が含むプルランおよびパーム油の総質量に対するパーム油の割合は、50質量%である。なお、パーム油は、クリーンオーブンなどの加熱装置内で加温し、液体状に溶解させてから用いた。
(Test example 1)
On a magnetic stirrer heated to 40 ° C., add palm oil to an aqueous pullulan solution in a thermally conductive container and mix for 10 minutes using a stirrer bar to form a needle-shaped part. A liquid needle-like portion forming liquid was prepared. Pullulan is a water-soluble material and palm oil is an oily material. The ratio of palm oil to the total mass of pullulan and palm oil contained in the needle-forming liquid was 50% by mass. The palm oil was used after being heated in a heating device such as a clean oven and dissolved in a liquid state.
 四角錐形状の凹部を有する凹版を用意し、針状部形成液を凹部に充填した。凹部の開口面は1辺が800μmの正方形形状を有し、凹部の深さは1.8mmである。さらに、凹部上にも針状部形成液を広げることで、支持板部に対応する部分を形成した。そして、この針状部形成液の充填された凹版を、温度25℃、湿度30%の環境で、72時間、通風しつつ乾燥した。これにより、凹部の充填物である針状部、および、支持板部が形成された。 An intaglio plate having quadrangular pyramid-shaped recesses was prepared, and the recesses were filled with the needle-shaped portion forming liquid. The opening surface of the recess has a square shape with one side of 800 μm, and the depth of the recess is 1.8 mm. Furthermore, the portion corresponding to the support plate portion was formed by spreading the needle-shaped portion forming liquid over the concave portion as well. Then, the intaglio plate filled with the needle-shaped portion forming liquid was dried in an environment of 25° C. temperature and 30% humidity for 72 hours while being ventilated. As a result, the needle-like portion, which is the filling material for the recess, and the support plate portion were formed.
 続いて、支持板部を把持して凹版から針状部を離型することによって、試験例1の針状部を得た。
 (試験例2)
 針状部形成液におけるパーム油の割合を変更したこと以外は、試験例1と同様の材料および工程によって試験例2の針状部を得た。試験例2における針状部形成液でのパーム油の割合は、10質量%である。
Subsequently, the needle-like portion of Test Example 1 was obtained by holding the support plate portion and releasing the needle-like portion from the intaglio.
(Test example 2)
Needles of Test Example 2 were obtained using the same materials and processes as those of Test Example 1, except that the proportion of palm oil in the needle-like portion-forming liquid was changed. The proportion of palm oil in the needle-shaped portion-forming liquid in Test Example 2 was 10% by mass.
 (試験例3)
 針状部形成液におけるパーム油の割合を変更したこと以外は、試験例1と同様の材料および工程によって試験例3の針状部を得た。試験例3における針状部形成液でのパーム油の割合は、1質量%である。
(Test example 3)
Needles of Test Example 3 were obtained using the same materials and processes as in Test Example 1, except that the proportion of palm oil in the needle-shaped portion-forming liquid was changed. The proportion of palm oil in the needle-shaped portion-forming liquid in Test Example 3 was 1% by mass.
 (試験例4)
 針状部形成液に、添加剤として界面活性剤であるショ糖脂肪酸エステルを加えたこと以外は、試験例1と同様の材料および工程によって試験例4の針状部を得た。試験例4における針状部形成液でのショ糖脂肪酸エステルの割合は、1質量%である。
(Test example 4)
Needles of Test Example 4 were obtained using the same materials and processes as in Test Example 1, except that a sucrose fatty acid ester, which is a surfactant, was added as an additive to the needle-like portion-forming liquid. The ratio of the sucrose fatty acid ester in the needle-shaped portion-forming liquid in Test Example 4 was 1% by mass.
 (試験例5)
 針状部形成液に、添加剤として界面活性剤であるショ糖脂肪酸エステルを加えたこと以外は、試験例1と同様の材料および工程によって試験例5の針状部を得た。試験例5における針状部形成液でのショ糖脂肪酸エステルの割合は、0.1質量%である。
(Test Example 5)
Needles of Test Example 5 were obtained using the same materials and processes as in Test Example 1, except that a surfactant, sucrose fatty acid ester, was added as an additive to the needle-like portion-forming solution. The ratio of the sucrose fatty acid ester in the needle-shaped portion-forming liquid in Test Example 5 was 0.1% by mass.
 (試験例6)
 油性材料としてワセリンを用いたこと、および、針状部形成液に、添加剤として界面活性剤であるショ糖脂肪酸エステルを加えたこと以外は、試験例1と同様の材料および工程によって試験例6の針状部を得た。試験例6の針状部形成液において、ワセリンの割合は67質量%であり、ショ糖脂肪酸エステルの割合は、1質量%である。
(Test example 6)
Test Example 6 was performed using the same materials and processes as in Test Example 1, except that petrolatum was used as the oily material, and sucrose fatty acid ester, which is a surfactant, was added as an additive to the needle-shaped portion-forming liquid. needles were obtained. In the needle-shaped portion-forming liquid of Test Example 6, the percentage of petroleum jelly was 67% by mass, and the percentage of sucrose fatty acid ester was 1% by mass.
 (試験例7)
 針状部形成液におけるワセリンの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例7の針状部を得た。試験例7における針状部形成液でのワセリンの割合は、50質量%である。
(Test Example 7)
A needle-like portion of Test Example 7 was obtained using the same material and process as in Test Example 6, except that the proportion of petroleum jelly in the needle-like portion-forming liquid was changed. The proportion of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 7 was 50% by mass.
 (試験例8)
 針状部形成液におけるワセリンの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例8の針状部を得た。試験例8における針状部形成液でのワセリンの割合は、33質量%である。
(Test Example 8)
A needle-shaped portion of Test Example 8 was obtained using the same material and process as in Test Example 6, except that the proportion of petroleum jelly in the needle-shaped portion-forming liquid was changed. The ratio of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 8 was 33% by mass.
 (試験例9)
 針状部形成液におけるワセリンの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例9の針状部を得た。試験例9における針状部形成液でのワセリンの割合は、10質量%である。
(Test Example 9)
A needle-shaped portion of Test Example 9 was obtained using the same material and process as in Test Example 6, except that the proportion of petrolatum in the needle-shaped portion-forming liquid was changed. The proportion of petroleum jelly in the needle-shaped portion-forming liquid in Test Example 9 was 10% by mass.
 (試験例10)
 針状部形成液におけるワセリンおよびショ糖脂肪酸エステルの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例10の針状部を得た。試験例10の針状部形成液において、ワセリンの割合は50質量%であり、ショ糖脂肪酸エステルの割合は、5質量%である。
(Test Example 10)
Needles of Test Example 10 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 10, the percentage of petroleum jelly was 50% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
 (試験例11)
 針状部形成液におけるワセリンおよびショ糖脂肪酸エステルの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例11の針状部を得た。試験例11の針状部形成液において、ワセリンの割合は30質量%であり、ショ糖脂肪酸エステルの割合は、5質量%である。
(Test Example 11)
Needles of Test Example 11 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 11, the percentage of petrolatum was 30% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
 (試験例12)
 針状部形成液におけるワセリンおよびショ糖脂肪酸エステルの割合を変更したこと以外は、試験例6と同様の材料および工程によって試験例12の針状部を得た。試験例12の針状部形成液において、ワセリンの割合は10質量%であり、ショ糖脂肪酸エステルの割合は、5質量%である。
(Test Example 12)
Needles of Test Example 12 were obtained using the same materials and processes as in Test Example 6, except that the proportions of petrolatum and sucrose fatty acid ester in the needle-like portion-forming liquid were changed. In the needle-shaped portion-forming liquid of Test Example 12, the percentage of petroleum jelly was 10% by mass, and the percentage of sucrose fatty acid ester was 5% by mass.
 (成形性評価)
 <離型性>
 各試験例について、針状部を凹版から剥離するように離型を実施し、離型の容易性を3段階で評価した。評価では、凹版からの針状部の剥離が困難であって、針状部が複数の部分に分裂するサンプルが生じた場合を1点、凹版からの針状部の剥離が可能であるが、針状部の一部が欠けたサンプルが1割を超える割合で生じた場合を2点、凹版から針状部の剥離が可能であって、9割以上のサンプルについて欠けのない針状部が得られた場合を3点とした。
(Moldability evaluation)
<Releasability>
For each test example, mold release was performed so as to separate the needle-like portion from the intaglio plate, and ease of mold release was evaluated on a three-grade scale. In the evaluation, when it was difficult to peel the needle-like portion from the intaglio, and a sample in which the needle-like portion was split into a plurality of parts was generated, one score was given. 2 points when more than 10% of the samples were partially chipped, and 90% or more of the samples had no chipped needles if the needles could be peeled off from the intaglio. The case where it was obtained was set as 3 points.
 <追従性>
 各試験例について、針状部の形状を観察して、凹部の形状への針状部の形状の追従性を3段階で評価した。評価では、凹部に針状部形成液が入り込まず、針状部である突起が形成されていないサンプルが生じた場合を1点、針状部の形状が凹部の形状と異なるサンプルが1割を超える割合で生じた場合を2点、9割以上のサンプルについて凹部の形状に一致した形状の針状部が得られた場合を3点とした。なお、凹部の形状と異なる針状部には、凹部よりも小さいあるいは大きい針状部、および、気泡の含有等により表面に凹凸が形成されていて凹部に沿った表面が得られていない針状部が含まれる。
<Followability>
For each test example, the shape of the needle-like portion was observed, and the followability of the shape of the needle-like portion to the shape of the concave portion was evaluated in three stages. In the evaluation, 1 point was obtained when the needle-shaped part-forming liquid did not enter the concave part, and a sample in which the needle-shaped part was not formed was formed. A score of 2 was given when it occurred at a rate exceeding 3, and a score of 3 was given when a needle-like portion having a shape matching the shape of the concave portion was obtained for 90% or more of the samples. In addition, the needle-shaped portion different from the shape of the recess includes a needle-shaped portion that is smaller or larger than the recess, and a needle-shaped portion that has unevenness on the surface due to the inclusion of air bubbles or the like and does not have a surface along the recess. part is included.
 <安定性>
 各試験例について、針状部の形状を観察して、複数のサンプルにおける形状の安定性を3段階で評価した。評価では、複数のサンプルにおいて、所望の形状に形成された針状部の割合が50%未満である場合を1点、複数のサンプルにおいて、所望の形状に形成された針状部の割合が50%以上85%未満である場合を2点、複数のサンプルにおいて、所望の形状に形成された針状部の割合が85%以上である場合を3点とした。所望の形状の針状部は、欠けがなくかつ凹部の形状に一致した針状部である。
<Stability>
For each test example, the shape of the needle-like portion was observed, and the stability of the shape in a plurality of samples was evaluated on a three-grade scale. In the evaluation, in a plurality of samples, 1 point when the ratio of needle-like portions formed in the desired shape is less than 50%, and in a plurality of samples, the ratio of needle-like portions formed in the desired shape is 50. % or more and less than 85% was given 2 points, and a case where the ratio of needle-like portions formed in a desired shape in a plurality of samples was 85% or more was given 3 points. The desired shape of the needle-like portion is a needle-like portion that has no chipping and matches the shape of the recess.
 (形状消失速度評価)
 各試験例の針状部を水に浸けて、針状部の形状が失われるまで、すなわち針状部が完全に溶けるまでに要する時間を計測した。評価では、計測結果が3分以上4分未満である場合を1点、計測結果が4分以上である場合を2点とした。なお、試験例4,5,6,10,11,12については、所望の形状の針状部が得られていない、もしくは、針状部が脆く、形状を保ったまま針状部を水に浸ける試験を実施することが困難であったため、形状の消失速度の計測を行っていない。
(Evaluation of shape disappearance rate)
The needle-shaped portion of each test example was immersed in water, and the time required for the needle-shaped portion to lose its shape, that is, until the needle-shaped portion was completely dissolved, was measured. In the evaluation, 1 point was given when the measurement result was 3 minutes or more and less than 4 minutes, and 2 points were given when the measurement result was 4 minutes or more. In Test Examples 4, 5, 6, 10, 11, and 12, the desired shape of the needle-like portion was not obtained, or the needle-like portion was brittle and the needle-like portion was soaked in water while maintaining its shape. Due to the difficulty of conducting the immersion test, the shape disappearance rate was not measured.
 なお、参考例として、プルラン水溶液を針状部形成液として用いて試験例1と同様の工程により針状部を作製した。参考例の針状部は、油性材料および添加剤を含まず、水溶性材料のみから形成されている。参考例の針状部を水に浸けて形状が失われるまでに要する時間を計測したところ、計測結果は1分程度であった。 As a reference example, a needle-like portion was produced by the same process as in Test Example 1 using an aqueous pullulan solution as a needle-like portion-forming liquid. The needle-shaped portion of the reference example does not contain an oily material or additives, and is formed only from a water-soluble material. When the needle-shaped portion of the reference example was soaked in water and the time required for the needle-like portion to lose its shape was measured, the measurement result was about 1 minute.
 (評価結果)
 表1に、各試験例について、油性材料の種類、油性材料の割合、添加剤の割合、成形性評価および形状消失速度評価の評価結果、総合評価を示す。総合評価は、各評価の点数の合計である。
(Evaluation results)
Table 1 shows the type of oily material, the proportion of oily material, the proportion of additive, evaluation results of formability evaluation and shape disappearance rate evaluation, and overall evaluation for each test example. Comprehensive evaluation is the sum of the points of each evaluation.
Figure JPOXMLDOC01-appb-T000001
 表1が示すように、油性材料の割合、および、界面活性剤の添加の有無と添加量に応じて、針状部の成形の容易性が変わる。全体として、油性材料の割合が小さい方が、針状部の成形性が高められる傾向がある。油性材料がパーム油の場合は、成形性の向上に対するショ糖脂肪酸エステルの寄与は確認できなかった。一方、油性材料がワセリンの場合、ショ糖脂肪酸エステルの添加によって針状部形成液へのワセリンの混合が容易になり、また、ショ糖脂肪酸エステルの添加割合が1質量%程度であると、良好な成形性が得られやすい傾向が確認された。
Figure JPOXMLDOC01-appb-T000001
As shown in Table 1, the easiness of forming the needle-like portion varies depending on the ratio of the oily material and whether or not the surfactant is added and the amount of surfactant added. As a whole, there is a tendency that the smaller the ratio of the oily material, the higher the formability of the needle-shaped portion. When the oily material was palm oil, the contribution of the sucrose fatty acid ester to the improvement of moldability could not be confirmed. On the other hand, when the oily material is petrolatum, the addition of the sucrose fatty acid ester facilitates the mixing of the petrolatum with the needle-like portion-forming liquid, and the addition ratio of the sucrose fatty acid ester of about 1% by mass is favorable. It was confirmed that there is a tendency that good moldability is easily obtained.
 また、形状の消失速度については、計測を実施したいずれの試験例においても、水溶性材料のみからなる参考例の針状部と比較して、形状の消失に要する時間が長くなる、すなわち針状部の溶ける速さが遅くなることが確認された。
 総合評価が8点以上であると、各評価に関わる特性をバランスよく備える針状部であると言えるため、好ましい。
Further, regarding the disappearance rate of the shape, in all test examples in which measurement was performed, the time required for the disappearance of the shape was longer than that of the needle-shaped portion of the reference example made of only the water-soluble material. It was confirmed that the melting speed of the part slowed down.
A total evaluation of 8 points or more is preferable because it can be said that the acicular portion has well-balanced characteristics related to each evaluation.
 [実施例1] 
 第3実施形態の収容デバイスおよび細胞移植ユニットについて、具体的な実施例を用いて説明する。
[Example 1]
The accommodation device and cell transplantation unit of the third embodiment will be described using specific examples.
 (製造方法)
 四角錐形状の凹部を有する型を用意し、針状部の形成のための溶液として、プルラン水溶液を凹部に滴下した。そして、このプルラン水溶液の充填された型を、温度25℃、湿度30%の環境で、72時間、通風しつつ乾燥した。乾燥が進むにつれて、型の濡れ性とプルラン水溶液の表面張力とのバランスに起因して、凹部の充填物の内部に空洞が成長する。乾燥が完了した後、充填物を離型することにより、上記空洞である収容孔を有する針状部が得られた。針状部の基端に位置する面は1辺が500μmの正方形形状を有し、針状部の長さは1.8mmである。
(Production method)
A mold having quadrangular pyramid-shaped concave portions was prepared, and an aqueous pullulan solution was dropped into the concave portions as a solution for forming the needle-like portions. Then, the mold filled with the pullulan aqueous solution was dried in an environment of temperature 25° C. and humidity 30% for 72 hours while being ventilated. As drying progresses, cavities grow inside the filling of the recesses due to the balance between the wettability of the mold and the surface tension of the aqueous pullulan solution. After the drying was completed, the filling was released from the mold to obtain a needle-like portion having the above-mentioned hollow accommodation hole. The face located at the proximal end of the needle-like portion has a square shape with a side of 500 μm, and the length of the needle-like portion is 1.8 mm.
 続いて、収容孔内に脂肪酸グリセリドを塗布することによって膜状の非水溶部を形成した。これにより、非水溶部によって区画された収容部が形成され、実施例1の収容デバイスが得られた。マイクロスコープを用いて収容部の開口部の径を計測した。その結果、開口部の径は300μmであった。 Subsequently, a film-like water-insoluble portion was formed by applying fatty acid glyceride inside the accommodation hole. As a result, storage portions partitioned by water-insoluble portions were formed, and the storage device of Example 1 was obtained. The diameter of the opening of the container was measured using a microscope. As a result, the diameter of the opening was 300 μm.
 (機能試験)
 実施例1の収容デバイスの収容部に着色した水を注入し、経過を観察したところ、10分経過しても針状部の外形は変化せず、針状部の溶解は確認されなかった。また、37℃に保温したアガロースゲルに、針状部を刺して、経過を観察したところ、針状部は速やかに溶解し、アガロースゲルの内部に、変形した非水溶部からなる籠状の構造が確認された。さらに、針状部を刺してから30分経過後には、非水溶部の変形が進んで液状になっていることが確認された。
(Functional test)
Colored water was injected into the storage portion of the storage device of Example 1, and the progress was observed. The appearance of the needle-like portion did not change even after 10 minutes, and dissolution of the needle-like portion was not confirmed. In addition, when the agarose gel kept at 37° C. was pierced with the needle-like part and the progress was observed, the needle-like part dissolved rapidly, and a cage-like structure consisting of the deformed water-insoluble part was formed inside the agarose gel. was confirmed. Furthermore, it was confirmed that the deformation of the non-water-soluble portion proceeded and became liquid 30 minutes after the needle-like portion was pricked.
 (収容試験)
 丸底の96ウェルプレートの各ウェルに、4×10cellsのヒト毛乳頭細胞を播種し3日間培養した。これにより、各ウェル内に細胞塊が形成された。形成された細胞塊の直径は、約300μmであった。
(Containment test)
4×10 3 cells of human dermal papilla cells were seeded in each well of a round-bottomed 96-well plate and cultured for 3 days. This resulted in the formation of cell clumps in each well. The diameter of the formed cell mass was about 300 µm.
 実施例1の収容デバイスの収容部内に、補助液としてリン酸緩衝液をチューブを用いて注入した。さらに、マイクロピペットを用いて、細胞塊を収容部の開口部内に滴下した。開口部を上に配置した状態で収容デバイスを放置すると、重力によって細胞塊は収容部の内部に沈んでいった。なお、開口部の径よりも大きい細胞塊は、重力のみの作用では収容部内に入っていかないため、卓上遠心機を用いて収容デバイスに遠心処理を行うことで、細胞塊を収容部内に沈めた。遠心処理の回転数は5000rpm、処理時間は60秒間である。 A phosphate buffer solution was injected as an auxiliary liquid into the housing portion of the housing device of Example 1 using a tube. Furthermore, using a micropipette, the cell mass was dropped into the opening of the container. When the containing device was left with the opening facing upward, the cell clusters sank into the containing part due to gravity. Since cell masses larger than the diameter of the opening do not enter the storage unit by the action of gravity alone, the storage device was subjected to centrifugation using a desktop centrifuge to sink the cell masses into the storage unit. . The centrifugation speed is 5000 rpm, and the treatment time is 60 seconds.
 10個の収容デバイスに上記の方法で細胞塊を入れ、各収容デバイスを外側からマイクロスコープで観察した。実施例1の針状部および非水溶部は透明であるため、外側から細胞塊の位置を確認することができる。観察の結果、9割以上の収容デバイスにおいて、細胞塊が収容部の底部付近に収容されていることが確認された。 Cell clusters were placed in 10 storage devices by the above method, and each storage device was observed from the outside with a microscope. Since the acicular part and the water-insoluble part of Example 1 are transparent, the position of the cell mass can be confirmed from the outside. As a result of observation, it was confirmed that in 90% or more of the containing devices, the cell mass was contained near the bottom of the containing portion.
 その後、細胞塊を収容した収容デバイスを、37℃に保温した液体培地に浸漬することによって、針状部および非水溶部を液状化させて、細胞塊を回収した。針状部への収容に起因して細胞塊に損壊が生じているかを確認するために、針状部への収容の前後での細胞塊の大きさを比較した。大きさの比較は、落射式顕微鏡を用いた観察によって所定面に投影された細胞塊の面積の比較により行った。その結果、すべての細胞塊について細胞塊の面積の8割以上が維持されていた。したがって、針状部への収容に起因した細胞塊の損壊は生じていないと結論できる。 After that, the storage device containing the cell mass was immersed in a liquid medium kept at 37°C to liquefy the needle-shaped part and the water-insoluble part, and the cell mass was recovered. In order to confirm whether the cell aggregates were damaged due to accommodation in the needle-like portion, the sizes of the cell aggregates before and after accommodation in the needle-like portion were compared. The size comparison was carried out by comparing the areas of the cell clusters projected onto a predetermined surface by observation using an epi-illumination microscope. As a result, 80% or more of the cell aggregate area was maintained for all cell aggregates. Therefore, it can be concluded that the cell aggregates were not damaged due to accommodation in the needle-like portion.

Claims (12)

  1.  生体内への対象物の配置に用いられる収容デバイスであって、
     生体を刺すことが可能な形状を有する針状部を備えた針状体であって、前記対象物を前記針状部の内部に保持するように構成された前記針状体を備え、
     前記針状体の材料には、水溶性材料と水に対して難溶な材料とが含まれる
     収容デバイス。
    A containment device for use in placing an object in vivo, comprising:
    A needle-like body having a needle-like portion having a shape capable of piercing a living body, the needle-like body configured to hold the object inside the needle-like portion,
    The material of the needle-shaped body includes a water-soluble material and a material that is sparingly soluble in water.
  2.  前記針状部は、前記水溶性材料である水溶性高分子を含み、前記対象物を収容するように構成された領域を前記針状部の内部に区画するための収容孔を有し、
     前記針状体は、前記収容孔内で前記対象物が配置される領域を囲む非水溶部であって、前記生体内において前記対象物を露出させるように変形するように構成された前記非水溶部を備え、
     前記非水溶部は、前記水に対して難溶な材料を含む
     請求項1に記載の収容デバイス。
    The needle-like portion includes a water-soluble polymer, which is the water-soluble material, and has an accommodation hole for partitioning a region configured to accommodate the object inside the needle-like portion,
    The needle-shaped body is a water-insoluble portion surrounding a region in which the object is arranged in the accommodation hole, and is configured to deform in the living body so as to expose the object. having a department,
    The containing device according to claim 1, wherein the water-insoluble portion includes a material that is sparingly soluble in the water.
  3.  前記非水溶部は、生体内の温度に起因して前記生体内で融解するように構成されている
     請求項2に記載の収容デバイス。
    3. The containment device of claim 2, wherein the non-aqueous portion is configured to melt in-vivo due to in-vivo temperature.
  4.  前記非水溶部は、前記収容孔の内側面を被覆する膜状を有する
     請求項2または3に記載の収容デバイス。
    The housing device according to claim 2 or 3, wherein the non-water-soluble portion has a film-like shape that covers the inner surface of the housing hole.
  5.  前記収容孔は、前記針状部の基端に開口しており、
     前記収容孔の開口を閉塞可能に構成された封止部を備える
     請求項2~4のいずれか一項に記載の収容デバイス。
    The accommodation hole is open to the proximal end of the needle-like portion,
    The housing device according to any one of claims 2 to 4, further comprising a sealing portion configured to be able to close the opening of the housing hole.
  6.  前記収容デバイスは、前記針状部の基端部を支持する基板部を備え、
     前記基板部は、第1面と、前記第1面とは反対側の面である第2面とを有し、
     前記第1面から前記針状部が延び、
     前記収容孔は、前記第2面に開口し、
     前記非水溶部は、前記収容孔の内側面上から前記第2面上に連続して広がっている
     請求項2~5のいずれか一項に記載の収容デバイス。
    The containment device includes a base portion that supports a proximal end portion of the needle-like portion,
    The substrate portion has a first surface and a second surface opposite to the first surface,
    The needle-like portion extends from the first surface,
    The accommodation hole opens to the second surface,
    The storage device according to any one of claims 2 to 5, wherein the non-water-soluble portion extends continuously from the inner side surface of the storage hole to the second surface.
  7.  前記非水溶部は、油脂および高級アルコールの少なくとも一方を含む
     請求項2~6のいずれか一項に記載の収容デバイス。
    The storage device according to any one of claims 2 to 6, wherein the water-insoluble portion contains at least one of fat and higher alcohol.
  8.  前記対象物を収容するように構成された前記領域には、前記対象物と共に、水性材料を含む流体が収容される
     請求項4に記載の収容デバイス。
    5. The containment device of claim 4, wherein the area configured to contain the object contains a fluid comprising an aqueous material together with the object.
  9.  前記針状部が、前記水溶性材料と前記水に対して難溶な材料である油性材料とを含み、
     前記水溶性材料は、水溶性高分子を含み、
     前記油性材料は、植物油脂、動物油脂、鉱油、および、これらを原料として合成された油脂の少なくとも1つを含む
     請求項1に記載の収容デバイス。
    the needle-shaped portion includes the water-soluble material and the oily material that is a material that is poorly soluble in water;
    The water-soluble material comprises a water-soluble polymer,
    The storage device according to claim 1, wherein the oily material includes at least one of vegetable oil, animal oil, mineral oil, and oil synthesized using these as raw materials.
  10.  前記針状部における前記油性材料の割合は、60質量%以下である
     請求項9に記載の収容デバイス。
    The containing device according to claim 9, wherein the ratio of the oily material in the needle-like portion is 60% by mass or less.
  11.  前記針状部は、前記水溶性材料を含む水溶性部と、前記油性材料を含む油性部とを有する
     請求項9に記載の収容デバイス。
    The containing device according to claim 9, wherein the needle-like portion has a water-soluble portion containing the water-soluble material and an oily portion containing the oily material.
  12.  前記油性部は、前記針状部の表層に位置する
     請求項11に記載の収容デバイス。
    The containing device according to claim 11, wherein the oily portion is located on the surface layer of the needle-like portion.
PCT/JP2022/037681 2021-10-07 2022-10-07 Storage device WO2023058760A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-165598 2021-10-07
JP2021165598A JP2023056312A (en) 2021-10-07 2021-10-07 Containing device and cell transplantation unit

Publications (1)

Publication Number Publication Date
WO2023058760A1 true WO2023058760A1 (en) 2023-04-13

Family

ID=85804373

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/037681 WO2023058760A1 (en) 2021-10-07 2022-10-07 Storage device

Country Status (2)

Country Link
JP (1) JP2023056312A (en)
WO (1) WO2023058760A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010029634A (en) * 2008-07-01 2010-02-12 Kosumedei Seiyaku Kk Microneedle array and method for manufacturing the same
WO2017104144A1 (en) * 2015-12-18 2017-06-22 株式会社ラボ・ジュヴェルサ Microneedle and microneedle patch
US20170189660A1 (en) * 2015-12-30 2017-07-06 Sun Young BAEK Microneedle for inhibiting deformation and degeneration in moisture environment and manufacturing method thereof
JP2018135286A (en) * 2017-02-21 2018-08-30 凸版印刷株式会社 Uneven structure, percutaneous administration device, and percutaneous administration device set
WO2020203674A1 (en) * 2019-03-29 2020-10-08 凸版印刷株式会社 Cell transplantation device and cell transplantation system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010029634A (en) * 2008-07-01 2010-02-12 Kosumedei Seiyaku Kk Microneedle array and method for manufacturing the same
WO2017104144A1 (en) * 2015-12-18 2017-06-22 株式会社ラボ・ジュヴェルサ Microneedle and microneedle patch
US20170189660A1 (en) * 2015-12-30 2017-07-06 Sun Young BAEK Microneedle for inhibiting deformation and degeneration in moisture environment and manufacturing method thereof
JP2018135286A (en) * 2017-02-21 2018-08-30 凸版印刷株式会社 Uneven structure, percutaneous administration device, and percutaneous administration device set
WO2020203674A1 (en) * 2019-03-29 2020-10-08 凸版印刷株式会社 Cell transplantation device and cell transplantation system

Also Published As

Publication number Publication date
JP2023056312A (en) 2023-04-19

Similar Documents

Publication Publication Date Title
EP2130910B1 (en) Method for production of three-dimensional structure of cells
US20200009364A1 (en) Microneedles and compositions for skin augmentation
JP2004517934A (en) Hair follicle formation by injection of hair follicle precursor cells
US9833405B2 (en) Biodegradable microdepot delivery system for topical delivery
Chen et al. Microneedle-based technology for cell therapy: current status and future directions
JP2021516542A (en) Exobibo subcutaneous injection model
WO2023058760A1 (en) Storage device
US20040068284A1 (en) Method for stimulating hair growth and kit for carrying out said method
EP2164536B1 (en) Method for preparing an acellular organic tissue
JP2021509344A (en) Highly loaded microneedles and compositions for skin enhancement
JP2023136623A (en) Transplanting device, and method for manufacturing the same
JP2023136627A (en) Implanting tool
JP2023125342A (en) Storage device and cell transplantation unit
CN105530967B (en) Including the double-needle type syringe that the injection transplantation of cartilage replaces material with body volume and injected for it
CN106176573A (en) A kind of solubility hollow microneedles and preparation method thereof
CN214105569U (en) Device for hair regeneration
KR102005579B1 (en) Porous scaffold for cell culture and preparation method thereof
Rassman et al. Rapid Fire Hair Implanter Carousel. A new surgical instrument for the automation of hair transplantation
WO2022050408A1 (en) Cell transplanting kit, cell transplanting device, and method for taking in transplant
Zheng et al. Organoid‐Loaded Cryomicroneedles for Biomimic Hair Regeneration
JP2022096766A (en) Cell transplantation apparatus, unit for housing cell, method for housing transplant, and transplant arrangement method
JP5748394B2 (en) Acicular body manufacturing method and acicular body
WO2009144569A2 (en) Hydrogel capable of containing and conveying cells
JP2022138356A (en) Needle-like body, cell transplantation unit and use method of cell transplantation unit
JP2023114344A (en) Implantation instrument

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22878627

Country of ref document: EP

Kind code of ref document: A1